Peter Carroll, MD, MPH

Title(s)Professor, Urology
SchoolSchool of Medicine
Address550 16th Street, #001
San Francisco CA 94158
Phone415-353-7171
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency School of Medicine -Urology
    Memorial Sloan Kettering Cancer Center, NY, NY06/1986Urologic Oncology
    University of California, BerkeleyMPH06/2008
    University of California, San Francisco01/2021Diversity, Equity, and Inclusion Champion Training

    Collapse Overview 
    Collapse Overview
    My research interests include identifying clinical and pathologic determinants of prostate cancer detection, recurrence, progression, and mortality; discovering novel biomarkers for prostate cancer diagnostics and prognostics, developing evidence-based guidelines for improved management of prostate cancer including surveillance alone, refining the use and outcomes of robotic surgery for prostate cancer, and examining the impact of lifestyle on prostate cancer induction and progression.

    Collapse Research 
    Collapse Research Activities and Funding
    Effectiveness of Early Stage Prostate Cancer Treatment
    NIH RC1CA146596Sep 30, 2009 - Aug 31, 2012
    Role: Principal Investigator
    UCSF KURe Career Development Program
    NIH K12DK083021Sep 30, 2008 - Jul 31, 2020
    Role: Co-Principal Investigator
    Male Reproductive Health Research Career Development Program
    NIH K12HD053943Sep 30, 2006 - Aug 31, 2012
    Role: Principal Investigator
    Active Surveillance for Early Stage Prostate Cancer: Selection, Monitoring
    NIH R13CA121759May 5, 2006 - Apr 30, 2007
    Role: Principal Investigator
    Molecular Effects of Nutrition Supplements in Prostate
    NIH R01CA101042Jun 10, 2003 - May 31, 2009
    Role: Principal Investigator
    UCSF PROSTATE CANCER SPORE
    NIH P50CA089520Sep 25, 2000 - Jun 30, 2010
    Role: Principal Investigator
    Cancer Center Support Grant
    NIH P30CA082103Aug 5, 1999 - May 31, 2023
    Role: Co-Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Evaluation of URO17® to improve non-invasive detection of bladder cancer. Urol Oncol. 2024 Mar 28. Porten SP, Wang EY, Vohra P, Carroll PR, Jahanfard S, Kim NW. PMID: 38553264.
      View in: PubMed   Mentions:    Fields:    
    2. The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancer. Cancer. 2024 Jan 27. Braun AE, Chan JM, Neuhaus J, Cowan JE, Kenfield SA, Van Blarigan EL, Tenggara I, Broering JM, Simko JP, Carroll PR, Cooperberg MR. PMID: 38280206.
      View in: PubMed   Mentions:    Fields:    
    3. High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker. Sci Rep. 2024 01 04; 14(1):486. Liu S, Hawley SJ, Kunder CA, Hsu EC, Shen M, Westphalen L, Auman H, Newcomb LF, Lin DW, Nelson PS, Feng Z, Tretiakova MS, True LD, Vakar-Lopez F, Carroll PR, Simko J, Gleave ME, Troyer DA, McKenney JK, Brooks JD, Liss MA, Stoyanova T. PMID: 38177207; PMCID: PMC10766957.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative study. BMC Cancer. 2023 Dec 05; 23(1):1191. Guan A, Santiago-Rodríguez EJ, Chung BI, Shim JK, Allen L, Kuo MC, Lau K, Loya Z, Brooks JD, Cheng I, DeRouen MC, Frosch DL, Golden T, Leppert JT, Lichtensztajn DY, Lu Q, Oh D, Sieh W, Wadhwa M, Cooperberg MR, Carroll PR, Gomez SL, Shariff-Marco S. PMID: 38053037; PMCID: PMC10696696.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. The Impact of Delayed Radical Prostatectomy on Recurrence Outcomes After Initial Active Surveillance: Results from a Large Institutional Cohort. Eur Urol Oncol. 2023 Dec 05. Shee K, Cowan JE, Washington SL, Shinohara K, Nguyen HG, Cooperberg MR, Carroll PR. PMID: 38057193.
      View in: PubMed   Mentions:    Fields:    
    6. Delphi consensus project on prostate-specific membrane antigen (PSMA)-targeted surgery-outcomes from an international multidisciplinary panel. Eur J Nucl Med Mol Imaging. 2023 Nov 28. Berrens AC, Scheltema M, Maurer T, Hermann K, Hamdy FC, Knipper S, Dell'Oglio P, Mazzone E, de Barros HA, Sorger JM, van Oosterom MN, Stricker PD, van Leeuwen PJ, Rietbergen DDD, Valdes Olmos RA, Vidal-Sicart S, Carroll PR, Buckle T, van der Poel HG, van Leeuwen FWB. PMID: 38012448.
      View in: PubMed   Mentions:    Fields:    
    7. Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancer. Histopathology. 2024 Mar; 84(4):614-623. Greenland NY, Cowan JE, Stohr BA, Simko JP, Carroll PR, Chan E. PMID: 38012532.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Effect of a Home-based Walking Intervention on Cardiopulmonary Fitness and Quality of Life Among Men with Prostate Cancer on Active Surveillance: The Active Surveillance Exercise Randomized Controlled Trial. Eur Urol Oncol. 2023 Oct 29. Van Blarigan EL, Kenfield SA, Olshen A, Panchal N, Encabo K, Tenggara I, Graff RE, Bang AS, Shinohara K, Cooperberg MR, Carroll PR, Jones LW, Winters-Stone K, Luke A, Chan JM. PMID: 37907387.
      View in: PubMed   Mentions: 2     Fields:    
    9. What is the most effective and safest Non-steroidal anti-inflammatory drug for treating osteoarthritis in patients with comorbidities? Expert Opin Drug Metab Toxicol. 2023 Jul-Dec; 19(10):681-695. Geczy QE, Thirumaran AJ, Carroll PR, McLachlan AJ, Hunter DJ. PMID: 37817419.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer. Eur Urol. 2023 Oct 17. Herlemann A, Cowan JE, Washington SL, Wong AC, Broering JM, Carroll PR, Cooperberg MR. PMID: 37858454.
      View in: PubMed   Mentions: 1     Fields:    
    11. Ten-year work burden after prostate cancer treatment. Cancer Med. 2023 Sep; 12(18):19234-19244. Washington SL, Lonergan PE, Cowan JE, Zhao S, Broering JM, Palmer NR, Hicks C, Cooperberg MR, Carroll PR. PMID: 37724617; PMCID: PMC10557888.
      View in: PubMed   Mentions: 1     Fields:    
    12. Editorial Comment. Urol Pract. 2023 Sep; 10(5):422. Carroll PR. PMID: 37594039.
      View in: PubMed   Mentions:
    13. First-in-human Evaluation of a Prostate-specific Membrane Antigen-targeted Near-infrared Fluorescent Small Molecule for Fluorescence-based Identification of Prostate Cancer in Patients with High-risk Prostate Cancer Undergoing Robotic-assisted Prostatectomy. Eur Urol Oncol. 2024 Feb; 7(1):63-72. Nguyen HG, van den Berg NS, Antaris AL, Xue L, Greenberg S, Rosenthal JW, Muchnik A, Klaassen A, Simko JP, Dutta S, Sorger JM, Munster P, Carroll PR. PMID: 37516587.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Multi-institutional Development and External Validation of a Machine Learning Model for the Prediction of Distant Metastasis in Patients Treated by Salvage Radiotherapy for Biochemical Failure After Radical Prostatectomy. Eur Urol Focus. 2024 Jan; 10(1):66-74. Sabbagh A, Tilki D, Feng J, Huland H, Graefen M, Wiegel T, Böhmer D, Hong JC, Valdes G, Cowan JE, Cooperberg M, Feng FY, Mohammad T, Shelan M, D'Amico AV, Carroll PR, Mohamad O. PMID: 37507248.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Presurgical 68Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial. Eur Urol. 2023 12; 84(6):588-596. Djaïleb L, Armstrong WR, Thompson D, Gafita A, Farolfi A, Rajagopal A, Grogan TR, Nguyen K, Benz MR, Hotta M, Barbato F, Ceci F, Schwarzenböck SM, Unterrainer M, Zacho HD, Juarez R, Cooperberg M, Carroll P, Washington S, Reiter RE, Eiber M, Herrmann K, Fendler WP, Czernin J, Hope TA, Calais J. PMID: 37482512.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    16. Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer Subtypes. Eur Urol Oncol. 2024 Apr; 7(2):222-230. Chappidi MR, Sjöström M, Greenland NY, Cowan JE, Baskin AS, Shee K, Simko JP, Chan E, Stohr BA, Washington SL, Nguyen HG, Quigley DA, Davicioni E, Feng FY, Carroll PR, Cooperberg MR. PMID: 37474400.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    17. Explainable ML models for a deeper insight on treatment decision for localized prostate cancer. Sci Rep. 2023 07 17; 13(1):11532. Han JH, Lee S, Lee B, Baek OK, Washington SL, Herlemann A, Lonergan PE, Carroll PR, Jeong CW, Cooperberg MR. PMID: 37460568; PMCID: PMC10352331.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Impact of Stress Urinary Incontinence After Radical Prostatectomy on Time to Intervention, Quality of Life and Work Status. Urology. 2023 Oct; 180:242-248. Braun AE, Washington SL, Cowan JE, Hampson LA, Carroll PR. PMID: 37442296.
      View in: PubMed   Mentions: 1     Fields:    
    19. Barriers and confidence among colorectal and prostate cancer survivors participating in two behavioral intervention studies. Support Care Cancer. 2023 Jul 10; 31(8):453. Liu VN, Zuniga KB, Paciorek A, Zhang L, Chan JM, Carroll PR, Van Loon K, Laffan A, Venook A, Van Blarigan EL, Kenfield SA. PMID: 37428241.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Long-term complications and health-related quality of life outcomes after radical prostatectomy with or without subsequent radiation treatment for prostate cancer. Urol Oncol. 2023 10; 41(10):429.e9-429.e14. Baskin A, Cowan JE, Braun A, Lonergan PE, Mohamad O, Washington SL, Zhao S, Broering JM, Cooperberg MR, Breyer BN, Carroll PR. PMID: 37407420.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study. Mod Pathol. 2023 Oct; 36(10):100241. Patel P, Harmon S, Iseman R, Ludkowski O, Auman H, Hawley S, Newcomb LF, Lin DW, Nelson PS, Feng Z, Boyer HD, Tretiakova MS, True LD, Vakar-Lopez F, Carroll PR, Cooperberg MR, Chan E, Simko J, Fazli L, Gleave M, Hurtado-Coll A, Thompson IM, Troyer D, McKenney JK, Wei W, Choyke PL, Bratslavsky G, Turkbey B, Siemens DR, Squire J, Peng YP, Brooks JD, Jamaspishvili T. PMID: 37343766; PMCID: PMC10592257.
      View in: PubMed   Mentions:    Fields:    
    22. Prostate Cancer in Transgender Women in the Veterans Affairs Health System, 2000-2022. JAMA. 2023 06 06; 329(21):1877-1879. Nik-Ahd F, De Hoedt A, Butler C, Anger JT, Carroll PR, Cooperberg MR, Freedland SJ. PMID: 37119522; PMCID: PMC10148974.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    23. The Long-term Incidence and Quality of Life Outcomes Associated With Treatment-Related Toxicities of External Beam Radiotherapy for Prostate Cancer. Urology. 2023 Aug; 178:114-119. Lonergan PE, Baskin A, Greenberg SA, Mohamad O, Washington SL, Zhao S, Cowan JE, Broering JM, Nguyen HG, Cooperberg MR, Breyer BN, Carroll PR. PMID: 37244430.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Post-diagnostic health behaviour scores and risk of prostate cancer progression and mortality. Br J Cancer. 2023 08; 129(2):346-355. Langlais CS, Graff RE, Van Blarigan EL, Neuhaus JM, Cowan JE, Broering JM, Carroll P, Kenfield SA, Chan JM. PMID: 37217583; PMCID: PMC10338438.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin. Clin Genitourin Cancer. 2023 10; 21(5):e394-e404. Jindal T, Zhang L, Deshmukh P, Reyes K, Chan E, Kumar V, Zhu X, Maldonado E, Feng S, Johnson M, Angelidakis A, Kwon D, Desai A, Borno HT, Bose R, Wong A, Hong J, Carroll P, Meng M, Porten S, Aggarwal R, Small EJ, Fong L, Chou J, Friedlander T, de Kouchkovsky I, Koshkin VS. PMID: 37316414.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. A Novel Standardized Morbidity and Mortality Process to Promote Discourse, Improve Education, and Facilitate Practice Change: The M-PROVE Model. Urol Pract. 2023 07; 10(4):391-397. Bowman M, Yang H, Ahn J, Carroll PR, Hampson LA. PMID: 37228231.
      View in: PubMed   Mentions:
    27. Stability of Prognostic Estimation Using the CAPRA Score Incorporating Imaging-based vs Physical Exam-based Staging. J Urol. 2023 08; 210(2):281-289. Chang K, Greenberg SA, Cowan JE, Parker R, Shee K, Washington SL, Nguyen HG, Shinohara K, Carroll PR, Cooperberg MR. PMID: 37099018.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    28. PSA density does not improve predictive accuracy of the UCSF-CAPRA score. Prostate. 2023 07; 83(10):922-928. Parker R, Bell A, Chang K, Greenberg S, Washington SL, Cowan JE, Carroll PR, Cooperberg MR. PMID: 37078628.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. Seeing the unseen: how can we best identify transgender women within the Veterans Affairs healthcare system's electronic medical record? J Sex Med. 2023 03 31; 20(4):559-567. Nik-Ahd F, Waller J, De Hoedt AM, Garcia MM, Figueiredo JC, Carroll PR, Cooperberg MR, Freedland SJ. PMID: 36814112.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    30. Observation, Radiotherapy, or Radical Prostatectomy for Localized Prostate Cancer: Survival Analysis in the United States. World J Mens Health. 2023 Oct; 41(4):940-950. Han JH, Herlemann A, Washington SL, Lonergan PE, Carroll PR, Cooperberg MR, Jeong CW. PMID: 37118954; PMCID: PMC10523124.
      View in: PubMed   Mentions: 1  
    31. Limited Relevance of the Very Low Risk Prostate Cancer Classification in the Modern Era: Results from a Large Institutional Active Surveillance Cohort. Eur Urol. 2023 07; 84(1):9-12. Shee K, Cowan JE, Balakrishnan A, Escobar D, Chang K, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 36870794.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death. J Clin Oncol. 2023 05 01; 41(13):2428-2435. Tilki D, Chen MH, Wu J, Huland H, Graefen M, Mohamad O, Cowan JE, Feng FY, Carroll PR, D'Amico AV. PMID: 36857638; PMCID: PMC10150889.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    33. Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer. Eur Urol Oncol. 2023 Oct; 6(5):501-507. Sabbagh A, Washington SL, Tilki D, Hong JC, Feng J, Valdes G, Chen MH, Wu J, Huland H, Graefen M, Wiegel T, Böhmer D, Cowan JE, Cooperberg M, Feng FY, Roach M, Trock BJ, Partin AW, D'Amico AV, Carroll PR, Mohamad O. PMID: 36868922.
      View in: PubMed   Mentions: 1     Fields:    
    34. The natural history of a delayed detectable PSA after radical prostatectomy. Prostate Cancer Prostatic Dis. 2023 Dec; 26(4):759-764. Szymaniak JA, Washington SL, Cowan JE, Cooperberg MR, Lonergan PE, Nguyen HG, Meng MV, Carroll PR. PMID: 36765111; PMCID: PMC10638081.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. Prostate cancer lesion detection, volume quantification and high-grade cancer differentiation using cancer risk maps derived from multiparametric MRI with histopathology as the reference standard. Magn Reson Imaging. 2023 06; 99:48-57. Gibbons M, Simko JP, Carroll PR, Noworolski SM. PMID: 36641104.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    36. Protocol for a 4-arm randomized controlled trial testing remotely delivered exercise-only, diet-only, and exercise + diet interventions among men with prostate cancer treated with radical prostatectomy (Prostate 8-II). Contemp Clin Trials. 2023 02; 125:107079. Van Blarigan EL, Chan JM, Sanchez A, Zhang L, Winters-Stone K, Liu V, Macaire G, Panchal N, Graff RE, Tenggara I, Luke A, Simko JP, Cooperberg MR, Carroll PR, Kenfield SA. PMID: 36621597.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    37. Use of Voice Recordings in the Consultation of Patients Seeking Genital Gender-Affirming Surgery: An Opportunity for Broader Application Throughout Surgery? J Surg Res (Houst). 2022; 5(4):618-625. Smith SM, Stelmar J, Lee G, Carroll PR, Garcia MM. PMID: 36643404; PMCID: PMC9836232.
      View in: PubMed   Mentions: 2  
    38. Health Literacy and Appropriateness of Self-Care and Pain Management in Osteoarthritis: An Understanding of the Patient's Perspective. Arthritis Care Res (Hoboken). 2023 04; 75(4):848-859. Hunter DJ, McLachlan AJ, Carroll PR, Wakefield TAN, Stosic R. PMID: 34941010.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    39. Factors that influence treatment decisions: A qualitative study of racially and ethnically diverse patients with low- and very-low risk prostate cancer. Cancer Med. 2023 03; 12(5):6307-6317. Guan A, Shim JK, Allen L, Kuo MC, Lau K, Loya Z, Brooks JD, Carroll PR, Cheng I, Chung BI, DeRouen MC, Frosch DL, Golden T, Leppert JT, Lichtensztajn DY, Lu Q, Oh DL, Sieh W, Wadhwa M, Gomez SL, Shariff-Marco S. PMID: 36404625; PMCID: PMC10028041.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    40. Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance Study. Nutr Cancer. 2023; 75(2):618-626. Schenk JM, Liu M, Neuhouser ML, Newcomb LF, Zheng Y, Zhu K, Brooks JD, Carroll PR, Dash A, Ellis WJ, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Wagner AA, Lin DW. PMID: 36343223; PMCID: PMC9974882.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Prostate-Specific Antigen Screening in Transgender Patients. Eur Urol. 2023 Jan; 83(1):48-54. Nik-Ahd F, Jarjour A, Figueiredo J, Anger JT, Garcia M, Carroll PR, Cooperberg MR, Vidal AC, Freedland SJ. PMID: 36344317.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    42. Emulation of a target trial with sustained treatment strategies: an application to prostate cancer using both inverse probability weighting and the g-formula. Eur J Epidemiol. 2022 Oct 26. Smith LH, García-Albéniz X, Chan JM, Zhao S, Cowan JE, Broering JM, Cooperberg MR, Carroll PR, Hernán MA. PMID: 36289138.
      View in: PubMed   Mentions:    Fields:    
    43. Cost-effectiveness analysis of primary treatments for localised prostate cancer: A population-based Markov analysis using real-world evidence. Eur J Cancer Care (Engl). 2022 Nov; 31(6):e13740. Weng X, Zhong L, Xiang P, Li Y, Paciorek A, Dong L, Broering J, Carroll PR, Sanda M, Wilson L. PMID: 36239065.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    44. Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading, but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort. Reply. J Urol. 2023 Jan; 209(1):73. Carroll P. PMID: 36484446.
      View in: PubMed   Mentions:    Fields:    
    45. Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort. J Urol. 2022 Sep 06; 101097JU0000000000002956. Shee K, Washington SL, Cowan JE, de la Calle CM, Baskin AS, Chappidi MR, Escobar D, Nguyen HG, Cooperberg MR, Carroll PR. PMID: 36067374.
      View in: PubMed   Mentions: 1     Fields:    
    46. Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality. Cancer Epidemiol Biomarkers Prev. 2022 09 02; 31(9):1760-1768. Langlais CS, Graff RE, Van Blarigan EL, Kenfield SA, Neuhaus J, Tabung FK, Cowan JE, Broering JM, Carroll P, Chan JM. PMID: 35767977; PMCID: PMC9444922.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    47. Risk of progression following a negative biopsy in prostate cancer active surveillance. Prostate Cancer Prostatic Dis. 2023 06; 26(2):403-409. Beckmann K, Santaolalla A, Sugimoto M, Carroll P, Rubio J, Villers A, Bjartell A, Morgan T, Dasgupta P, Van Hemelrijck M, Elhage O, Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. PMID: 36008540; PMCID: PMC10247354.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    48. Blood Prostate-specific Antigen by Volume of Benign, Gleason Pattern 3 and 4 Prostate Tissue. Urology. 2022 12; 170:154-160. Andolfi C, Vickers AJ, Cooperberg MR, Carroll PR, Cowan JE, Paner GP, Helfand BT, Liauw SL, Eggener SE. PMID: 35987380; PMCID: PMC10515713.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    49. Adverse Pathological Findings at Radical Prostatectomy following Active Surveillance: Results from the Movember GAP3 Cohort. Cancers (Basel). 2022 07 22; 14(15). Marenghi C, Qiu Z, Helleman J, Nieboer D, Rubio-Briones J, Carroll PR, Lee LS, Valdagni R, Boutros PC, Nicolai N, Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. PMID: 35892817; PMCID: PMC9332009.
      View in: PubMed   Mentions: 1  
    50. Medium Term Outcomes of Focal Cryoablation for Intermediate and High Risk Prostate Cancer: MRI and PSA are Not Predictive of Residual or Recurrent Disease. Urol Oncol. 2022 10; 40(10):451.e15-451.e20. Baskin A, Charondo LB, Balakrishnan A, Cowan JE, Cooperberg MR, Carroll PR, Nguyen H, Shinohara K. PMID: 35851186.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    51. Patient engagement in a mobile health intervention to improve preparedness for prostate biopsy. Urol Oncol. 2022 09; 40(9):407.e1-407.e7. Balakrishnan AS, Nguyen HG, Shinohara K, Carroll PR, Odisho AY. PMID: 35840464.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    52. Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance. J Urol. 2022 11; 208(5):1037-1045. Filson CP, Zhu K, Huang Y, Zheng Y, Newcomb LF, Williams S, Brooks JD, Carroll PR, Dash A, Ellis WJ, Gleave ME, Liss MA, Martin F, McKenney JK, Morgan TM, Wagner AA, Sokoll LJ, Sanda MG, Chan DW, Lin DW. PMID: 35830553; PMCID: PMC10189606.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    53. Development and Service Evaluation of an ad hoc Virtual Arthroplasty Clinic during COVID-19: Experiences from Irish National Orthopaedic Hospital. Malays Orthop J. 2022 Jul; 16(2):46-54. Murphy B, Carroll P, Daly R, McLaverty A, Keogh P, O'Byrne J, Cashman J. PMID: 35992987; PMCID: PMC9388817.
      View in: PubMed   Mentions:
    54. Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative. Eur Urol Open Sci. 2022 Jul; 41:126-133. Remmers S, Helleman J, Nieboer D, Trock B, Hyndman ME, Moore CM, Gnanapragasam V, Shiong Lee L, Elhage O, Klotz L, Carroll P, Pickles T, Bjartell A, Robert G, Frydenberg M, Sugimoto M, Ehdaie B, Morgan TM, Rubio-Briones J, Semjonow A, Bangma CH, Roobol MJ, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. PMID: 35813247; PMCID: PMC9257656.
      View in: PubMed   Mentions: 2  
    55. Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance. Cancer Med. 2022 11; 11(22):4332-4340. Brady L, Newcomb LF, Zhu K, Zheng Y, Boyer H, Sarkar N, McKenney JK, Brooks JD, Carroll PR, Dash A, Ellis WJ, Filson CP, Gleave ME, Liss MA, Martin F, Morgan TM, Thompson IM, Wagner AA, Pritchard CC, Lin DW, Nelson PS. PMID: 35467778; PMCID: PMC9678104.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    56. Editorial Comment. J Urol. 2022 07; 208(1):108. Carroll PR. PMID: 35450426.
      View in: PubMed   Mentions:    Fields:    
    57. The effect of preoperative membranous urethral length on likelihood of postoperative urinary incontinence after robot-assisted radical prostatectomy. Prostate Cancer Prostatic Dis. 2022 02; 25(2):344-350. Greenberg SA, Cowan JE, Lonergan PE, Washington SL, Nguyen HG, Zagoria RJ, Carroll PR. PMID: 35352026.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    58. Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 Trial. Adv Radiat Oncol. 2022 Sep-Oct; 7(5):100941. Shee K, de la Calle CM, Chang AJ, Wong AC, Feng FY, Gottschalk AR, Carroll PR, Nguyen HG. PMID: 35847550; PMCID: PMC9280039.
      View in: PubMed   Mentions: 1  
    59. Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database. Prostate. 2022 05; 82(7):876-879. Beckmann KR, Bangma CH, Helleman J, Bjartell A, Carroll PR, Morgan T, Nieboer D, Santaolalla A, Trock BJ, Valdagni R, Roobol MJ, Global Action Plan Active Surveillance Prostate Cancer [G.A.P.3] Consortium. PMID: 35254666; PMCID: PMC9541488.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    60. Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosis. Hum Pathol. 2022 04; 122:84-91. Ruder S, Gao Y, Ding Y, Bu P, Miles B, De Marzo A, Wheeler T, McKenney JK, Auman H, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave M, Platz E, Trock B, Han M, Sayeeduddin M, True LD, Rowley D, Lin DW, Nelson PS, Thompson IM, Feng Z, Wei W, Brooks JD, Ittmann M, Lee M, Ayala G. PMID: 35176252; PMCID: PMC9832989.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    61. Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma. Mod Pathol. 2022 08; 35(8):1092-1100. Chan E, McKenney JK, Hawley S, Corrigan D, Auman H, Newcomb LF, Boyer HD, Carroll PR, Cooperberg MR, Klein E, Fazli L, Gleave ME, Hurtado-Coll A, Simko JP, Nelson PS, Thompson IM, Tretiakova MS, Troyer D, True LD, Vakar-Lopez F, Lin DW, Brooks JD, Feng Z, Nguyen JK. PMID: 35145197; PMCID: PMC9314256.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    62. Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states. Nat Commun. 2022 01 10; 13(1):141. Song H, Weinstein HNW, Allegakoen P, Wadsworth MH, Xie J, Yang H, Castro EA, Lu KL, Stohr BA, Feng FY, Carroll PR, Wang B, Cooperberg MR, Shalek AK, Huang FW. PMID: 35013146; PMCID: PMC8748675.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    63. Osteoarthritis management: Does the pharmacist play a role in bridging the gap between what patients actually know and what they ought to know? Insights from a national online survey. Health Expect. 2022 06; 25(3):936-946. McLachlan AJ, Carroll PR, Hunter DJ, Wakefield TAN, Stosic R. PMID: 34997667; PMCID: PMC9122430.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    64. The Natural History of Untreated Biopsy Grade Group Progression and Delayed Definitive Treatment for Men on Active Surveillance for Early-Stage Prostate Cancer. J Urol. 2022 05; 207(5):1001-1009. Chappidi MR, Bell A, Cowan JE, Greenberg SA, Lonergan PE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 34981949.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    65. Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. Eur Urol Open Sci. 2022 Jan; 35:59-67. Olivier J, Li W, Nieboer D, Helleman J, Roobol M, Gnanapragasam V, Frydenberg M, Sugimoto M, Carroll P, Morgan TM, Valdagni R, Rubio-Briones J, Robert G, Stricker P, Hayen A, Schoots I, Haider M, Moore CM, Denton B, Villers A, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance GAP3 Consortium. PMID: 35024633; PMCID: PMC8738894.
      View in: PubMed   Mentions: 5  
    66. Molecular risk classifier score and biochemical recurrence risk are associated with cribriform pattern type in Gleason 3+4=7 prostate cancer. Investig Clin Urol. 2022 01; 63(1):27-33. Greenland NY, Cooperberg MR, Wong AC, Chan E, Carroll PR, Simko JP, Stohr BA. PMID: 34983120; PMCID: PMC8756156.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    67. Development and evaluation of an interprofessional student-led influenza vaccination clinic for medical, nursing and pharmacy students. Pharm Pract (Granada). 2021 Oct-Dec; 19(4):2449. Carroll PR, Hanrahan J. PMID: 35474645; PMCID: PMC9013193.
      View in: PubMed   Mentions: 4  
    68. Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS Cohort. J Urol. 2022 04; 207(4):805-813. Waisman Malaret AJ, Chang P, Zhu K, Zheng Y, Newcomb LF, Liu M, McKenney JK, Brooks JD, Carroll P, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Lin DW, Wagner AA. PMID: 34854745; PMCID: PMC8917057.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    69. Androgen Deprivation Therapy and the Risk of Dementia after Treatment for Prostate Cancer. J Urol. 2022 04; 207(4):832-840. Lonergan PE, Washington SL, Cowan JE, Zhao S, Broering JM, Cooperberg MR, Carroll PR. PMID: 34854749.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    70. Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment. HGG Adv. 2022 Jan 13; 3(1). Jiang Y, Meyers TJ, Emeka AA, Cooley LF, Cooper PR, Lancki N, Helenowski I, Kachuri L, Lin DW, Stanford JL, Newcomb LF, Kolb S, Finelli A, Fleshner NE, Komisarenko M, Eastham JA, Ehdaie B, Benfante N, Logothetis CJ, Gregg JR, Perez CA, Garza S, Kim J, Marks LS, Delfin M, Barsa D, Vesprini D, Klotz LH, Loblaw A, Mamedov A, Goldenberg SL, Higano CS, Spillane M, Wu E, Carter HB, Pavlovich CP, Mamawala M, Landis T, Carroll PR, Chan JM, Cooperberg MR, Cowan JE, Morgan TM, Siddiqui J, Martin R, Klein EA, Brittain K, Gotwald P, Barocas DA, Dallmer JR, Gordetsky JB, Steele P, Kundu SD, Stockdale J, Roobol MJ, Venderbos LDF, Sanda MG, Arnold R, Patil D, Evans CP, Dall'Era MA, Vij A, Costello AJ, Chow K, Corcoran NM, Rais-Bahrami S, Phares C, Scherr DS, Flynn T, Karnes RJ, Koch M, Dhondt CR, Nelson JB, McBride D, Cookson MS, Stratton KL, Farriester S, Hemken E, Stadler WM, Pera T, Banionyte D, Bianco FJ, Lopez IH, Loeb S, Taneja SS, Byrne N, Amling CL, Martinez A, Boileau L, Gaylis FD, Petkewicz J, Kirwen N, Helfand BT, Xu J, Scholtens DM, Catalona WJ, Witte JS. PMID: 34993496; PMCID: PMC8725988.
      View in: PubMed   Mentions: 10  
    71. Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database. Eur Urol Open Sci. 2021 Dec; 34:47-54. Beckmann K, Santaolalla A, Helleman J, Carroll P, Ha Chung B, Shiong Lee L, Perry A, Rubio-Briones J, Sugimoto M, Trock B, Valdagni R, Dasgupta P, Van Hemelrijck M, Elhage O, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. PMID: 34934967; PMCID: PMC8655390.
      View in: PubMed   Mentions: 1  
    72. Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial. JAMA Oncol. 2021 Nov 01; 7(11):1635-1642. Hope TA, Eiber M, Armstrong WR, Juarez R, Murthy V, Lawhn-Heath C, Behr SC, Zhang L, Barbato F, Ceci F, Farolfi A, Schwarzenböck SM, Unterrainer M, Zacho HD, Nguyen HG, Cooperberg MR, Carroll PR, Reiter RE, Holden S, Herrmann K, Zhu S, Fendler WP, Czernin J, Calais J. PMID: 34529005; PMCID: PMC8446902.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCTClinical Trials
    73. Identification of prostate cancer using multiparametric MR imaging characteristics of prostate tissues referenced to whole mount histopathology. Magn Reson Imaging. 2022 01; 85:251-261. Gibbons M, Starobinets O, Simko JP, Kurhanewicz J, Carroll PR, Noworolski SM. PMID: 34666162; PMCID: PMC9931199.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    74. Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer. Cancer. 2022 Jan 15; 128(2):269-274. Kirk PS, Zhu K, Zheng Y, Newcomb LF, Schenk JM, Brooks JD, Carroll PR, Dash A, Ellis WJ, Filson CP, Gleave ME, Liss M, Martin F, McKenney JK, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW, Gore JL. PMID: 34516660; PMCID: PMC8738121.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    75. Active surveillance in intermediate-risk prostate cancer with PSA 10-20 ng/mL: pathological outcome analysis of a population-level database. Prostate Cancer Prostatic Dis. 2022 Apr; 25(4):690-693. Lonergan PE, Jeong CW, Washington SL, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR. PMID: 34508180; PMCID: PMC9705238.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    76. Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium. J Urol. 2022 01; 207(1):127-136. Chang P, Wagner AA, Regan MM, Smith JA, Saigal CS, Litwin MS, Hu JC, Cooperberg MR, Carroll PR, Klein EA, Kibel AS, Andriole GL, Han M, Partin AW, Wood DP, Crociani CM, Greenfield TK, Patil D, Hembroff LA, Davis K, Stork L, Spratt DE, Wei JT, Sanda MG, PROST-QA/RP2 Consortium. PMID: 34433304; PMCID: PMC8840795.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    77. Individual Patient Data Meta-analysis of Discrimination of the Four Kallikrein Panel Associated With the Inclusion of Prostate Volume. Urology. 2021 11; 157:102-106. Vertosick EA, Zappala S, Punnen S, Hugosson J, Boorjian SA, Haese A, Carroll P, Cooperberg M, Bjartell A, Lilja H, Vickers AJ. PMID: 34450175; PMCID: PMC8671182.
      View in: PubMed   Mentions: 1     Fields:    
    78. Natural history of an immediately detectable PSA following radical prostatectomy in a contemporary cohort. Prostate. 2021 09; 81(13):1009-1017. Lonergan PE, Cowan JE, Washington SL, Greenberg SA, Nguyen HG, Carroll PR. PMID: 34288004.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    79. Effect of Diagnostic Biopsy Practice Location on Grade/Volume Reclassification in Active Surveillance for Prostate Cancer: A Multicenter Analysis from the Canary PASS Cohort. Urol Pract. 2021 Sep; 8(5):576-582. Waisman Malaret AJ, Chang P, Newcomb L, Faino A, Zheng Y, Zhu K, McKenney JK, Brooks JD, Dash A, Ellis WJ, Filson CP, Gleave M, Liss M, Martin FM, Morgan T, Carroll P, Nelson P, Lin DW, Wagner AA. PMID: 37145399.
      View in: PubMed   Mentions:
    80. Association of Age With Risk of Adverse Pathological Findings in Men Undergoing Delayed Radical Prostatectomy Following Active Surveillance. Urology. 2021 09; 155:91-95. de la Calle CM, Shee K, Chu CE, Cowan JE, Nguyen HG, Carroll PR. PMID: 34118228.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    81. A bicentric retrospective analysis of clinical utility of 18F-fluciclovine PET in biochemically recurrent prostate cancer following primary radiation therapy: is it helpful in patients with a PSA rise less than the Phoenix criteria? Eur J Nucl Med Mol Imaging. 2021 12; 48(13):4463-4471. Salavati A, Gencturk M, Koksel Y, Schik AN, Carroll PR, Feng FY, Rowe SP, Lawhn-Heath C, Hope TA, Froelich JW. PMID: 34091713.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    82. Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death. J Clin Oncol. 2021 07 10; 39(20):2284-2293. Tilki D, Chen MH, Wu J, Huland H, Graefen M, Wiegel T, Böhmer D, Mohamad O, Cowan JE, Feng FY, Carroll PR, Trock BJ, Partin AW, D'Amico AV. PMID: 34086480.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    83. Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen. J Urol. 2021 09; 206(3):706-714. Greenberg SA, Washington SL, Lonergan PE, Cowan JE, Baskin AS, Nguyen HG, Odisho AY, Simko JP, Carroll PR. PMID: 33905262.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    84. Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing. JCO Precis Oncol. 2021; 5. Chen E, Cario CL, Leong L, Lopez K, Márquez CP, Li PS, Oropeza E, Tenggara I, Cowan J, Simko JP, Kageyama R, Wells DK, Chan JM, Friedlander T, Aggarwal R, Paris PL, Feng F, Carroll PR, Witte JS. PMID: 34250416; PMCID: PMC8232833.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    85. SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study. Cancers (Basel). 2021 Apr 23; 13(9). Maggi M, Del Giudice F, Falagario UG, Cocci A, Russo GI, Di Mauro M, Sepe GS, Galasso F, Leonardi R, Iacona G, Carroll PR, Cooperberg MR, Porreca A, Ferro M, Lucarelli G, Terracciano D, Cormio L, Carrieri G, De Berardinis E, Sciarra A, Busetto GM. PMID: 33922626; PMCID: PMC8122883.
      View in: PubMed   Mentions: 28  
    86. Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes. Int J Mol Sci. 2021 Apr 22; 22(9). Salciccia S, Capriotti AL, Laganà A, Fais S, Logozzi M, De Berardinis E, Busetto GM, Di Pierro GB, Ricciuti GP, Del Giudice F, Sciarra A, Carroll PR, Cooperberg MR, Sciarra B, Maggi M. PMID: 33922033; PMCID: PMC8122596.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimalsCells
    87. Reply by Authors. J Urol. 2021 07; 206(1):61. Pienta KJ, Gorin MA, Rowe SP, Carroll PR, Pouliot F, Probst S, Saperstein L, Preston MA, Alva AS, Patnaik A, Durack JC, Stambler N, Lin T, Jensen J, Wong V, Siegel BA, Morris MJ. PMID: 33853358.
      View in: PubMed   Mentions: 1     Fields:    
    88. Post-diagnostic coffee and tea consumption and risk of prostate cancer progression by smoking history. Cancer Causes Control. 2021 Jun; 32(6):635-644. Langlais CS, Chan JM, Kenfield SA, Cowan JE, Graff RE, Broering JM, Carroll P, Van Blarigan EL. PMID: 33837499; PMCID: PMC8189293.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    89. Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer. Eur Urol. 2021 06; 79(6):717-721. Chu CE, Alshalalfa M, Sjöström M, Zhao SG, Liu Y, Chou J, Herlemann A, Mahal B, Kishan AU, Spratt DE, Cooperberg M, Small E, Wong A, Porten S, Hope TA, Ross AE, Davicioni E, Nguyen P, Karnes RJ, Carroll PR, Schaeffer E, Feng FY. PMID: 33840559.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    90. Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience. Letter. J Urol. 2021 07; 206(1):171-172. Gaylis FD, Cooperberg MR, Chen RC, Malin J, Loeb S, Witte JS, Carroll PR, Cohen ES, Dato PE, Lin DW, Zheng Y, Seibert TM, Setzler C, Wilt W, Gomez SL, Chan JML, Catalona WJ. PMID: 33818133.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    91. The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer. Reply. J Urol. 2021 07; 206(1):174. Carroll PR, Maggi M. PMID: 33683938.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    92. Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus. Urol Oncol. 2021 11; 39(11):781.e17-781.e24. Tan WP, Rastinehad AR, Klotz L, Carroll PR, Emberton M, Feller JF, George AK, Gill IS, Gupta RT, Katz AE, Lebastchi AH, Marks LS, Marra G, Pinto PA, Song DY, Sidana A, Ward JF, Sanchez-Salas R, Rosette J, Polascik TJ, Focal Therapy Group Authors. PMID: 33676851; PMCID: PMC8654321.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    93. Cell-free DNA concentration and fragment size as a biomarker for prostate cancer. Sci Rep. 2021 03 03; 11(1):5040. Chen E, Cario CL, Leong L, Lopez K, Márquez CP, Chu C, Li PS, Oropeza E, Tenggara I, Cowan J, Simko JP, Chan JM, Friedlander T, Wyatt AW, Aggarwal R, Paris PL, Carroll PR, Feng F, Witte JS. PMID: 33658587; PMCID: PMC7930042.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    94. A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY). J Urol. 2021 07; 206(1):52-61. Pienta KJ, Gorin MA, Rowe SP, Carroll PR, Pouliot F, Probst S, Saperstein L, Preston MA, Alva AS, Patnaik A, Durack JC, Stambler N, Lin T, Jensen J, Wong V, Siegel BA, Morris MJ. PMID: 33634707; PMCID: PMC8556578.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCTClinical Trials
    95. Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study. Clin Cancer Res. 2021 07 01; 27(13):3674-3682. Morris MJ, Rowe SP, Gorin MA, Saperstein L, Pouliot F, Josephson D, Wong JYC, Pantel AR, Cho SY, Gage KL, Piert M, Iagaru A, Pollard JH, Wong V, Jensen J, Lin T, Stambler N, Carroll PR, Siegel BA, CONDOR Study Group. PMID: 33622706; PMCID: PMC8382991.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansCTClinical Trials
    96. A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillance. BMC Urol. 2021 Feb 04; 21(1):18. Merriel SWD, Moon D, Dundee P, Corcoran N, Carroll P, Partin A, Smith JA, Hamdy F, Moore C, Ost P, Costello T. PMID: 33541309; PMCID: PMC7863517.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    97. Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer. Eur Urol Oncol. 2022 10; 5(5):537-543. Chu CE, Cowan JE, Lonergan PE, Washington SL, Fasulo V, de la Calle CM, Shinohara K, Westphalen AC, Carroll PR. PMID: 33483265.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    98. Feasibility and Acceptability of a Remotely Delivered, Web-Based Behavioral Intervention for Men With Prostate Cancer: Four-Arm Randomized Controlled Pilot Trial. J Med Internet Res. 2020 12 31; 22(12):e19238. Chan JM, Van Blarigan EL, Langlais CS, Zhao S, Ramsdill JW, Daniel K, Macaire G, Wang E, Paich K, Kessler ER, Beer TM, Lyons KS, Broering JM, Carroll PR, Kenfield SA, Winters-Stone KM. PMID: 33382378; PMCID: PMC7808895.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    99. Editorial Comment. J Urol. 2021 03; 205(3):777-778. Carroll PR. PMID: 33355500.
      View in: PubMed   Mentions:    Fields:    
    100. Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease. Sci Rep. 2020 12 10; 10(1):21750. Smith R, Liu M, Liby T, Bayani N, Bucher E, Chiotti K, Derrick D, Chauchereau A, Heiser L, Alumkal J, Feiler H, Carroll P, Korkola JE. PMID: 33303959; PMCID: PMC7729982.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    101. A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer. Eur Urol. 2021 03; 79(3):374-383. Jairath NK, Dal Pra A, Vince R, Dess RT, Jackson WC, Tosoian JJ, McBride SM, Zhao SG, Berlin A, Mahal BA, Kishan AU, Den RB, Freedland SJ, Salami SS, Kaffenberger SD, Pollack A, Tran P, Mehra R, Morgan TM, Weiner AB, Mohamad O, Carroll PR, Cooperberg MR, Karnes RJ, Nguyen PL, Michalski JM, Tward JD, Feng FY, Schaeffer EM, Spratt DE. PMID: 33293078.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    102. Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy. Urology. 2021 Mar; 149:168-173. Chu CE, Law L, Zuniga K, Lin TK, Tsourounis C, Rodriguez-Monguio R, Lazar A, Washington SL, Cooperberg MR, Greene KL, Carroll PR, Pruthi RS, Meng MV, Chen LL, Porten SP. PMID: 33278460.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    103. Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US. JAMA Netw Open. 2020 12 01; 3(12):e2031349. Washington SL, Jeong CW, Lonergan PE, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR. PMID: 33369661; PMCID: PMC7770559.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    104. Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate Cancer. J Urol. 2021 Apr; 205(4):1047-1054. Cullen J, Lynch JA, Klein EA, Van Den Eeden SK, Carroll PR, Mohler JL, Knezevic D, Farrington TA, Lu R. PMID: 33493001.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    105. Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate. JAMA Oncol. 2020 12 01; 6(12):1912-1920. Dess RT, Suresh K, Zelefsky MJ, Freedland SJ, Mahal BA, Cooperberg MR, Davis BJ, Horwitz EM, Terris MK, Amling CL, Aronson WJ, Kane CJ, Jackson WC, Hearn JWD, Deville C, DeWeese TL, Greco S, McNutt TR, Song DY, Sun Y, Mehra R, Kaffenberger SD, Morgan TM, Nguyen PL, Feng FY, Sharma V, Tran PT, Stish BJ, Pisansky TM, Zaorsky NG, Moraes FY, Berlin A, Finelli A, Fossati N, Gandaglia G, Briganti A, Carroll PR, Karnes RJ, Kattan MW, Schipper MJ, Spratt DE. PMID: 33090219; PMCID: PMC7582232.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    106. The Clinical Significance of Multiple Negative Surveillance Prostate Biopsies for Men on Active Surveillance-Does Cancer Vanish or Simply Hide? J Urol. 2021 Jan; 205(1):109-114. Chu CE, Cowan JE, Fasulo V, Washington SL, de la Calle C, Shoemaker J, Carroll PR. PMID: 33198555.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    107. Reply by Authors. J Urol. 2021 02; 205(2):339-340. Schenk JM, Newcomb LF, Zheng Y, Faino AV, Zhu K, Nyame YA, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW. PMID: 33155864.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    108. The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer. J Urol. 2020 12; 204(6):1222-1228. Maggi M, Cowan JE, Fasulo V, Washington SL, Lonergan PE, Sciarra A, Nguyen HG, Carroll PR. PMID: 33157570.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    109. Comparison of biopsy under-sampling and annual progression using hidden markov models to learn from prostate cancer active surveillance studies. Cancer Med. 2020 12; 9(24):9611-9619. Li W, Denton BT, Nieboer D, Carroll PR, Roobol MJ, Morgan TM, Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium. PMID: 33159431; PMCID: PMC7774732.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    110. Multiple Tissue Biomarkers Independently and Additively Predict Prostate Cancer Pathology Outcomes. Eur Urol. 2021 01; 79(1):141-149. Cooperberg MR, Cowan JE, Lindquist KJ, Kobayashi Y, Simko JP, Bengtsson H, Singh K, Ngo V, Avila A, Newcomb LF, Tretriakova M, Lin DW, Stone S, Carroll PR, Paris PL. PMID: 33148472.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    111. Editorial Comment. J Urol. 2021 01; 205(1):121. Chu C, Carroll P. PMID: 33136472.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    112. Assessment of Postprostatectomy Radiotherapy as Adjuvant or Salvage Therapy in Patients With Prostate Cancer: A Systematic Review. JAMA Oncol. 2020 Nov 01; 6(11):1793-1800. Sachdev S, Carroll P, Sandler H, Nguyen PL, Wafford E, Auffenberg G, Schaeffer E, Roach M, Evans CP, Hussain M. PMID: 32852528.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    113. Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the Prostate. JCO Precis Oncol. 2020 Nov; 4:1228-1238. Hall WA, Fishbane N, Liu Y, Xu MJ, Davicioni E, Mahal BA, Den RB, Dess RT, Jackson WC, Wong AC, Schaeffer EM, Karnes RJ, Carroll PR, Cooperberg MR, Bismar TA, Kim HL, Klein EA, Davis JW, Ross AE, Tosoian JJ, Morgan TM, Mehra R, Salami SS, Nguyen PL, Lawton CAF, Spratt DE, Feng F. PMID: 35050780.
      View in: PubMed   Mentions: 2     Fields:    
    114. Influence of pelvic lymph node dissection and node-positive disease on biochemical recurrence, secondary treatment, and survival after radical prostatectomy in men with prostate cancer. Prostate. 2021 02; 81(2):102-108. Washington SL, Cowan JE, Herlemann A, Zuniga KB, Masic S, Nguyen HG, Carroll PR. PMID: 33075151.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    115. Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy. Eur Urol Oncol. 2022 02; 5(1):61-69. Fasulo V, Cowan JE, Maggi M, Washington SL, Nguyen HG, Shinohara K, Lazzeri M, Casale P, Carroll PR. PMID: 33069628.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    116. Natural language processing systems for pathology parsing in limited data environments with uncertainty estimation. JAMIA Open. 2020 Oct; 3(3):431-438. Odisho AY, Park B, Altieri N, DeNero J, Cooperberg MR, Carroll PR, Yu B. PMID: 33381748; PMCID: PMC7751177.
      View in: PubMed   Mentions: 5  
    117. Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability. JAMA Oncol. 2020 10 01; 6(10):e203187. Cooperberg MR, Zheng Y, Faino AV, Newcomb LF, Zhu K, Cowan JE, Brooks JD, Dash A, Gleave ME, Martin F, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Carroll PR, Lin DW. PMID: 32852532; PMCID: PMC7453344.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    118. Student-led interprofessional influenza vaccination clinic in a time of coronavirus. Med Educ. 2020 11; 54(11):1078-1079. Hanrahan JR, Carroll PR. PMID: 32984968; PMCID: PMC7537206.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    119. Reply by Authors. J Urol. 2020 12; 204(6):1221. Lonergan PE, Washington SL, Cowan JE, Zhao S, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 32969756.
      View in: PubMed   Mentions:    Fields:    
    120. Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk category. Prostate. 2020 12; 80(16):1421-1428. Greenland NY, Cowan JE, Chan E, Carroll PR, Stohr BA, Simko JP. PMID: 32946625.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    121. Clinical Utility of 4Kscore®, ExosomeDx™ and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate Cancer. J Urol. 2021 02; 205(2):452-460. de la Calle CM, Fasulo V, Cowan JE, Lonergan PE, Maggi M, Gadzinski AJ, Yeung RA, Saita A, Cooperberg MR, Shinohara K, Carroll PR, Nguyen HG. PMID: 32897802.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    122. A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer. BMC Cancer. 2020 Aug 28; 20(1):820. Cario CL, Chen E, Leong L, Emami NC, Lopez K, Tenggara I, Simko JP, Friedlander TW, Li PS, Paris PL, Carroll PR, Witte JS. PMID: 32859160; PMCID: PMC7456018.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    123. How Often Does Magnetic Resonance Imaging Detect Prostate Cancer Missed by Transrectal Ultrasound? Eur Urol Focus. 2021 Nov; 7(6):1268-1273. Herlemann A, Overland MR, Washington SL, Cowan JE, Westphalen AC, Carroll PR, Nguyen HG, Shinohara K, Cooperberg MR. PMID: 32868222.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    124. False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial. Eur J Nucl Med Mol Imaging. 2021 02; 48(2):501-508. Fendler WP, Calais J, Eiber M, Simko JP, Kurhanewicz J, Santos RD, Feng FY, Reiter RE, Rettig MB, Nickols NG, Kishan AU, PSMA PET Reader Group, Slavik R, Carroll PR, Lawhn-Heath C, Herrmann K, Czernin J, Hope TA. PMID: 32808077; PMCID: PMC7835157.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    125. Examining initial treatment and survival among men with metastatic prostate cancer: An analysis from the CaPSURE registry. Urol Oncol. 2020 10; 38(10):793.e1-793.e11. Borno HT, Cowan JE, Zhao S, Broering JM, Carroll PR, Ryan CJ. PMID: 32782182.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    126. Rapid Utilization of Telehealth in a Comprehensive Cancer Center as a Response to COVID-19: Cross-Sectional Analysis. J Med Internet Res. 2020 07 06; 22(7):e19322. Lonergan PE, Washington Iii SL, Branagan L, Gleason N, Pruthi RS, Carroll PR, Odisho AY. PMID: 32568721; PMCID: PMC7340164.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCellsPHPublic Health
    127. Multiparametric Magnetic Resonance Imaging Alone is Insufficient to Detect Grade Reclassification in Active Surveillance for Prostate Cancer. Eur Urol. 2020 10; 78(4):515-517. Chu CE, Lonergan PE, Washington SL, Cowan JE, Shinohara K, Westphalen AC, Carroll PR, Cooperberg MR. PMID: 32631744.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    128. Re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51. Eur Urol. 2020 09; 78(3):e110-e111. Chu CE, Lonergan PE, Carroll PR. PMID: 32622551.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    129. Risk Factors for Biopsy Reclassification over Time in Men on Active Surveillance for Early Stage Prostate Cancer. J Urol. 2020 12; 204(6):1216-1221. Lonergan PE, Washington SL, Cowan JE, Zhao S, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 32519915.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    130. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. J Clin Oncol. 2020 08 20; 38(24):2798-2811. Giri VN, Knudsen KE, Kelly WK, Cheng HH, Cooney KA, Cookson MS, Dahut W, Weissman S, Soule HR, Petrylak DP, Dicker AP, AlDubayan SH, Toland AE, Pritchard CC, Pettaway CA, Daly MB, Mohler JL, Parsons JK, Carroll PR, Pilarski R, Blanco A, Woodson A, Rahm A, Taplin ME, Polascik TJ, Helfand BT, Hyatt C, Morgans AK, Feng F, Mullane M, Powers J, Concepcion R, Lin DW, Wender R, Mark JR, Costello A, Burnett AL, Sartor O, Isaacs WB, Xu J, Weitzel J, Andriole GL, Beltran H, Briganti A, Byrne L, Calvaresi A, Chandrasekar T, Chen DYT, Den RB, Dobi A, Crawford ED, Eastham J, Eggener S, Freedman ML, Garnick M, Gomella PT, Handley N, Hurwitz MD, Izes J, Karnes RJ, Lallas C, Languino L, Loeb S, Lopez AM, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann M, Mille P, Miner MM, Morgan T, Moreno J, Mucci L, Myers RE, Nielsen SM, O'Neil B, Pinover W, Pinto P, Poage W, Raj GV, Rebbeck TR, Ryan C, Sandler H, Schiewer M, Scott EMD, Szymaniak B, Tester W, Trabulsi EJ, Vapiwala N, Yu EY, Zeigler-Johnson C, Gomella LG. PMID: 32516092; PMCID: PMC7430215.
      View in: PubMed   Mentions: 93     Fields:    Translation:Humans
    131. The Relative Impact of Urinary and Sexual Function vs Bother on Health Utility for Men With Prostate Cancer. JNCI Cancer Spectr. 2020 Oct; 4(5):pkaa044. Jeong CW, Herlemann A, Cowan JE, Broering JM, Ten Ham RMT, Wilson LS, Carroll PR, Cooperberg MR. PMID: 33134826; PMCID: PMC7583149.
      View in: PubMed   Mentions:    Fields:    
    132. Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial. J Nucl Med. 2020 12; 61(12):1793-1799. Fendler WP, Ferdinandus J, Czernin J, Eiber M, Flavell RR, Behr SC, Wu IK, Lawhn-Heath C, Pampaloni MH, Reiter RE, Rettig MB, Gartmann J, Murthy V, Slavik R, Carroll PR, Herrmann K, Calais J, Hope TA. PMID: 32358094; PMCID: PMC9364898.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCTClinical Trials
    133. Magnetic Resonance Imaging for the Detection of High Grade Cancer in the Canary Prostate Active Surveillance Study. J Urol. 2020 10; 204(4):701-706. Liss MA, Newcomb LF, Zheng Y, Garcia MP, Filson CP, Boyer H, Brooks JD, Carroll PR, Cooperberg MR, Ellis WJ, Gleave ME, Martin FM, Morgan T, Nelson PS, Wagner AA, Thompson IM, Lin DW. PMID: 32343189; PMCID: PMC7483329.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    134. Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology. 2020 07; 296(1):76-84. Westphalen AC, McCulloch CE, Anaokar JM, Arora S, Barashi NS, Barentsz JO, Bathala TK, Bittencourt LK, Booker MT, Braxton VG, Carroll PR, Casalino DD, Chang SD, Coakley FV, Dhatt R, Eberhardt SC, Foster BR, Froemming AT, Fütterer JJ, Ganeshan DM, Gertner MR, Mankowski Gettle L, Ghai S, Gupta RT, Hahn ME, Houshyar R, Kim C, Kim CK, Lall C, Margolis DJA, McRae SE, Oto A, Parsons RB, Patel NU, Pinto PA, Polascik TJ, Spilseth B, Starcevich JB, Tammisetti VS, Taneja SS, Turkbey B, Verma S, Ward JF, Warlick CA, Weinberger AR, Yu J, Zagoria RJ, Rosenkrantz AB. PMID: 32315265; PMCID: PMC7373346.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    135. Expansile cribriform Gleason pattern 4 has histopathologic and molecular features of aggressiveness and greater risk of biochemical failure compared to glomerulation Gleason pattern 4. Prostate. 2020 05; 80(8):653-659. Greenland NY, Cowan JE, Zhang L, Carroll PR, Chan E, Stohr BA, Simko JP. PMID: 32220141.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    136. Editorial Comment. J Urol. 2020 06; 203(6):1121. Carroll PR, Chu C. PMID: 32186448.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    137. Evaluation of a vaccination training program for pharmacy graduands in Australia. Curr Pharm Teach Learn. 2020 07; 12(7):850-857. Carroll PR, Chen Y, Vicheth P, Webber P, Hanrahan JR. PMID: 32540047.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    138. The New Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting Database: Opportunities and Limitations. Eur Urol. 2020 09; 78(3):335-344. Jeong CW, Washington SL, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR. PMID: 31980309.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    139. Reply by Authors. J Urol. 2020 04; 203(4):733. Schenk JM, Newcomb LF, Zheng Y, Faino AV, Zhu K, Nyame YA, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW. PMID: 31951502.
      View in: PubMed   Mentions:    Fields:    
    140. MRI-Based Prostate-Specific Antigen Density Predicts Gleason Score Upgrade in an Active Surveillance Cohort. AJR Am J Roentgenol. 2020 03; 214(3):574-578. Washington SL, Baskin AS, Ameli N, Nguyen HG, Westphalen AC, Shinohara K, Carroll PR. PMID: 31913068.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    141. Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients. Cancer Med. 2020 01; 9(1):125-132. Belkora J, Chan JM, Cooperberg MR, Neuhaus J, Stupar L, Weinberg T, Broering JM, Tenggara I, Cowan JE, Rosenfeld S, Kenfield SA, Van Blarigan EL, Simko JP, Witte J, Carroll PR. PMID: 31714037; PMCID: PMC6943165.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    142. Understanding the Major Factors Affecting Response Shift Effects on Health-Related Quality of Life: What the Then-Test Measures in a Longitudinal Prostate Cancer Registry. Clin Genitourin Cancer. 2020 02; 18(1):e21-e27. Ten Ham RMT, Broering JM, Cooperberg MR, Carroll P, Wilson LS. PMID: 31796344.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    143. Active surveillance for intermediate-risk prostate cancer: yes, but for whom? Curr Opin Urol. 2019 11; 29(6):605-611. Overland MR, Washington SL, Carroll PR, Cooperberg MR, Herlemann A. PMID: 31436567.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    144. African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study. J Urol. 2020 04; 203(4):727-733. Schenk JM, Newcomb LF, Zheng Y, Faino AV, Zhu K, Nyame YA, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW. PMID: 31651227; PMCID: PMC7384451.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    145. Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer. J Urol. 2020 Apr; 203(4):706-712. Bjurlin MA, Carroll PR, Eggener S, Fulgham PF, Margolis DJ, Pinto PA, Rosenkrantz AB, Rubenstein JN, Rukstalis DB, Taneja SS, Turkbey B. PMID: 31642740; PMCID: PMC8274953.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansPHPublic Health
    146. Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohorts. Cancer. 2020 02 01; 126(3):583-592. Lange JM, Laviana AA, Penson DF, Lin DW, Bill-Axelson A, Carlsson SV, Newcomb LF, Trock BJ, Carter HB, Carroll PR, Cooperberg MR, Cowan JE, Klotz LH, Etzioni RB. PMID: 31639200; PMCID: PMC6980275.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    147. A GABAergic Maf-expressing interneuron subset regulates the speed of locomotion in Drosophila. Nat Commun. 2019 10 22; 10(1):4796. Babski H, Jovanic T, Surel C, Yoshikawa S, Zwart MF, Valmier J, Thomas JB, Enriquez J, Carroll P, Garcès A. PMID: 31641138; PMCID: PMC6805931.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    148. Reply by Authors. J Urol. 2019 11; 202(5):958. Gross MD, Sedrakyan A, Bianco FJ, Carroll PR, Daskivich TJ, Eggener SE, Ehdaie B, Fisher B, Gorin MA, Hunt B, Jiang H, Klein EA, Marinac-Dabic D, Montgomery JS, Polascik TJ, Priester AM, Rastinehad AR, Viviano CJ, Wysock JS, Hu JC. PMID: 31364932.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    149. SPARED Collaboration: Patient Selection for Partial Gland Ablation in Men with Localized Prostate Cancer. J Urol. 2019 11; 202(5):952-958. Gross MD, Sedrakyan A, Bianco FJ, Carroll PR, Daskivich TJ, Eggener SE, Ehdaie B, Fisher B, Gorin MA, Hunt B, Jiang H, Klein EA, Marinac-Dabic D, Montgomery JS, Polascik TJ, Priester AM, Rastinehad AR, Viviano CJ, Wysock JS, Hu JC. PMID: 31144591.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    150. Hematuria Practice Guidelines That Explicitly Consider Harms and Costs. JAMA Intern Med. 2019 Oct 01; 179(10):1362-1364. Bauer SR, Carroll PR, Grady D. PMID: 31355847; PMCID: PMC6986985.
      View in: PubMed   Mentions:    Fields:    
    151. Germline testing in those at risk of prostate cancer. Can J Urol. 2019 Oct; 26(5 Suppl 2):31-33. Carroll PR, Witte JS, Parsons JK. PMID: 31629425.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    152. Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public Workshop. J Urol. 2020 01; 203(1):115-119. Weinstock C, Suzman D, Kluetz P, Baxley J, Viviano C, Ibrahim A, Jarow J, Sridhara R, Liu K, Carroll P, Eggener S, Hu JC, Hussain M, King M, Klein E, Kungel T, Makarov D, Pinto PA, Rini B, Roach M, Sandler H, Schlegel PN, Song D, Goldberg K, Pazdur R, Beaver JA. PMID: 31502940; PMCID: PMC8274949.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    153. A 17-Gene Genomic Prostate Score as a Predictor of Adverse Pathology in Men on Active Surveillance. J Urol. 2019 10; 202(4):702-709. Kornberg Z, Cooperberg MR, Cowan JE, Chan JM, Shinohara K, Simko JP, Tenggara I, Carroll PR. PMID: 31026214.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    154. Trends in Complementary and Alternative Medicine Use among Patients with Prostate Cancer. J Urol. 2019 10; 202(4):689-695. Zuniga KB, Zhao S, Kenfield SA, Cedars B, Cowan JE, Van Blarigan EL, Broering JM, Carroll PR, Chan JM. PMID: 31091175; PMCID: PMC7017721.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    155. Identification and Characterization of Circulating Tumor Cells in Men Who have Undergone Prostatectomy for Clinically Localized, High Risk Prostate Cancer. J Urol. 2019 10; 202(4):732-741. Friedlander TW, Welty C, Anantharaman A, Schonhoft JD, Jendrisak A, Lee J, Li P, Hough J, Stromlund A, Edwards M, Sangar S, Kobayashi Y, Simko J, Farrokhian N, Lindquist K, Greene S, Ontiveros P, Graf R, Rodriquez A, Suraneni M, Wang Y, Landers M, Carroll P, Cooperberg MR, Dittamore R, Paris PL. PMID: 31216253.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    156. Stability of a 17-Gene Genomic Prostate Score in Serial Testing of Men on Active Surveillance for Early Stage Prostate Cancer. J Urol. 2019 10; 202(4):696-701. Cedars BE, Washington SL, Cowan JE, Leapman M, Tenggara I, Chan JM, Cooperberg MR, Carroll PR. PMID: 30958742.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    157. Obesity at Diagnosis and Prostate Cancer Prognosis and Recurrence Risk Following Primary Treatment by Radical Prostatectomy. Cancer Epidemiol Biomarkers Prev. 2019 11; 28(11):1917-1925. Langlais CS, Cowan JE, Neuhaus J, Kenfield SA, Van Blarigan EL, Broering JM, Cooperberg MR, Carroll P, Chan JM. PMID: 31462398; PMCID: PMC6825577.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    158. Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance. Prostate Cancer Prostatic Dis. 2020 03; 23(1):136-143. Herlemann A, Huang HC, Alam R, Tosoian JJ, Kim HL, Klein EA, Simko JP, Chan JM, Lane BR, Davis JW, Davicioni E, Feng FY, McCue P, Kim H, Den RB, Bismar TA, Carroll PR, Cooperberg MR. PMID: 31455846; PMCID: PMC8076042.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    159. Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts. Eur Urol. 2019 11; 76(5):693-702. Drost FH, Nieboer D, Morgan TM, Carroll PR, Roobol MJ, Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP) Consortium. PMID: 31451332.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    160. Evaluating the Safety of Active Surveillance: Outcomes of Deferred Radical Prostatectomy after an Initial Period of Surveillance. J Urol. 2019 09; 202(3):506-510. Balakrishnan AS, Cowan JE, Cooperberg MR, Shinohara K, Nguyen HG, Carroll PR. PMID: 30958738.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    161. Guidelines should be assessed based on the underlying evidence. CMAJ. 2019 08 06; 191(31):E871. Carroll PR, Parsons JK. PMID: 31387962; PMCID: PMC6682483.
      View in: PubMed   Mentions:    Fields:    
    162. Robust Health Utility Assessment Among Long-term Survivors of Prostate Cancer: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor Registry. Eur Urol. 2019 12; 76(6):743-751. Jeong CW, Cowan JE, Broering JM, Ten Ham RMT, Wilson LS, Carroll PR, Cooperberg MR. PMID: 31345635.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    163. Detection of clinically signifi cant prostate cancer with PIRADS v2 scores, PSA density, and ADC values in regions with and without mpMRI visible lesions. Int Braz J Urol. 2019 Jul-Aug; 45(4):713-723. Westphalen AC, Fazel F, Nguyen H, Cabarrus M, Hanley-Knutson K, Shinohara K, Carroll PR. PMID: 31136112; PMCID: PMC6837611.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    164. Automating the Capture of Structured Pathology Data for Prostate Cancer Clinical Care and Research. JCO Clin Cancer Inform. 2019 07; 3:1-8. Odisho AY, Bridge M, Webb M, Ameli N, Eapen RS, Stauf F, Cowan JE, Washington SL, Herlemann A, Carroll PR, Cooperberg MR. PMID: 31314550; PMCID: PMC6874052.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    165. Correlation of a Commercial Genomic Risk Classifier with Histological Patterns in Prostate Cancer. J Urol. 2019 07; 202(1):90-95. Greenland NY, Zhang L, Cowan JE, Carroll PR, Stohr BA, Simko JP. PMID: 30810466.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    166. A Mobile Health Intervention for Prostate Biopsy Patients Reduces Appointment Cancellations: Cohort Study. J Med Internet Res. 2019 06 02; 21(6):e14094. Balakrishnan AS, Nguyen HG, Shinohara K, Au Yeung R, Carroll PR, Odisho AY. PMID: 31199294; PMCID: PMC6592401.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    167. Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial. JAMA Oncol. 2019 Jun 01; 5(6):856-863. Fendler WP, Calais J, Eiber M, Flavell RR, Mishoe A, Feng FY, Nguyen HG, Reiter RE, Rettig MB, Okamoto S, Emmett L, Zacho HD, Ilhan H, Wetter A, Rischpler C, Schoder H, Burger IA, Gartmann J, Smith R, Small EJ, Slavik R, Carroll PR, Herrmann K, Czernin J, Hope TA. PMID: 30920593; PMCID: PMC6567829.
      View in: PubMed   Mentions: 231     Fields:    Translation:HumansCTClinical Trials
    168. Trends and Predictors of Adjuvant Therapy for Adverse Features Following Radical Prostatectomy: An Analysis From Cancer of the Prostate Strategic Urologic Research Endeavor. Urology. 2019 Sep; 131:157-165. Balakrishnan AS, Zhao S, Cowan JE, Broering JM, Cooperberg MR, Carroll PR. PMID: 31150694.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    169. The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement. Eur Urol. 2019 Sep; 76(3):268-272. Cooperberg MR, Carroll PR, Dall'Era MA, Davies BJ, Davis JW, Eggener SE, Feng FY, Lin DW, Morgan TM, Morgans AK, Spratt DE, Taneja SS, Penson DF. PMID: 31128968.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    170. Single-Center Prospective Evaluation of 68Ga-PSMA-11 PET in Biochemical Recurrence of Prostate Cancer. AJR Am J Roentgenol. 2019 08; 213(2):266-274. Lawhn-Heath C, Flavell RR, Behr SC, Yohannan T, Greene KL, Feng F, Carroll PR, Hope TA. PMID: 31039025.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    171. Editorial Comment. J Urol. 2019 04; 201(4):820. Carroll P, Schmidt B. PMID: 30947462.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    172. Location of Recurrence by Gallium-68 PSMA-11 PET Scan in Prostate Cancer Patients Eligible for Salvage Radiotherapy. Urology. 2019 07; 129:165-171. Boreta L, Gadzinski AJ, Wu SY, Xu M, Greene K, Quanstrom K, Nguyen HG, Carroll PR, Hope TA, Feng FY. PMID: 30928607.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    173. Longitudinal Comparison of Patient-Level Outcomes and Costs Across Prostate Cancer Treatments With Urinary Problems. Am J Mens Health. 2019 Mar-Apr; 13(2):1557988319835326. Tang J, Zhong L, Paoli C, Paciorek A, Carroll P, Wilson L. PMID: 30836832; PMCID: PMC6440060.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    174. The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target. J Natl Cancer Inst. 2019 03 01; 111(3):301-310. Zhao SG, Lehrer J, Chang SL, Das R, Erho N, Liu Y, Sjöström M, Den RB, Freedland SJ, Klein EA, Karnes RJ, Schaeffer EM, Xu M, Speers C, Nguyen PL, Ross AE, Chan JM, Cooperberg MR, Carroll PR, Davicioni E, Fong L, Spratt DE, Feng FY. PMID: 30321406.
      View in: PubMed   Mentions: 97     Fields:    Translation:Humans
    175. Editorial Comment. J Urol. 2019 02; 201(2):298-299. Carroll P. PMID: 30634361.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    176. Genomic Prostate Score, PI-RADS™ version 2 and Progression in Men with Prostate Cancer on Active Surveillance. J Urol. 2019 02; 201(2):300-307. Kornberg Z, Cowan JE, Westphalen AC, Cooperberg MR, Chan JM, Zhao S, Shinohara K, Carroll PR. PMID: 30179620.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    177. Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS). Prostate Cancer Prostatic Dis. 2019 09; 22(3):438-445. Newcomb LF, Zheng Y, Faino AV, Bianchi-Frias D, Cooperberg MR, Brown MD, Brooks JD, Dash A, Fabrizio MD, Gleave ME, Liss M, Morgan TM, Thompson IM, Wagner AA, Carroll PR, Nelson PS, Lin DW. PMID: 30664734; PMCID: PMC6642858.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    178. Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer. Eur Urol Oncol. 2019 11; 2(6):685-690. Xu MJ, Kornberg Z, Gadzinski AJ, Diao D, Cowan JE, Wu SY, Boreta L, Spratt DE, Behr SC, Nguyen HG, Cooperberg MR, Davicioni E, Roach M, Hope TA, Carroll PR, Feng FY. PMID: 31411984.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    179. Feasibility, Acceptability, and Behavioral Outcomes from a Technology-enhanced Behavioral Change Intervention (Prostate 8): A Pilot Randomized Controlled Trial in Men with Prostate Cancer. Eur Urol. 2019 06; 75(6):950-958. Kenfield SA, Van Blarigan EL, Ameli N, Lavaki E, Cedars B, Paciorek AT, Monroy C, Tantum LK, Newton RU, Signorell C, Suh JH, Zhang L, Cooperberg MR, Carroll PR, Chan JM. PMID: 30638635.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    180. Continued 5α-Reductase Inhibitor Use after Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the PASS. J Urol. 2019 01; 201(1):106-111. Kearns JT, Faino AV, Schenk JM, Newcomb LF, Brooks JD, Carroll PR, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner A, Zheng Y, Lin DW. PMID: 30076904; PMCID: PMC10958899.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    181. Impact of Staging 68Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate Cancer. Urology. 2019 03; 125:154-162. Wu SY, Boreta L, Shinohara K, Nguyen H, Gottschalk AR, Hsu IC, Roach M, Westphalen AC, Feng FY, Carroll PR, Chang AJ, Hope TA. PMID: 30580002.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    182. Metaanalysis of 68Ga-PSMA-11 PET Accuracy for the Detection of Prostate Cancer Validated by Histopathology. J Nucl Med. 2019 06; 60(6):786-793. Hope TA, Goodman JZ, Allen IE, Calais J, Fendler WP, Carroll PR. PMID: 30530831; PMCID: PMC6581235.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    183. Phase I Study of CTT1057, an 18F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer. J Nucl Med. 2019 07; 60(7):910-916. Behr SC, Aggarwal R, VanBrocklin HF, Flavell RR, Gao K, Small EJ, Blecha J, Jivan S, Hope TA, Simko JP, Kurhanewicz J, Noworolski SM, Korn NJ, De Los Santos R, Cooperberg MR, Carroll PR, Nguyen HG, Greene KL, Langton-Webster B, Berkman CE, Seo Y. PMID: 30464040; PMCID: PMC6604687.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    184. Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2018 Nov 15; 7(11):e11257. Winters-Stone KM, Kenfield SA, Van Blarigan EL, Moe EL, Ramsdill JW, Daniel K, Macaire G, Paich K, Kessler ER, Kucuk O, Gillespie TW, Lyons KS, Beer TM, Broering JM, Carroll PR, Chan JM. PMID: 30442638; PMCID: PMC6265599.
      View in: PubMed   Mentions: 5  
    185. Diagnostic Accuracy of 68Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer. Radiology. 2018 12; 289(3):730-737. Hicks RM, Simko JP, Westphalen AC, Nguyen HG, Greene KL, Zhang L, Carroll PR, Hope TA. PMID: 30226456; PMCID: PMC6283324.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    186. A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial Biopsy. Eur Urol. 2018 12; 74(6):731-738. McKiernan J, Donovan MJ, Margolis E, Partin A, Carter B, Brown G, Torkler P, Noerholm M, Skog J, Shore N, Andriole G, Thompson I, Carroll P. PMID: 30237023.
      View in: PubMed   Mentions: 110     Fields:    Translation:HumansCellsCTClinical Trials
    187. Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies. Eur Urol Oncol. 2019 05; 2(3):333-336. van der Kwast TH, Helleman J, Nieboer D, Bruinsma SM, Roobol MJ, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium, Trock B, Ehdaie B, Carroll P, Filson C, Kim J, Logothetis C, Morgan T, Klotz L, Pickles T, Hyndman E, Moore CM, Gnanapragasam V, Van Hemelrijck M, Dasgupta P, Bangma C, Roobol M, Villers A, Rannikko A, Valdagni R, Perry A, Hugosson J, Rubio-Briones J, Bjartell A, Hefermehl L, Shiong LL, Frydenberg M, Kakehi Y, Chung BH, van der Kwast T, Obbink H, van der Linden W, Hulsen T, de Jonge C, Kattan M, Xinge J, Muir K, Lophatananon A, Fahey M, Steyerberg E, Nieboer D, Zhang L, Guo W, Benfante N, Cowan J, Patil D, Tolosa E, Kim TK, Mamedov A, LaPointe V, Crump T, Kimberly-Duffell J, Santaolalla A, Nieboer D, Olivier JT, Rancati T, Ahlgren H, Mascarós J, Löfgren A, Lehmann K, Lin CH, Hirama H, Lee KS, Jenster G, Auvinen A, Bjartell A, Haider M, van Bochove K, Carter B, Gledhill S, Buzza M, Bangma C, Roobol M, Bruinsma S, Helleman J. PMID: 31200849.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    188. Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy. Eur Urol. 2018 11; 74(5):668-675. Leapman MS, Nguyen HG, Cowan JE, Xue L, Stohr B, Simko J, Cooperberg MR, Carroll PR. PMID: 30181067.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    189. Practice patterns of primary EBRT with and without ADT in prostate cancer treatment. Prostate Cancer Prostatic Dis. 2019 03; 22(1):117-124. Schmidt B, Eapen RS, Cowan JE, Broering JM, Greene KL, Carroll PR, Cooperberg MR. PMID: 30171230.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    190. USPTF Prostate Cancer Screening Recommendations-A Step in the Right Direction. JAMA Surg. 2018 08 01; 153(8):701-702. Carroll PR. PMID: 29801146.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    191. Effect of Oscillation on Perineal Pressure in Cyclists: Implications for Micro-Trauma. Sex Med. 2018 Sep; 6(3):239-247. Sanford T, Gadzinski AJ, Gaither T, Osterberg EC, Murphy GP, Carroll PR, Breyer BN. PMID: 29936216; PMCID: PMC6085221.
      View in: PubMed   Mentions: 2  
    192. The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer. Eur Urol. 2018 10; 74(4):444-452. Cooperberg MR, Erho N, Chan JM, Feng FY, Fishbane N, Zhao SG, Simko JP, Cowan JE, Lehrer J, Alshalalfa M, Kolisnik T, Chelliserry J, Margrave J, Aranes M, Plessis MD, Buerki C, Tenggara I, Davicioni E, Carroll PR. PMID: 29853306; PMCID: PMC6586429.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    193. Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer. Eur Urol Oncol. 2018 10; 1(5):386-394. Masic S, Cowan JE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 31158077.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    194. Optimal Radical Therapy for Localized Prostate Cancer: Recreation of the Self-Fulfilling Prophecy With Combination Brachytherapy? J Clin Oncol. 2018 10 10; 36(29):2914-2917. Spratt DE, Carroll PR. PMID: 29782208.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    195. Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer. Eur Urol Oncol. 2018 05; 1(1):78-82. Aggarwal R, Wei X, Kim W, Small EJ, Ryan CJ, Carroll P, Cooperberg M, Evans MJ, Hope T. PMID: 31100231.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    196. Development of a stress response therapy targeting aggressive prostate cancer. Sci Transl Med. 2018 05 02; 10(439). Nguyen HG, Conn CS, Kye Y, Xue L, Forester CM, Cowan JE, Hsieh AC, Cunningham JT, Truillet C, Tameire F, Evans MJ, Evans CP, Yang JC, Hann B, Koumenis C, Walter P, Carroll PR, Ruggero D. PMID: 29720449; PMCID: PMC6045425.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansAnimalsCells
    197. Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study. Eur Urol. 2018 05; 73(5):706-712. Kearns JT, Faino AV, Newcomb LF, Brooks JD, Carroll PR, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Zheng Y, Lin DW. PMID: 29433973; PMCID: PMC6064187.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    198. Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes. Eur Urol. 2018 08; 74(2):211-217. Cooperberg MR, Brooks JD, Faino AV, Newcomb LF, Kearns JT, Carroll PR, Dash A, Etzioni R, Fabrizio MD, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW, Zheng Y. PMID: 29433975; PMCID: PMC6263168.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    199. Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer. Oncotarget. 2018 Jan 19; 9(5):6550-6561. Sahoo D, Wei W, Auman H, Hurtado-Coll A, Carroll PR, Fazli L, Gleave ME, Lin DW, Nelson PS, Simko J, Thompson IM, Leach RJ, Troyer DA, True LD, McKenney JK, Feng Z, Brooks JD. PMID: 29464091; PMCID: PMC5814231.
      View in: PubMed   Mentions: 7     Fields:    
    200. Scatter Artifact with Ga-68-PSMA-11 PET: Severity Reduced With Furosemide Diuresis and Improved Scatter Correction. Mol Imaging. 2018 Jan-Dec; 17:1536012118811741. Lawhn-Heath C, Flavell RR, Korenchan DE, Deller T, Lake S, Carroll PR, Hope TA. PMID: 31749411; PMCID: PMC6287320.
      View in: PubMed   Mentions: 3     Fields:    
    201. Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy. JAMA Oncol. 2017 12 01; 3(12):1663-1672. Zhao SG, Chang SL, Erho N, Yu M, Lehrer J, Alshalalfa M, Speers C, Cooperberg MR, Kim W, Ryan CJ, Den RB, Freedland SJ, Posadas E, Sandler H, Klein EA, Black P, Seiler R, Tomlins SA, Chinnaiyan AM, Jenkins RB, Davicioni E, Ross AE, Schaeffer EM, Nguyen PL, Carroll PR, Karnes RJ, Spratt DE, Feng FY. PMID: 28494073; PMCID: PMC5824281.
      View in: PubMed   Mentions: 135     Fields:    Translation:Humans
    202. Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer. J Clin Oncol. 2018 02 20; 36(6):581-590. Spratt DE, Zhang J, Santiago-Jiménez M, Dess RT, Davis JW, Den RB, Dicker AP, Kane CJ, Pollack A, Stoyanova R, Abdollah F, Ross AE, Cole A, Uchio E, Randall JM, Nguyen H, Zhao SG, Mehra R, Glass AG, Lam LLC, Chelliserry J, du Plessis M, Choeurng V, Aranes M, Kolisnik T, Margrave J, Alter J, Jordan J, Buerki C, Yousefi K, Haddad Z, Davicioni E, Trabulsi EJ, Loeb S, Tewari A, Carroll PR, Weinmann S, Schaeffer EM, Klein EA, Karnes RJ, Feng FY, Nguyen PL. PMID: 29185869; PMCID: PMC6530900.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    203. Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance Cohorts. Ann Intern Med. 2018 01 02; 168(1):1-9. Inoue LYT, Lin DW, Newcomb LF, Leonardson AS, Ankerst D, Gulati R, Carter HB, Trock BJ, Carroll PR, Cooperberg MR, Cowan JE, Klotz LH, Mamedov A, Penson DF, Etzioni R. PMID: 29181514; PMCID: PMC5752581.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    204. Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSURE™). Prostate. 2018 Jan; 78(1):32-39. Tat D, Kenfield SA, Cowan JE, Broering JM, Carroll PR, Van Blarigan EL, Chan JM. PMID: 29105845; PMCID: PMC5716878.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    205. Cycling, and Male Sexual and Urinary Function: Results from a Large, Multinational, Cross-Sectional Study. J Urol. 2018 03; 199(3):798-804. Awad MA, Gaither TW, Murphy GP, Chumnarnsongkhroh T, Metzler I, Sanford T, Sutcliffe S, Eisenberg ML, Carroll PR, Osterberg EC, Breyer BN. PMID: 29031767.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    206. Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa). PLoS One. 2017; 12(10):e0185535. Leapman MS, Westphalen AC, Ameli N, Lawrence HJ, Febbo PG, Cooperberg MR, Carroll PR. PMID: 29016610; PMCID: PMC5634556.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    207. Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers. Prostate. 2017 Dec; 77(16):1573-1582. Zhou CK, Stanczyk FZ, Hafi M, Veneroso CC, Lynch B, Falk RT, Niwa S, Emanuel E, Gao YT, Hemstreet GP, Zolfghari L, Carroll PR, Manyak MJ, Sesterhenn IA, Levine PH, Hsing AW, Cook MB. PMID: 28971497; PMCID: PMC5683095.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    208. Characterization and stratification of prostate lesions based on comprehensive multiparametric MRI using detailed whole-mount histopathology as a reference standard. NMR Biomed. 2017 Dec; 30(12). Starobinets O, Simko JP, Kuchinsky K, Kornak J, Carroll PR, Greene KL, Kurhanewicz J, Noworolski SM. PMID: 28961382; PMCID: PMC9592076.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    209. Impact of Lesion Visibility on Transrectal Ultrasound on the Prediction of Clinically Significant Prostate Cancer (Gleason Score 3 + 4 or Greater) with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Biopsy. J Urol. 2018 03; 199(3):699-705. Garcia-Reyes K, Nguyen HG, Zagoria RJ, Shinohara K, Carroll PR, Behr SC, Westphalen AC. PMID: 28941918.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    210. Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical Prostatectomy. J Urol. 2018 03; 199(3):719-725. Nguyen HG, Welty C, Lindquist K, Ngo V, Gilbert E, Bengtsson H, Magi-Galluzzi C, Jean-Gilles J, Yao J, Cooperberg M, Messing E, Klein EA, Carroll PR, Paris PL. PMID: 28941923.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    211. Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer. EJNMMI Res. 2017 Sep 19; 7(1):77. Lake ST, Greene KL, Westphalen AC, Behr SC, Zagoria R, Small EJ, Carroll PR, Hope TA. PMID: 28929350; PMCID: PMC5605480.
      View in: PubMed   Mentions: 16  
    212. The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy. Cancer. 2017 Dec 01; 123(23):4574-4582. Welty CJ, Sanford TH, Wright JL, Carroll PR, Cooperberg MR, Meng MV, Porten SP. PMID: 28881475.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    213. Impact of the integration of proton magnetic resonance imaging spectroscopy to PI-RADS 2 for prediction of high grade and high stage prostate cancer. Radiol Bras. 2017 Sep-Oct; 50(5):299-307. Leapman MS, Wang ZJ, Behr SC, Kurhanewicz J, Zagoria RJ, Carroll PR, Westphalen AC. PMID: 29085163; PMCID: PMC5656070.
      View in: PubMed   Mentions: 5  
    214. Relationships between Circulating and Intraprostatic Sex Steroid Hormone Concentrations. Cancer Epidemiol Biomarkers Prev. 2017 11; 26(11):1660-1666. Cook MB, Stanczyk FZ, Wood SN, Pfeiffer RM, Hafi M, Veneroso CC, Lynch B, Falk RT, Zhou CK, Niwa S, Emanuel E, Gao YT, Hemstreet GP, Zolfghari L, Carroll PR, Manyak MJ, Sesterhann IA, Levine PH, Hsing AW. PMID: 28830872; PMCID: PMC5668163.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    215. Outcomes of men on active surveillance for low-risk prostate cancer at a safety-net hospital. Urol Oncol. 2017 11; 35(11):663.e9-663.e14. Osterberg EC, Palmer NRA, Harris CR, Murphy GP, Blaschko SD, Chu C, Allen IE, Cooperberg MR, Carroll PR, Breyer BN. PMID: 28826701.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    216. Impact of 68Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer. J Nucl Med. 2017 12; 58(12):1956-1961. Hope TA, Aggarwal R, Chee B, Tao D, Greene KL, Cooperberg MR, Feng F, Chang A, Ryan CJ, Small EJ, Carroll PR. PMID: 28522741.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    217. Community-based Outcomes of Open versus Robot-assisted Radical Prostatectomy. Eur Urol. 2018 02; 73(2):215-223. Herlemann A, Cowan JE, Carroll PR, Cooperberg MR. PMID: 28499617.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    218. AUA Policy Statement on the Use of Multiparametric Magnetic Resonance Imaging in the Diagnosis, Staging and Management of Prostate Cancer. J Urol. 2017 10; 198(4):832-838. Fulgham PF, Rukstalis DB, Turkbey IB, Rubenstein JN, Taneja S, Carroll PR, Pinto PA, Bjurlin MA, Eggener S. PMID: 28483574; PMCID: PMC7905434.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansPHPublic Health
    219. Management of intermediate-risk prostate cancer with active surveillance: never or sometimes? Curr Opin Urol. 2017 May; 27(3):231-237. Masic S, Washington SL, Carroll PR. PMID: 28234748.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    220. The Fitbit One Physical Activity Tracker in Men With Prostate Cancer: Validation Study. JMIR Cancer. 2017 Apr 18; 3(1):e5. Van Blarigan EL, Kenfield SA, Tantum L, Cadmus-Bertram LA, Carroll PR, Chan JM. PMID: 28420602; PMCID: PMC5413797.
      View in: PubMed   Mentions: 15  
    221. Report of the Second Asian Prostate Cancer (A-CaP) Study Meeting. Prostate Int. 2017 Sep; 5(3):95-103. Kim CS, Lee JY, Chung BH, Kim WJ, Fai NC, Hakim L, Umbas R, Ong TA, Lim J, Letran JL, Chiong E, Wu TL, Lojanapiwat B, Türkeri L, Murphy DG, Gardiner RA, Moretti K, Cooperberg M, Carroll P, Mun SK, Hinotsu S, Hirao Y, Ozono S, Horie S, Onozawa M, Kitagawa Y, Kitamura T, Namiki M, Akaza H. PMID: 28828352; PMCID: PMC5551923.
      View in: PubMed   Mentions: 3  
    222. Active Surveillance in Younger Men With Prostate Cancer. J Clin Oncol. 2017 Jun 10; 35(17):1898-1904. Leapman MS, Cowan JE, Nguyen HG, Shinohara KK, Perez N, Cooperberg MR, Catalona WJ, Carroll PR. PMID: 28346806; PMCID: PMC5466007.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    223. Interpreting Patient Reported Urinary and Sexual Function Outcomes across Multiple Validated Instruments. J Urol. 2017 09; 198(3):671-677. Vertosick EA, Vickers AJ, Cowan JE, Broering JM, Carroll PR, Cooperberg MR. PMID: 28342935; PMCID: PMC5636214.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    224. Low-risk Prostate Cancer: Identification, Management, and Outcomes. Eur Urol. 2017 08; 72(2):238-249. Moschini M, Carroll PR, Eggener SE, Epstein JI, Graefen M, Montironi R, Parker C. PMID: 28318726.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    225. Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure. Nat Rev Urol. 2017 May; 14(5):312-322. Bruinsma SM, Roobol MJ, Carroll PR, Klotz L, Pickles T, Moore CM, Gnanapragasam VJ, Villers A, Rannikko A, Valdagni R, Frydenberg M, Kakehi Y, Filson CP, Bangma CH, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium. PMID: 28290462.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    226. A randomised clinical study to determine the effect of a toothpaste containing enzymes and proteins on plaque oral microbiome ecology. Sci Rep. 2017 02 27; 7:43344. Adams SE, Arnold D, Murphy B, Carroll P, Green AK, Smith AM, Marsh PD, Chen T, Marriott RE, Brading MG. PMID: 28240240; PMCID: PMC5327414.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    227. Medicine information exchange networks among healthcare professionals and prescribing in geriatric medicine wards. Br J Clin Pharmacol. 2017 06; 83(6):1185-1196. Chan B, Reeve E, Matthews S, Carroll PR, Long JC, Held F, Latt M, Naganathan V, Caplan GA, Hilmer SN. PMID: 28009444; PMCID: PMC5427233.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    228. Application of a Prognostic Gleason Grade Grouping System to Assess Distant Prostate Cancer Outcomes. Eur Urol. 2017 05; 71(5):750-759. Leapman MS, Cowan JE, Simko J, Roberge G, Stohr BA, Carroll PR, Cooperberg MR. PMID: 27940155.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    229. Tissue Sources for Accurate Measurement of Germline DNA Genotypes in Prostate Cancer Patients Treated With Radical Prostatectomy. Prostate. 2017 03; 77(4):425-434. Emami NC, Leong L, Wan E, Van Blarigan EL, Cooperberg MR, Tenggara I, Carroll PR, Chan JM, Witte JS, Simko JP. PMID: 27900799; PMCID: PMC5479703.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    230. Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study. Eur Urol. 2017 09; 72(3):448-454. Lin DW, Newcomb LF, Brown MD, Sjoberg DD, Dong Y, Brooks JD, Carroll PR, Cooperberg M, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Zheng Y, Canary Prostate Active Surveillance Study Investigators. PMID: 27889277; PMCID: PMC7327706.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    231. MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study. PLoS One. 2016; 11(11):e0165236. Eminaga O, Wei W, Hawley SJ, Auman H, Newcomb LF, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave ME, Lin DW, Nelson PS, Thompson IM, True LD, McKenney JK, Feng Z, Fazli L, Brooks JD. PMID: 27846218; PMCID: PMC5112958.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    232. Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort. Am J Surg Pathol. 2016 11; 40(11):1439-1456. McKenney JK, Wei W, Hawley S, Auman H, Newcomb LF, Boyer HD, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Tretiakova MS, Vakar-Lopez F, Carroll PR, Cooperberg MR, Gleave ME, Lance RS, Lin DW, Nelson PS, Thompson IM, True LD, Feng Z, Brooks JD. PMID: 27635949.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    233. Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study. J Urol. 2017 04; 197(4):1026-1033. Macleod LC, Ellis WJ, Newcomb LF, Zheng Y, Brooks JD, Carroll PR, Gleave ME, Lance RS, Nelson PS, Thompson IM, Wagner AA, Wei JT, Lin DW. PMID: 27810448; PMCID: PMC5571762.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    234. Risk Stratification of Newly Diagnosed Prostate Cancer with Genomic Platforms. Urol Pract. 2017 Jul; 4(4):322-328. Leapman MS, Carroll PR. PMID: 37592678.
      View in: PubMed   Mentions:
    235. Variation and Predictors of Surgical Case Costs among Urologists. Urol Pract. 2017 Jul; 4(4):277-284. Hampson LA, Odisho AY, Meng MV, Carroll PR. PMID: 30906821; PMCID: PMC6425944.
      View in: PubMed   Mentions: 1  
    236. What is the best way not to treat prostate cancer? Urol Oncol. 2017 02; 35(2):42-50. Leapman MS, Carroll PR. PMID: 27746147.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    237. Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis. Lancet Oncol. 2016 Nov; 17(11):1612-1620. Zhao SG, Chang SL, Spratt DE, Erho N, Yu M, Ashab HA, Alshalalfa M, Speers C, Tomlins SA, Davicioni E, Dicker AP, Carroll PR, Cooperberg MR, Freedland SJ, Karnes RJ, Ross AE, Schaeffer EM, Den RB, Nguyen PL, Feng FY. PMID: 27743920.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCells
    238. Setting an Agenda for Assessment of Health-related Quality of Life Among Men with Prostate Cancer on Active Surveillance: A Consensus Paper from a European School of Oncology Task Force. Eur Urol. 2017 02; 71(2):274-280. Villa S, Kendel F, Venderbos L, Rancati T, Bangma C, Carroll P, Denis L, Klotz L, Korfage IJ, Lane AJ, Magnani T, Mastris K, Rannikko A, Roobol M, Trock B, Van den Bergh R, Van Poppel H, Valdagni R, Bellardita L. PMID: 27720532.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    239. Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes. PLoS One. 2016; 11(10):e0164558. Garcia MM, Gottschalk AR, Brajtbord J, Konety BR, Meng MV, Roach M, Carroll PR. PMID: 27711167; PMCID: PMC5053526.
      View in: PubMed   Mentions:    Fields:    
    240. Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer. Cancer Immunol Res. 2016 11; 4(11):948-958. Wei XX, Chan S, Kwek S, Lewis J, Dao V, Zhang L, Cooperberg MR, Ryan CJ, Lin AM, Friedlander TW, Rini B, Kane C, Simko JP, Carroll PR, Small EJ, Fong L. PMID: 27688020; PMCID: PMC5115633.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    241. A Randomized Study of Intraoperative Autologous Retropubic Urethral Sling on Urinary Control after Robotic Assisted Radical Prostatectomy. J Urol. 2017 02; 197(2):369-375. Nguyen HG, Punnen S, Cowan JE, Leapman M, Cary C, Welty C, Weinberg V, Cooperberg MR, Meng MV, Greene KL, Garcia M, Carroll PR. PMID: 27693447.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    242. 68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience. J Nucl Med. 2017 Jan; 58(1):81-84. Hope TA, Truillet C, Ehman EC, Afshar-Oromieh A, Aggarwal R, Ryan CJ, Carroll PR, Small EJ, Evans MJ. PMID: 27660139; PMCID: PMC5209643.
      View in: PubMed   Mentions: 87     Fields:    Translation:HumansAnimalsCells
    243. A complicated case of splenic injury after colonoscopy - a video vignette. Colorectal Dis. 2016 Sep; 18(9):920-1. Kelly B, Heneghan H, Carroll P, McDermott E. PMID: 27454078.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    244. Magnetic Resonance Imaging-Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance. Eur Urol. 2017 08; 72(2):275-281. Tran GN, Leapman MS, Nguyen HG, Cowan JE, Shinohara K, Westphalen AC, Carroll PR. PMID: 27595378.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    245. 18F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate- to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons. Radiology. 2017 Feb; 282(2):429-436. Choi JY, Yang J, Noworolski SM, Behr S, Chang AJ, Simko JP, Nguyen HG, Carroll PR, Kurhanewicz J, Seo Y. PMID: 27513849; PMCID: PMC5283870.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    246. Validity of the Cancer of the Prostate Risk Assessment Score Derived From Targeted Biopsy: Modeling Evidence From Ultrasound Lesion-Directed Biopsy. Clin Genitourin Cancer. 2017 02; 15(1):93-99. Leapman MS, Ameli N, Shinohara K, Nguyen HG, Meng MV, Cooperberg MR, Carroll PR. PMID: 27522449.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    247. A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment. Prostate Cancer Prostatic Dis. 2016 12; 19(4):390-394. Liss MA, Schenk JM, Faino AV, Newcomb LF, Boyer H, Brooks JD, Carroll PR, Dash A, Fabrizio MD, Gleave ME, Nelson PS, Neuhouser ML, Wei JT, Zheng Y, Wright JL, Lin DW, Thompson IM. PMID: 27431498; PMCID: PMC5564326.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    248. An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care. Urology. 2016 Oct; 96:116-120. Crawford ED, Rosenberg MT, Partin AW, Cooperberg MR, Maccini M, Loeb S, Pettaway CA, Shore ND, Arangua P, Hoenemeyer J, Leveridge M, Leapman M, Pinto P, Thompson IM, Carroll P, Eastham J, Gomella L, Klein EA. PMID: 27450937; PMCID: PMC5568096.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    249. A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy. JAMA Oncol. 2016 Jul 01; 2(7):882-9. McKiernan J, Donovan MJ, O'Neill V, Bentink S, Noerholm M, Belzer S, Skog J, Kattan MW, Partin A, Andriole G, Brown G, Wei JT, Thompson IM, Carroll P. PMID: 27032035.
      View in: PubMed   Mentions: 265     Fields:    Translation:HumansCells
    250. Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy. J Urol. 2016 11; 196(5):1408-1414. Leapman MS, Freedland SJ, Aronson WJ, Kane CJ, Terris MK, Walker K, Amling CL, Carroll PR, Cooperberg MR. PMID: 27352635; PMCID: PMC5542578.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    251. Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task Force. Eur Urol. 2017 04; 71(4):648-655. Moore CM, Giganti F, Albertsen P, Allen C, Bangma C, Briganti A, Carroll P, Haider M, Kasivisvanathan V, Kirkham A, Klotz L, Ouzzane A, Padhani AR, Panebianco V, Pinto P, Puech P, Rannikko A, Renard-Penna R, Touijer K, Turkbey B, van Poppel H, Valdagni R, Walz J, Schoots I. PMID: 27349615.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    252. Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort. Prostate. 2016 11; 76(15):1409-19. Brooks JD, Wei W, Pollack JR, West RB, Shin JH, Sunwoo JB, Hawley SJ, Auman H, Newcomb LF, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave ME, Lin DW, Nelson PS, Thompson IM, True LD, McKenney JK, Feng Z, Fazli L. PMID: 27325561; PMCID: PMC5557496.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    253. PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer. Eur Urol Focus. 2016 Jun; 2(2):180-188. Lotan TL, Wei W, Morais CL, Hawley ST, Fazli L, Hurtado-Coll A, Troyer D, McKenney JK, Simko J, Carroll PR, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, True LD, Feng Z, Brooks JD. PMID: 27617307; PMCID: PMC5014432.
      View in: PubMed   Mentions: 33     Fields:    
    254. Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH. Mod Pathol. 2016 08; 29(8):904-14. Lotan TL, Wei W, Ludkovski O, Morais CL, Guedes LB, Jamaspishvili T, Lopez K, Hawley ST, Feng Z, Fazli L, Hurtado-Coll A, McKenney JK, Simko J, Carroll PR, Gleave M, Lin DW, Nelson PS, Thompson IM, True LD, Brooks JD, Lance R, Troyer D, Squire JA. PMID: 27174589; PMCID: PMC4967011.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    255. Quantified Clinical Risk Change as an End Point During Prostate Cancer Active Surveillance. Eur Urol. 2017 09; 72(3):329-332. Leapman MS, Ameli N, Cooperberg MR, Chu C, Hussein A, Shinohara K, Carroll PR. PMID: 27157998.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    256. Immediate androgen deprivation: for all or for some? Lancet Oncol. 2016 06; 17(6):683-684. Leapman MS, Carroll PR. PMID: 27155739.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    257. Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies. Prostate Cancer Prostatic Dis. 2016 09; 19(3):264-70. Tretiakova MS, Wei W, Boyer HD, Newcomb LF, Hawley S, Auman H, Vakar-Lopez F, McKenney JK, Fazli L, Simko J, Troyer DA, Hurtado-Coll A, Thompson IM, Carroll PR, Ellis WJ, Gleave ME, Nelson PS, Lin DW, True LD, Feng Z, Brooks JD. PMID: 27136741; PMCID: PMC5536893.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    258. NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016. J Natl Compr Canc Netw. 2016 May; 14(5):509-19. Carroll PR, Parsons JK, Andriole G, Bahnson RR, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP, Kawachi MH, Kim S, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Moses KA, Nadler RB, Poch M, Scales C, Shaneyfelt TM, Smaldone MC, Sonn G, Sprenkle P, Vickers AJ, Wake R, Shead DA, Freedman-Cass DA. PMID: 27160230; PMCID: PMC10184498.
      View in: PubMed   Mentions: 142     Fields:    Translation:Humans
    259. Serial Anatomical Prostate Ultrasound during Prostate Cancer Active Surveillance. J Urol. 2016 Sep; 196(3):727-33. Eltemamy MM, Leapman MS, Cowan JE, Westphalen A, Shinohara K, Carroll PR. PMID: 27117443.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    260. Long-term Outcomes Following Radiation Therapy For Prostate Cancer Patients With Lymph Node Metastases at Diagnosis Treated With and Without Surgery. Am J Clin Oncol. 2016 Apr; 39(2):167-72. Crehange G, Izaguirre A, Weinberg V, Hsu CC, Gottschalk AR, Hsu IC, Shinohara K, Carroll P, Roach M. PMID: 24441584.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    261. Asia prostate cancer study (A-CaP Study) launch symposium. Prostate Int. 2016 Sep; 4(3):88-96. Akaza H, Hirao Y, Kim CS, Oya M, Ozono S, Ye D, Cooperberg M, Hinotsu S, Lee JY, Zhu G, Namiki M, Horie S, Chung BH, Chen CH, Fai NC, Hakim L, Chiong E, Letran J, Umbas R, Suzuki K, Nishimura K, Ong TA, Lojanapiwat B, Wu TL, Kim WJ, Murphy D, Ogawa O, Carroll P, Naito S, Tsukamoto T. PMID: 27689065; PMCID: PMC5031897.
      View in: PubMed   Mentions: 6  
    262. Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens. J Mol Diagn. 2016 05; 18(3):395-406. Knudsen BS, Kim HL, Erho N, Shin H, Alshalalfa M, Lam LLC, Tenggara I, Chadwich K, Van Der Kwast T, Fleshner N, Davicioni E, Carroll PR, Cooperberg MR, Chan JM, Simko JP. PMID: 26945428; PMCID: PMC4851733.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    263. Active surveillance for prostate cancer: a narrative review of clinical guidelines. Nat Rev Urol. 2016 Mar; 13(3):151-67. Bruinsma SM, Bangma CH, Carroll PR, Leapman MS, Rannikko A, Petrides N, Weerakoon M, Bokhorst LP, Roobol MJ, Movember GAP3 consortium. PMID: 26813955.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    264. Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score. Urology. 2016 Mar; 89:69-75. Brand TC, Zhang N, Crager MR, Maddala T, Dee A, Sesterhenn IA, Simko JP, Cooperberg MR, Srivastava S, Rosner IL, Chan JM, Febbo PG, Carroll PR, Cullen J, Lawrence HJ. PMID: 26723180.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    265. NCCN Clinical Practice Guidelines Prostate Cancer Early Detection, Version 2.2015. J Natl Compr Canc Netw. 2015 Dec; 13(12):1534-61. Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP, Kawachi MH, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Nadler RB, Poch M, Scales C, Shaneyfelt TM, Smaldone MC, Sonn G, Sprenke P, Vickers AJ, Wake R, Shead DA, Freedman-Cass D. PMID: 26656522.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansPHPublic Health
    266. Who and when should we screen for prostate cancer? Interviews with key opinion leaders. BMC Med. 2015 Nov 27; 13:288. Carlsson S, Leapman M, Carroll P, Schröder F, Albertsen PC, Ilic D, Barry M, Frosch DL, Vickers A. PMID: 26612204; PMCID: PMC4662021.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    267. Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer. Prostate. 2016 Mar; 76(4):339-48. Nordström T, Van Blarigan EL, Ngo V, Roy R, Weinberg V, Song X, Simko J, Carroll PR, Chan JM, Paris PL. PMID: 26585352; PMCID: PMC5493324.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    268. Cell type-specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors. Sci Signal. 2015 Nov 17; 8(403):ra116. Hsieh AC, Nguyen HG, Wen L, Edlind MP, Carroll PR, Kim W, Ruggero D. PMID: 26577921; PMCID: PMC4739654.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    269. Treatment Trends for Prostate Cancer--Reply. JAMA. 2015 Nov 10; 314(18):1977-8. Cooperberg MR, Carroll PR. PMID: 26547474.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    270. New Genetic Markers for Prostate Cancer. Urol Clin North Am. 2016 Feb; 43(1):7-15. Leapman MS, Carroll PR. PMID: 26614025.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    271. Bicycle Trauma Injuries and Hospital Admissions in the United States, 1998-2013. JAMA. 2015 Sep 01; 314(9):947-9. Sanford T, McCulloch CE, Callcut RA, Carroll PR, Breyer BN. PMID: 26325564; PMCID: PMC4896174.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    272. Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort. J Urol. 2016 Feb; 195(2):313-20. Newcomb LF, Thompson IM, Boyer HD, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Ellis WJ, Fazli L, Feng Z, Gleave ME, Kunju P, Lance RS, McKenney JK, Meng MV, Nicolas MM, Sanda MG, Simko J, So A, Tretiakova MS, Troyer DA, True LD, Vakar-Lopez F, Virgin J, Wagner AA, Wei JT, Zheng Y, Nelson PS, Lin DW, Canary PASS Investigators. PMID: 26327354; PMCID: PMC4970462.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansPHPublic Health
    273. Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients. PLoS One. 2015; 10(7):e0132343. Brooks JD, Wei W, Hawley S, Auman H, Newcomb L, Boyer H, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, True LD, Feng Z, McKenney JK. PMID: 26172920; PMCID: PMC4501723.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    274. Trends in Management for Patients With Localized Prostate Cancer, 1990-2013. JAMA. 2015 Jul 07; 314(1):80-2. Cooperberg MR, Carroll PR. PMID: 26151271.
      View in: PubMed   Mentions: 244     Fields:    Translation:Humans
    275. Immediate versus delayed radical prostatectomy: updated outcomes following active surveillance of prostate cancer. Eur Urol. 2015 Sep; 68(3):458-63. Filippou P, Welty CJ, Cowan JE, Perez N, Shinohara K, Carroll PR. PMID: 26138041.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    276. What is the Optimal Way to Select Candidates for Active Surveillance of Prostate Cancer? J Urol. 2015 Sep; 194(3):615-6. Dall'Era M, Carroll P. PMID: 26079332.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    277. A comparison of medical and pharmacy students' knowledge and skills of pharmacology and pharmacotherapy. Br J Clin Pharmacol. 2015 Jun; 79(6):1028-9. Hilmer SN, Seale JP, Carroll PR. PMID: 25425109; PMCID: PMC4456135.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    278. Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter? BJU Int. 2015 Nov; 116(5):713-20. Hsu CC, Paciorek AT, Cooperberg MR, Roach M, Hsu IC, Carroll PR. PMID: 25600860.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    279. Trans-Pacific variation in outcomes for men treated with primary androgen-deprivation therapy (ADT) for prostate cancer. BJU Int. 2016 Jan; 117(1):102-9. Cooperberg MR, Hinotsu S, Namiki M, Carroll PR, Akaza H. PMID: 25238114.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    280. Patterns of Local Failure following Radiation Therapy for Prostate Cancer. J Urol. 2015 Oct; 194(4):977-82. Jalloh M, Leapman MS, Cowan JE, Shinohara K, Greene KL, Roach M, Chang AJ, Chan JM, Simko JP, Carroll PR. PMID: 25983194.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    281. A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer. Prostate. 2015 Aug 01; 75(11):1206-15. Troyer DA, Jamaspishvili T, Wei W, Feng Z, Good J, Hawley S, Fazli L, McKenney JK, Simko J, Hurtado-Coll A, Carroll PR, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, True LD, Brooks JD, Squire JA. PMID: 25939393; PMCID: PMC4475421.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    282. Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator. Eur Urol. 2015 Dec; 68(6):1083-8. Ankerst DP, Xia J, Thompson IM, Hoefler J, Newcomb LF, Brooks JD, Carroll PR, Ellis WJ, Gleave ME, Lance RS, Nelson PS, Wagner AA, Wei JT, Etzioni R, Lin DW. PMID: 25819722; PMCID: PMC4583313.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    283. Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study. Eur J Cancer. 2015 May; 51(7):817-24. Garcia-Albeniz X, Chan JM, Paciorek A, Logan RW, Kenfield SA, Cooperberg MR, Carroll PR, Hernán MA. PMID: 25794605; PMCID: PMC4402138.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    284. Impact of age on quality-of-life outcomes after treatment for localized prostate cancer. Eur Urol. 2015 Sep; 68(3):480-6. Hampson LA, Cowan JE, Zhao S, Carroll PR, Cooperberg MR. PMID: 25656807.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    285. Current Use of Imaging after Primary Treatment of Prostate Cancer. J Urol. 2015 Jul; 194(1):98-104. Hussein AA, Punnen S, Zhao S, Cowan JE, Leapman M, Tran TC, Washington SL, Truesdale MD, Carroll PR, Cooperberg MR. PMID: 25640648.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    286. Mycobacterium tuberculosis H37Rv has a single nucleotide polymorphism in PhoR which affects cell wall hydrophobicity and gene expression. Microbiology (Reading). 2015 Apr; 161(Pt 4):765-773. Schreuder LJ, Carroll P, Muwanguzi-Karugaba J, Kokoczka R, Brown AC, Parish T. PMID: 25635271.
      View in: PubMed   Mentions: 8     Fields:    Translation:Cells
    287. Untreated Gleason Grade Progression on Serial Biopsies during Prostate Cancer Active Surveillance: Clinical Course and Pathological Outcomes. J Urol. 2015 Jul; 194(1):85-90. Hussein AA, Welty CJ, Ameli N, Cowan JE, Leapman M, Porten SP, Shinohara K, Carroll PR. PMID: 25623742.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    288. Active surveillance for low-risk prostate cancer: developments to date. Eur Urol. 2015 Apr; 67(4):646-8. Bangma CH, Valdagni R, Carroll PR, van Poppel H, Klotz L, Hugosson J. PMID: 25435266.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    289. Sustainable Measurement of Response Shift in Prostate Cancer Patients: Adjusting Health Related Quality of Life with the Then-Test. Value Health. 2014 Nov; 17(7):A651. Ten Ham RM, Wilson LS, Broering JM, Cooperberg MR, Carroll P. PMID: 27202352.
      View in: PubMed   Mentions:    Fields:    
    290. Overdetection of recurrence after radical prostatectomy: estimates based on patient and tumor characteristics. Clin Cancer Res. 2014 Oct 15; 20(20):5302-10. Xia J, Trock BJ, Gulati R, Mallinger L, Cooperberg MR, Carroll PR, Carter HB, Etzioni R. PMID: 25320374; PMCID: PMC4203422.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    291. Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence. Prostate. 2015 Jan; 75(1):60-9. Gerstenberger JP, Bauer SR, Van Blarigan EL, Sosa E, Song X, Witte JS, Carroll PR, Chan JM. PMID: 25284284; PMCID: PMC4257852.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    292. Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer. J Urol. 2015 Mar; 193(3):807-11. Welty CJ, Cowan JE, Nguyen H, Shinohara K, Perez N, Greene KL, Chan JM, Meng MV, Simko JP, Cooperberg MR, Carroll PR. PMID: 25261803.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    293. Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer. J Natl Cancer Inst. 2014 Nov; 106(11). Fong L, Carroll P, Weinberg V, Chan S, Lewis J, Corman J, Amling CL, Stephenson RA, Simko J, Sheikh NA, Sims RB, Frohlich MW, Small EJ. PMID: 25255802; PMCID: PMC4241888.
      View in: PubMed   Mentions: 106     Fields:    Translation:HumansCellsCTClinical Trials
    294. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry. Eur Urol. 2015 Oct; 68(4):600-8. Punnen S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR. PMID: 25242555.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    295. Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2014 Sep; 12(9):1211-9; quiz 1219. Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP, Kawachi MH, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Nadler RB, Poch M, Scales C, Shanefelt TM, Vickers AJ, Wake R, Shead DA, Ho M, National comprehensive cancer network. PMID: 25190691.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansPHPublic Health
    296. Reply to Yuri Tolkach, Markus Kuczyk, Florian Imkamp's letter to the editor re: Eric A. Klein, Matthew R. Cooperberg, Cristina Magi-Galluzzi, et al. A 17-gene assay to predict prostate cancer aggressiveness in the context of gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur urol 2014;66:550-60. Eur Urol. 2014 Dec; 66(6):e117-8. Klein EA, Cooperberg MR, Carroll PR. PMID: 25150174.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    297. Seventh Joint Meeting of K-J-CaP and CaPSURE: extending the global initiative to improve prostate cancer management. Prostate Int. 2014; 2(2):50-69. Akaza H, Kim CS, Carroll P, Choi IY, Chung BH, Cooperberg MR, Hirao Y, Hinotsu S, Horie S, Lee JY, Namiki M, Ng CF, Onozawa M, Ozono S, Ueno S, Umbas R, Ye D, Zhu G. PMID: 26153555; PMCID: PMC4099396.
      View in: PubMed   Mentions: 3  
    298. miR-19, miR-345, miR-519c-5p serum levels predict adverse pathology in prostate cancer patients eligible for active surveillance. PLoS One. 2014; 9(6):e98597. Wang SY, Shiboski S, Belair CD, Cooperberg MR, Simko JP, Stoppler H, Cowan J, Carroll PR, Blelloch R. PMID: 24893170; PMCID: PMC4043973.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    299. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur Urol. 2014 Sep; 66(3):550-60. Klein EA, Cooperberg MR, Magi-Galluzzi C, Simko JP, Falzarano SM, Maddala T, Chan JM, Li J, Cowan JE, Tsiatis AC, Cherbavaz DB, Pelham RJ, Tenggara-Hunter I, Baehner FL, Knezevic D, Febbo PG, Shak S, Kattan MW, Lee M, Carroll PR. PMID: 24836057.
      View in: PubMed   Mentions: 261     Fields:    Translation:HumansCells
    300. Updated trends in imaging use in men diagnosed with prostate cancer. Prostate Cancer Prostatic Dis. 2014 Sep; 17(3):246-51. Porten SP, Smith A, Odisho AY, Litwin MS, Saigal CS, Carroll PR, Cooperberg MR, Urologic Disease of America Project. PMID: 24819235; PMCID: PMC4266691.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    301. Point/Counterpoint: early detection of prostate cancer: do the benefits outweigh the consequences? J Natl Compr Canc Netw. 2014 May; 12(5 Suppl):768-71. Carroll PR, Vickers AJ. PMID: 24853213.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    302. Evolution and immediate future of US screening guidelines. Urol Clin North Am. 2014 May; 41(2):229-35. Greene KL, Punnen S, Carroll PR. PMID: 24725485.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    303. Meaningful end points and outcomes in men on active surveillance for early-stage prostate cancer. Curr Opin Urol. 2014 May; 24(3):288-92. Welty CJ, Cooperberg MR, Carroll PR. PMID: 24614347; PMCID: PMC6586410.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    304. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics. Eur Urol. 2015 Mar; 67(3):451-7. Jalloh M, Myers F, Cowan JE, Carroll PR, Cooperberg MR. PMID: 24746973.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    305. Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshop. Urology. 2014 May; 83(5):975-8. Jarow JP, Thompson IM, Kluetz PG, Baxley J, Sridhara R, Scardino P, Carroll P, Albertsen P, Carter HB, Brawley O, Sartor O, Sandler H, Kiefert JJ, Morton RA. PMID: 24661332.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    306. A risk-adjusted definition of biochemical recurrence after radical prostatectomy. Prostate Cancer Prostatic Dis. 2014 Jun; 17(2):174-9. Morgan TM, Meng MV, Cooperberg MR, Cowan JE, Weinberg V, Carroll PR, Lin DW. PMID: 24614692.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    307. Endoscopic gold fiducial marker placement into the bladder wall to optimize radiotherapy targeting for bladder-preserving management of muscle-invasive bladder cancer: feasibility and initial outcomes. PLoS One. 2014; 9(3):e89754. Garcia MM, Gottschalk AR, Brajtbord J, Konety BR, Meng MV, Roach M, Carroll PR. PMID: 24594774; PMCID: PMC3940667.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    308. Prevalence and impact of fall-risk-increasing drugs, polypharmacy, and drug-drug interactions in robust versus frail hospitalised falls patients: a prospective cohort study. Drugs Aging. 2014 Mar; 31(3):225-32. Bennett A, Gnjidic D, Gillett M, Carroll P, Matthews S, Johnell K, Fastbom J, Hilmer S. PMID: 24452921.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    309. A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer. Urology. 2014 Mar; 83(3):592-6. Vickers AJ, Thompson IM, Klein E, Carroll PR, Scardino PT. PMID: 24581521.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    310. The ongoing need for improved risk stratification and monitoring for those on active surveillance for early stage prostate cancer. Eur Urol. 2014 Jun; 65(6):1032-3. Welty CJ, Carroll PR. PMID: 24636678.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    311. Age and baseline quality of life at radical prostatectomy--who has the most to lose? J Urol. 2014 Aug; 192(2):396-401. Brajtbord JS, Punnen S, Cowan JE, Welty CJ, Carroll PR. PMID: 24582539.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    312. Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer. BJU Int. 2014 Dec; 114(6b):E18-E24. Wang SY, Cowan JE, Cary KC, Chan JM, Carroll PR, Cooperberg MR. PMID: 24712895.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    313. The impact of frailty on pharmacokinetics in older people: using gentamicin population pharmacokinetic modeling to investigate changes in renal drug clearance by glomerular filtration. Eur J Clin Pharmacol. 2014 May; 70(5):549-55. Johnston C, Hilmer SN, McLachlan AJ, Matthews ST, Carroll PR, Kirkpatrick CM. PMID: 24522409.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    314. Physical activity and prostate gene expression in men with low-risk prostate cancer. Cancer Causes Control. 2014 Apr; 25(4):515-23. Magbanua MJ, Richman EL, Sosa EV, Jones LW, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM. PMID: 24504435; PMCID: PMC3990413.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    315. Role of endorectal MR imaging and MR spectroscopic imaging in defining treatable intraprostatic tumor foci in prostate cancer: quantitative analysis of imaging contour compared to whole-mount histopathology. Radiother Oncol. 2014 Feb; 110(2):303-8. Anwar M, Westphalen AC, Jung AJ, Noworolski SM, Simko JP, Kurhanewicz J, Roach M, Carroll PR, Coakley FV. PMID: 24444524; PMCID: PMC3969841.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    316. Overdiagnosis and overtreatment of prostate cancer. Eur Urol. 2014 Jun; 65(6):1046-55. Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter HB, Carroll P, Etzioni R. PMID: 24439788; PMCID: PMC4113338.
      View in: PubMed   Mentions: 352     Fields:    Translation:Humans
    317. The argument for palliative care in prostate cancer. Transl Androl Urol. 2013 Dec; 2(4):278-80. Sanford MT, Greene KL, Carroll PR. PMID: 26816740; PMCID: PMC4708113.
      View in: PubMed   Mentions: 2  
    318. Serial prostate biopsy and risk of lower urinary tract symptoms: results from a large, single-institution active surveillance cohort. Urology. 2014 Jan; 83(1):33-8. Glass AS, Hilton JF, Cowan JE, Washington SL, Carroll PR. PMID: 24246319.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    319. Clinical utility of endorectal MRI-guided prostate biopsy: preliminary experience. J Magn Reson Imaging. 2014 Aug; 40(2):314-23. Jung AJ, Westphalen AC, Kurhanewicz J, Wang ZJ, Carroll PR, Simko JP, Coakley FV. PMID: 24924999; PMCID: PMC4059791.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    320. Impact of androgen deprivation therapy on mental and emotional well-being in men with prostate cancer: analysis from the CaPSURE™ registry. J Urol. 2014 Apr; 191(4):964-70. Cary KC, Singla N, Cowan JE, Carroll PR, Cooperberg MR. PMID: 24184370.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    321. Temporal trends and predictors of salvage cancer treatment after failure following radical prostatectomy or radiation therapy: an analysis from the CaPSURE registry. Cancer. 2014 Feb 15; 120(4):507-12. Cary KC, Paciorek A, Fuldeore MJ, Carroll PR, Cooperberg MR. PMID: 24496867.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    322. Semiautomatic registration of digital histopathology images to in vivo MR images in molded and unmolded prostates. J Magn Reson Imaging. 2014 May; 39(5):1223-9. Starobinets O, Guo R, Simko JP, Kuchinsky K, Kurhanewicz J, Carroll PR, Greene KL, Noworolski SM. PMID: 24136783; PMCID: PMC3984354.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    323. Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™. J Urol. 2014 Apr; 191(4):971-6. Tomaszewski JJ, Richman EL, Sadetsky N, O'Keefe DS, Carroll PR, Davies BJ, Chan JM. PMID: 24095905; PMCID: PMC5480381.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    324. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol. 2013 Oct; 14(11):1112-1120. Ornish D, Lin J, Chan JM, Epel E, Kemp C, Weidner G, Marlin R, Frenda SJ, Magbanua MJM, Daubenmier J, Estay I, Hills NK, Chainani-Wu N, Carroll PR, Blackburn EH. PMID: 24051140.
      View in: PubMed   Mentions: 136     Fields:    Translation:Humans
    325. Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies. Eur Urol. 2014 Aug; 66(2):337-42. Cary KC, Cowan JE, Sanford M, Shinohara K, Perez N, Chan JM, Meng MV, Carroll PR. PMID: 24035632.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    326. Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence. Prostate. 2013 Dec; 73(16):1786-95. Bauer SR, Richman EL, Sosa E, Weinberg V, Song X, Witte JS, Carroll PR, Chan JM. PMID: 24038157; PMCID: PMC5501162.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    327. Early salvage radiotherapy following radical prostatectomy. Eur Urol. 2014 Jun; 65(6):1034-43. Pfister D, Bolla M, Briganti A, Carroll P, Cozzarini C, Joniau S, van Poppel H, Roach M, Stephenson A, Wiegel T, Zelefsky MJ. PMID: 23972524.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    328. Autologous retro-pubic urethral sling: a novel, quick, intra-operative technique to improve continence after robotic-assisted radical prostatectomy. J Robot Surg. 2014 Jun; 8(2):99-104. Punnen S, Clint Cary K, Glass AS, Cowan JE, Carroll PR. PMID: 27637518.
      View in: PubMed   Mentions: 3     Fields:    
    329. Measurement equivalence using a mixed-mode approach to administer health-related quality of life instruments. Qual Life Res. 2014 Mar; 23(2):495-508. Broering JM, Paciorek A, Carroll PR, Wilson LS, Litwin MS, Miaskowski C. PMID: 23943258.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    330. Reply to A. Azad et al. J Clin Oncol. 2013 Sep 10; 31(26):3296-7. Cooperberg MR, Cowan JE, Carroll PR. PMID: 23943835.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    331. Editorial comment. J Urol. 2013 Oct; 190(4):1223. Cary KC, Carroll PR. PMID: 23856519.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    332. A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer. BJU Int. 2013 Jul; 112(2):E67-75. Punnen S, Cowan JE, Dunn LB, Shumay DM, Carroll PR, Cooperberg MR. PMID: 23795800.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    333. Sixth joint meeting of J-CaP and CaPSURE--a multinational perspective on prostate cancer management and patient outcomes. Jpn J Clin Oncol. 2013 Jul; 43(7):756-66. Akaza H, Hinotsu S, Cooperberg MR, Chung BH, Youl Lee J, Umbas R, Tsukamoto T, Namiki M, Carroll P. PMID: 23723314.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    334. Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA era. Urology. 2013 Jul; 82(1):60-5. Glass AS, Cowan JE, Fuldeore MJ, Cooperberg MR, Carroll PR, Kenfield SA, Greene KL. PMID: 23706257.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    335. Endorectal MRI and MR spectroscopic imaging of prostate cancer: developing selection criteria for MR-guided focal therapy. J Magn Reson Imaging. 2014 Mar; 39(3):519-25. Chang ST, Westphalen AC, Jha P, Jung AJ, Carroll PR, Kurhanewicz J, Coakley FV. PMID: 23681669; PMCID: PMC3748229.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    336. Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy. Eur Urol. 2014 Jun; 65(6):1171-7. Punnen S, Freedland SJ, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Carroll PR, Cooperberg MR. PMID: 23587869.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    337. Benign prostate glandular tissue at radical prostatectomy surgical margins. Urology. 2013 Jul; 82(1):154-9. Odisho AY, Washington SL, Meng MV, Cowan JE, Simko JP, Carroll PR. PMID: 23522995; PMCID: PMC3696410.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    338. Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study. Clin Cancer Res. 2013 May 01; 19(9):2442-50. Lin DW, Newcomb LF, Brown EC, Brooks JD, Carroll PR, Feng Z, Gleave ME, Lance RS, Sanda MG, Thompson IM, Wei JT, Nelson PS, Canary Prostate Active Surveillance Study Investigators. PMID: 23515404; PMCID: PMC3674574.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    339. How does robot-assisted radical prostatectomy (RARP) compare with open surgery in men with high-risk prostate cancer? BJU Int. 2013 Aug; 112(4):E314-20. Punnen S, Meng MV, Cooperberg MR, Greene KL, Cowan JE, Carroll PR. PMID: 23451984.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    340. Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort. J Clin Oncol. 2013 Apr 10; 31(11):1428-34. Cooperberg MR, Simko JP, Cowan JE, Reid JE, Djalilvand A, Bhatnagar S, Gutin A, Lanchbury JS, Swanson GP, Stone S, Carroll PR. PMID: 23460710.
      View in: PubMed   Mentions: 146     Fields:    Translation:Humans
    341. Men with low preoperative sexual function may benefit from nerve sparing radical prostatectomy. J Urol. 2013 Sep; 190(3):981-6. Harris CR, Punnen S, Carroll PR. PMID: 23410984.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    342. Active surveillance: does serial prostate biopsy increase histological inflammation? Prostate Cancer Prostatic Dis. 2013 Jun; 16(2):165-9. Glass AS, Porten SP, Bonham M, Tran TC, Cowan JE, Punnen S, Chan JM, Carroll PR. PMID: 23318528.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    343. Focal therapy: a new active surveillance tool? Oncology (Williston Park). 2013 Jan 15; 27(1). Glass AS, Carroll PR. PMID: 25188237.
      View in: PubMed   Mentions:    Fields:    
    344. A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray. Adv Anat Pathol. 2013 Jan; 20(1):39-44. Hawley S, Fazli L, McKenney JK, Simko J, Troyer D, Nicolas M, Newcomb LF, Cowan JE, Crouch L, Ferrari M, Hernandez J, Hurtado-Coll A, Kuchinsky K, Liew J, Mendez-Meza R, Smith E, Tenggara I, Zhang X, Carroll PR, Chan JM, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, Feng Z, True LD, Brooks JD. PMID: 23232570; PMCID: PMC3535290.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    345. Prostate specific antigen best practice statement: 2009 update. J Urol. 2013 Jan; 189(1 Suppl):S2-S11. Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P, American Urological Association. PMID: 23234625.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    346. Role of active surveillance in the management of localized prostate cancer. J Natl Cancer Inst Monogr. 2012 Dec; 2012(45):202-6. Glass AS, Cooperberg MR, Meng MV, Carroll PR. PMID: 23271774; PMCID: PMC3540869.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    347. Salvage therapies after radiation therapy. Urol Oncol. 2012 Nov-Dec; 30(6):940-1. Eastham JA, Carroll P, Pisters L, Nguyen PT, Touijer K. PMID: 23218071.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    348. Prostate cancer mortality following active surveillance versus immediate radical prostatectomy. Clin Cancer Res. 2012 Oct 01; 18(19):5471-8. Xia J, Trock BJ, Cooperberg MR, Gulati R, Zeliadt SB, Gore JL, Lin DW, Carroll PR, Carter HB, Etzioni R. PMID: 23008476; PMCID: PMC3604990.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    349. Factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). BJU Int. 2013 Feb; 111(2):213-20. Resnick MJ, Guzzo TJ, Cowan JE, Knight SJ, Carroll PR, Penson DF. PMID: 22928860; PMCID: PMC3540193.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    350. Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy. J Clin Oncol. 2012 Oct 01; 30(28):3540-4. Choe KS, Cowan JE, Chan JM, Carroll PR, D'Amico AV, Liauw SL. PMID: 22927523; PMCID: PMC3454771.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    351. Reply to Jai Prakash, Apul Goel and Manish Garg's Letter to the Editor re: Anobel Y. Odisho, Anna B. Berry, Ardalan E. Ahmad, Matthew R. Cooperberg, Peter R. Carroll, Badrinath R. Konety. Reflex ImmunoCyt Testing for the Diagnosis of Bladder Cancer in Patients with Atypical Urine Cytology. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.04.019. Eur Urol. 2012 Nov; 62(5):e88. Odisho AY, Berry AB, Ahmad AE, Cooperberg MR, Carroll PR, Konety BR. PMID: 22921716.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    352. The impact of serial prostate biopsies on sexual function in men on active surveillance for prostate cancer. J Urol. 2012 Oct; 188(4):1252-8. Hilton JF, Blaschko SD, Whitson JM, Cowan JE, Carroll PR. PMID: 22902015.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    353. Gender differences in academic productivity and academic career choice among urology residents. J Urol. 2012 Oct; 188(4):1286-90. Yang G, Villalta JD, Weiss DA, Carroll PR, Breyer BN. PMID: 22902027; PMCID: PMC3552430.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    354. Active surveillance for low-risk prostate cancer. Crit Rev Oncol Hematol. 2013 Mar; 85(3):295-302. Bangma CH, Bul M, van der Kwast TH, Pickles T, Korfage IJ, Hoeks CM, Steyerberg EW, Jenster G, Kattan MW, Bellardita L, Carroll PR, Denis LJ, Parker C, Roobol MJ, Emberton M, Klotz LH, Rannikko A, Kakehi Y, Lane JA, Schröder FH, Semjonow A, Trock BJ, Valdagni R. PMID: 22878262.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansPHPublic Health
    355. The effect of behavioural risk factors on osteoporosis in Irish women. Ir J Med Sci. 2013 Mar; 182(1):97-105. Cummins NM, Jakeman PM, Sestak I, Murphy N, Carroll P. PMID: 22843417.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    356. Early detection of prostate cancer: more information, more clarity. Eur Urol. 2012 Nov; 62(5):753-5; discussion 755-6. Glass AS, Cooperberg MR, Carroll PR. PMID: 22766168.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    357. Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram. Prostate Cancer Prostatic Dis. 2012 Dec; 15(4):374-9. Kutikov A, Cooperberg MR, Paciorek AT, Uzzo RG, Carroll PR, Boorjian SA. PMID: 22710832; PMCID: PMC3815610.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    358. Local staging of prostate cancer: comparative accuracy of T2-weighted endorectal MR imaging and transrectal ultrasound. Clin Imaging. 2012 Sep-Oct; 36(5):547-52. Jung AJ, Coakley FV, Shinohara K, Carroll PR, Kurhanewicz J, Cowan JE, Westphalen AC. PMID: 22920360; PMCID: PMC3694423.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    359. Best practices in robot-assisted radical prostatectomy: recommendations of the Pasadena Consensus Panel. Eur Urol. 2012 Sep; 62(3):368-81. Montorsi F, Wilson TG, Rosen RC, Ahlering TE, Artibani W, Carroll PR, Costello A, Eastham JA, Ficarra V, Guazzoni G, Menon M, Novara G, Patel VR, Stolzenburg JU, Van der Poel H, Van Poppel H, Mottrie A, Pasadena Consensus Panel. PMID: 22763081.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    360. Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol. 2012 Dec; 62(6):976-83. Dall'Era MA, Albertsen PC, Bangma C, Carroll PR, Carter HB, Cooperberg MR, Freedland SJ, Klotz LH, Parker C, Soloway MS. PMID: 22698574.
      View in: PubMed   Mentions: 208     Fields:    Translation:Humans
    361. The quantitative Gleason score improves prostate cancer risk assessment. Cancer. 2012 Dec 15; 118(24):6046-54. Reese AC, Cowan JE, Brajtbord JS, Harris CR, Carroll PR, Cooperberg MR. PMID: 22674220.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    362. Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur Urol. 2012 Sep; 62(3):382-404. Novara G, Ficarra V, Mocellin S, Ahlering TE, Carroll PR, Graefen M, Guazzoni G, Menon M, Patel VR, Shariat SF, Tewari AK, Van Poppel H, Zattoni F, Montorsi F, Mottrie A, Rosen RC, Wilson TG. PMID: 22749851.
      View in: PubMed   Mentions: 139     Fields:    Translation:Humans
    363. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol. 2012 Sep; 62(3):405-17. Ficarra V, Novara G, Rosen RC, Artibani W, Carroll PR, Costello A, Menon M, Montorsi F, Patel VR, Stolzenburg JU, Van der Poel H, Wilson TG, Zattoni F, Mottrie A. PMID: 22749852.
      View in: PubMed   Mentions: 358     Fields:    Translation:Humans
    364. Regional cell proliferation in microdissected human prostate specimens after heavy water labeling in vivo: correlation with prostate epithelial cells isolated from seminal fluid. Clin Cancer Res. 2012 Jun 15; 18(12):3250-60. Hayes GM, Simko J, Holochwost D, Kuchinsky K, Busch R, Misell L, Murphy EJ, Carroll P, Chan J, Shinohara K, Hellerstein MK. PMID: 22553345.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    365. Characteristics of older and younger patients with suspected paracetamol toxicity. Australas J Ageing. 2012 Sep; 31(3):190-3. Kane A, Mitchell SJ, Carroll PR, Matthews S, Hilmer SN. PMID: 22950592.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    366. Reflex ImmunoCyt testing for the diagnosis of bladder cancer in patients with atypical urine cytology. Eur Urol. 2013 May; 63(5):936-40. Odisho AY, Berry AB, Ahmad AE, Cooperberg MR, Carroll PR, Konety BR. PMID: 22521093; PMCID: PMC3443544.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    367. Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109. Urology. 2012 Mar; 79(3):633-7. Berglund RK, Tangen CM, Powell IJ, Lowe BA, Haas GP, Carroll PR, Canby-Hagino ED, deVere White R, Hemstreet GP, Crawford ED, Thompson IM, Klein EA. PMID: 22386416; PMCID: PMC3839235.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    368. Proton beam therapy and treatment for localized prostate cancer: if you build it, they will come. Arch Intern Med. 2012 Feb 13; 172(3):280-3. Aaronson DS, Odisho AY, Hills N, Cress R, Carroll PR, Dudley RA, Cooperberg MR. PMID: 22332166.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    369. Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study. Int J Radiat Oncol Biol Phys. 2012 Apr 01; 82(5):e787-93. Arrayeh E, Westphalen AC, Kurhanewicz J, Roach M, Jung AJ, Carroll PR, Coakley FV. PMID: 22331003; PMCID: PMC3285390.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    370. Fifth Joint Meeting of J-CaP and CaPSURE: advancing the global understanding of prostate cancer and its management. Jpn J Clin Oncol. 2012 Mar; 42(3):226-36. Akaza H, Carroll P, Cooperberg MR, Hinotsu S. PMID: 22217576.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    371. Outcomes for radical prostatectomy: is it the singer, the song, or both? J Clin Oncol. 2012 Feb 10; 30(5):476-8. Cooperberg MR, Odisho AY, Carroll PR. PMID: 22215744.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    372. The Society of Urologic Oncology's reply to the US Preventative Services Task Force's recommendation on PSA testing. Urol Oncol. 2012 Jan-Feb; 30(1):117-9. Messing EM, Albertsen P, Andriole GL, Carroll PR, Klein EA. PMID: 22243597.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    373. Endorectal MRI of prostate cancer: incremental prognostic importance of gross locally advanced disease. AJR Am J Roentgenol. 2011 Dec; 197(6):1369-74. Muglia VF, Westphalen AC, Wang ZJ, Kurhanewicz J, Carroll PR, Coakley FV. PMID: 22109291; PMCID: PMC3703946.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    374. PSA screening: determinants of primary-care physician practice patterns. Prostate Cancer Prostatic Dis. 2012 Jun; 15(2):189-94. Tasian GE, Cooperberg MR, Potter MB, Cowan JE, Greene KL, Carroll PR, Chan JM. PMID: 22343837.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    375. Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer. BJU Int. 2012 Jul; 110(1):50-5. Washington SL, Bonham M, Whitson JM, Cowan JE, Carroll PR. PMID: 22077660.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    376. Poor agreement of prostate specific antigen doubling times calculated using ultrasensitive versus standard prostate specific antigen values: important impact on risk assessment. J Urol. 2011 Dec; 186(6):2228-32. Reese AC, Fradet V, Whitson JM, Davis CB, Carroll PR. PMID: 22014796.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    377. Among potent men post radical prostatectomy, does the need for phosphodiesterase inhibitors have an impact on sexual bother scores? BJU Int. 2012 May; 109(10):1520-4. Punnen S, Cooperberg MR, Sadetsky N, Carroll PR. PMID: 21999368; PMCID: PMC3288727.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    378. Changes in cancer volume in serial biopsies of men on active surveillance for early stage prostate cancer. J Urol. 2011 Nov; 186(5):1825-9. Porten SP, Whitson JM, Cowan JE, Perez N, Shinohara K, Carroll PR. PMID: 21944082.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    379. Prediction of erectile function following treatment for prostate cancer. JAMA. 2011 Sep 21; 306(11):1205-14. Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, Hembroff L, Sadetsky N, Saigal CS, Litwin MS, Klein E, Kibel AS, Hamstra DA, Pisters LL, Kuban DA, Kaplan ID, Wood DP, Ciezki J, Dunn RL, Carroll PR, Sanda MG. PMID: 21934053; PMCID: PMC3831607.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansPHPublic Health
    380. Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation. PLoS One. 2011; 6(9):e24004. Magbanua MJ, Roy R, Sosa EV, Weinberg V, Federman S, Mattie MD, Hughes-Fulford M, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM. PMID: 21912659; PMCID: PMC3164676.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    381. Vegetable and fruit intake after diagnosis and risk of prostate cancer progression. Int J Cancer. 2012 Jul 01; 131(1):201-10. Richman EL, Carroll PR, Chan JM. PMID: 21823116; PMCID: PMC3310254.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansAnimals
    382. Androgen deprivation therapy and cardiovascular risk. J Clin Oncol. 2011 Sep 10; 29(26):3510-6. Punnen S, Cooperberg MR, Sadetsky N, Carroll PR. PMID: 21844498; PMCID: PMC3179251.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    383. Active surveillance for prostate cancer: progress and promise. J Clin Oncol. 2011 Sep 20; 29(27):3669-76. Cooperberg MR, Carroll PR, Klotz L. PMID: 21825257.
      View in: PubMed   Mentions: 121     Fields:    Translation:HumansPHPublic Health
    384. Treatment trends for stage I renal cell carcinoma. J Urol. 2011 Aug; 186(2):394-9. Cooperberg MR, Mallin K, Kane CJ, Carroll PR. PMID: 21679982.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    385. The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: a multi-institutional study. J Urol. 2011 Aug; 186(2):465-9. McKenney JK, Simko J, Bonham M, True LD, Troyer D, Hawley S, Newcomb LF, Fazli L, Kunju LP, Nicolas MM, Vakar-Lopez F, Zhang X, Carroll PR, Brooks JD, Canary/Early Detection Research Network Prostate Active Surveillance Study Investigators. PMID: 21679996.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansPHPublic Health
    386. The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy. Cancer. 2011 Nov 15; 117(22):5039-46. Cooperberg MR, Hilton JF, Carroll PR. PMID: 21647869; PMCID: PMC3170662.
      View in: PubMed   Mentions: 160     Fields:    Translation:Humans
    387. Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance. J Clin Oncol. 2011 Jul 10; 29(20):2795-800. Porten SP, Whitson JM, Cowan JE, Cooperberg MR, Shinohara K, Perez N, Greene KL, Meng MV, Carroll PR. PMID: 21632511.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    388. Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res. 2011 Jun 01; 71(11):3889-95. Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM. PMID: 21610110; PMCID: PMC3107352.
      View in: PubMed   Mentions: 113     Fields:    Translation:Humans
    389. The contemporary concept of significant versus insignificant prostate cancer. Eur Urol. 2011 Aug; 60(2):291-303. Ploussard G, Epstein JI, Montironi R, Carroll PR, Wirth M, Grimm MO, Bjartell AS, Montorsi F, Freedland SJ, Erbersdobler A, van der Kwast TH. PMID: 21601982.
      View in: PubMed   Mentions: 116     Fields:    Translation:Humans
    390. Factors associated with downgrading in patients with high grade prostate cancer. Urol Oncol. 2013 May; 31(4):442-7. Whitson JM, Porten SP, Cowan JE, Simko JP, Cooperberg MR, Carroll PR. PMID: 21478037.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    391. Editorial comment. Urology. 2011 Apr; 77(4):984-5. Carroll PR, Whitson JM. PMID: 21477729.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    392. Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment. BJU Int. 2011 Apr; 107(8):1232-7. Dall'Era MA, Cowan JE, Simko J, Shinohara K, Davies B, Konety BR, Meng MV, Perez N, Greene K, Carroll PR. PMID: 20804478.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    393. The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancer. J Urol. 2011 May; 185(5):1656-60. Whitson JM, Porten SP, Hilton JF, Cowan JE, Perez N, Cooperberg MR, Greene KL, Meng MV, Simko JP, Shinohara K, Carroll PR. PMID: 21419438.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansPHPublic Health
    394. Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007). J Urol. 2011 May; 185(5):1631-6. Mallin K, David KA, Carroll PR, Milowsky MI, Nanus DM. PMID: 21419456.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    395. Impact of androgen deprivation on physical well-being in patients with prostate cancer: analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry. Cancer. 2011 Oct 01; 117(19):4406-13. Sadetsky N, Greene K, Cooperberg MR, Hubbard A, Carroll PR, Satariano W. PMID: 21412760.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    396. The example of CaPSURE: lessons learned from a national disease registry. World J Urol. 2011 Jun; 29(3):265-71. Porten SP, Cooperberg MR, Konety BR, Carroll PR. PMID: 21347810; PMCID: PMC3099175.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    397. Prostate cancer: reducing overtreatment: active surveillance in low-risk disease. Nat Rev Urol. 2011 Mar; 8(3):124-5. Whitson JM, Porten SP, Carroll PR. PMID: 21304508.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    398. The needs for men undergoing active surveillance (AS) for prostate cancer: results of a focus group study. J Clin Nurs. 2011 Feb; 20(3-4):581-6. Kazer MW, Bailey DE, Colberg J, Kelly WK, Carroll P. PMID: 21219530.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    399. Gentamicin pharmacokinetics in old age and frailty. Br J Clin Pharmacol. 2011 Feb; 71(2):224-31. Hilmer SN, Tran K, Rubie P, Wright J, Gnjidic D, Mitchell SJ, Matthews S, Carroll PR. PMID: 21219402; PMCID: PMC3040542.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    400. Oncological and functional outcomes of radical cystectomy and orthotopic bladder replacement in women. Urology. 2011 Apr; 77(4):878-83. Yang G, Whitson JM, Breyer BN, Konety BR, Carroll PR. PMID: 21215428; PMCID: PMC3607667.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    401. Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes? J Clin Oncol. 2011 Feb 01; 29(4):345-7. Carroll PR, Whitson JM, Cooperberg MR. PMID: 21189396.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    402. Urology resident publication output and its relationship to future academic achievement. J Urol. 2011 Feb; 185(2):642-6. Yang G, Zaid UB, Erickson BA, Blaschko SD, Carroll PR, Breyer BN. PMID: 21168863; PMCID: PMC3565588.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    403. Impact of age at diagnosis on prostate cancer treatment and survival. J Clin Oncol. 2011 Jan 10; 29(2):235-41. Bechis SK, Carroll PR, Cooperberg MR. PMID: 21135285; PMCID: PMC3058279.
      View in: PubMed   Mentions: 129     Fields:    Translation:Humans
    404. Incidence of bladder neck contracture after robot-assisted laparoscopic and open radical prostatectomy. BJU Int. 2010 Dec; 106(11):1734-8. Breyer BN, Davis CB, Cowan JE, Kane CJ, Carroll PR. PMID: 20438567; PMCID: PMC3565608.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    405. Outcomes of active surveillance for men with intermediate-risk prostate cancer. J Clin Oncol. 2011 Jan 10; 29(2):228-34. Cooperberg MR, Cowan JE, Hilton JF, Reese AC, Zaid HB, Porten SP, Shinohara K, Meng MV, Greene KL, Carroll PR. PMID: 21115873; PMCID: PMC3058278.
      View in: PubMed   Mentions: 96     Fields:    Translation:Humans
    406. Inaccuracies in assignment of clinical stage for localized prostate cancer. Cancer. 2011 Jan 15; 117(2):283-9. Reese AC, Sadetsky N, Carroll PR, Cooperberg MR. PMID: 21210472.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    407. Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients. Cancer Res. 2011 Jan 15; 71(2):550-60. Moltzahn F, Olshen AB, Baehner L, Peek A, Fong L, Stöppler H, Simko J, Hilton JF, Carroll P, Blelloch R. PMID: 21098088; PMCID: PMC3022112.
      View in: PubMed   Mentions: 142     Fields:    Translation:Humans
    408. Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer. Cancer Causes Control. 2011 Jan; 22(1):141-50. Chan JM, Weinberg V, Magbanua MJ, Sosa E, Simko J, Shinohara K, Federman S, Mattie M, Hughes-Fulford M, Haqq C, Carroll PR. PMID: 21103921; PMCID: PMC3002170.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    409. Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer. Cancer. 2010 Nov 15; 116(22):5226-34. Cooperberg MR, Vickers AJ, Broering JM, Carroll PR. PMID: 20690197; PMCID: PMC2975879.
      View in: PubMed   Mentions: 106     Fields:    Translation:Humans
    410. Disproportionate presentation of high risk prostate cancer in a safety net health system. J Urol. 2010 Nov; 184(5):1931-6. Porten SP, Richardson DA, Odisho AY, McAninch JW, Carroll PR, Cooperberg MR. PMID: 20846693.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    411. Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: results from CaPSURE. BJU Int. 2010 Sep; 106(5):627-32. Katz MS, Carroll PR, Cowan JE, Chan JM, D'Amico AV. PMID: 20151961.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    412. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians. Urol Oncol. 2012 Mar-Apr; 30(2):155-60. Tasian GE, Cooperberg MR, Cowan JE, Keyashian K, Greene KL, Daniels NA, Carroll PR, Chan JM. PMID: 20800514.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    413. Electronic patient self-assessment and management (SAM): a novel framework for cancer survivorship. BMC Med Inform Decis Mak. 2010 Jun 17; 10:34. Vickers AJ, Salz T, Basch E, Cooperberg MR, Carroll PR, Tighe F, Eastham J, Rosen RC. PMID: 20565745; PMCID: PMC2893444.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    414. Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging. Radiology. 2010 Jul; 256(1):176-83. Fradet V, Kurhanewicz J, Cowan JE, Karl A, Coakley FV, Shinohara K, Carroll PR. PMID: 20505068; PMCID: PMC2897693.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansPHPublic Health
    415. Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease. J Urol. 2010 Jul; 184(1):114-9. Reese AC, Cooperberg MR, Carroll PR. PMID: 20478578.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    416. Active surveillance for early-stage prostate cancer: defining the triggers for intervention. J Clin Oncol. 2010 Jun 10; 28(17):2807-9. Whitson JM, Carroll PR. PMID: 20439633.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    417. Increased risk of high-grade prostate cancer among infertile men. Cancer. 2010 May 01; 116(9):2140-7. Walsh TJ, Schembri M, Turek PJ, Chan JM, Carroll PR, Smith JF, Eisenberg ML, Van Den Eeden SK, Croughan MS. PMID: 20309846; PMCID: PMC2893877.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    418. Novel pyrrolo-1,5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivo. Br J Cancer. 2010 May 11; 102(10):1474-82. Bright SA, McElligott AM, O'Connell JW, O'Connor L, Carroll P, Campiani G, Deininger MW, Conneally E, Lawler M, Williams DC, Zisterer DM. PMID: 20407438; PMCID: PMC2869169.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    419. Urologist density and county-level urologic cancer mortality. J Clin Oncol. 2010 May 20; 28(15):2499-504. Odisho AY, Cooperberg MR, Fradet V, Ahmad AE, Carroll PR. PMID: 20406931; PMCID: PMC2881728.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    420. Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer. Cancer. 2010 Apr 15; 116(8):1901-8. Fang AC, Ahmad AE, Whitson JM, Ferrell LD, Carroll PR, Konety BR. PMID: 20186823.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    421. The 'CaP Calculator': an online decision support tool for clinically localized prostate cancer. BJU Int. 2010 May; 105(10):1417-22. Katz MS, Efstathiou JA, D'Amico AV, Kattan MW, Sanda MG, Nguyen PL, Smith MR, Carroll PR, Zietman AL. PMID: 20346051; PMCID: PMC3090683.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    422. Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. Clin Oncol (R Coll Radiol). 2010 May; 22(4):281-8. Healy LA, Ryan AM, Carroll P, Ennis D, Crowley V, Boyle T, Kennedy MJ, Connolly E, Reynolds JV. PMID: 20189371.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    423. Changes in specific domains of sexual function and sexual bother after radical prostatectomy. BJU Int. 2010 Oct; 106(7):1022-9. Le JD, Cooperberg MR, Sadetsky N, Hittelman AB, Meng MV, Cowan JE, Latini DM, Carroll PR, CaPSURE Investigators. PMID: 20184571.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    424. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010 Mar 01; 28(7):1117-23. Cooperberg MR, Broering JM, Carroll PR. PMID: 20124165; PMCID: PMC2834465.
      View in: PubMed   Mentions: 393     Fields:    Translation:Humans
    425. NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Canc Netw. 2010 Feb; 8(2):240-62. Kawachi MH, Bahnson RR, Barry M, Busby JE, Carroll PR, Carter HB, Catalona WJ, Cookson MS, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP, Howe RJ, Lange PH, Lilja H, Loughlin KR, Mohler J, Moul J, Nadler RB, Patterson SG, Presti JC, Stroup AM, Wake R, Wei JT. PMID: 20141680.
      View in: PubMed   Mentions: 93     Fields:    Translation:Humans
    426. Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. J Clin Oncol. 2010 Feb 20; 28(6):1069-74. Moses KA, Paciorek AT, Penson DF, Carroll PR, Master VA. PMID: 20100957; PMCID: PMC2834431.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    427. Eligibility for active surveillance and pathological outcomes for men undergoing radical prostatectomy in a large, community based cohort. J Urol. 2010 Jan; 183(1):138-43. Smaldone MC, Cowan JE, Carroll PR, Davies BJ. PMID: 19913808.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    428. The impact of male circumcision on HIV transmission. J Urol. 2010 Jan; 183(1):21-6. Doyle SM, Kahn JG, Hosang N, Carroll PR. PMID: 19913816.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    429. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010 Mar; 91(3):712-21. Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll PR, Chan JM. PMID: 20042525; PMCID: PMC3132069.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimals
    430. Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy. NMR Biomed. 2010 May; 23(4):391-8. Santos CF, Kurhanewicz J, Tabatabai ZL, Simko JP, Keshari KR, Gbegnon A, Santos RD, Federman S, Shinohara K, Carroll PR, Haqq CM, Swanson MG. PMID: 20033906; PMCID: PMC2891902.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    431. A group of genome-based biomarkers that add to a Kattan nomogram for predicting progression in men with high-risk prostate cancer. Clin Cancer Res. 2010 Jan 01; 16(1):195-202. Paris PL, Weinberg V, Albo G, Roy R, Burke C, Simko J, Carroll P, Collins C. PMID: 20028763; PMCID: PMC2854027.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    432. Editorial comment. J Urol. 2010 Feb; 183(2):564. Carroll PR. PMID: 20018313.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    433. Association of age and response to androgen-deprivation therapy with or without radiotherapy for prostate cancer: data from CaPSURE. BJU Int. 2010 Apr; 105(7):951-5. Aaronson D, Cowan J, Carroll P, Konety B. PMID: 19889066.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    434. The adjunctive use of power Doppler imaging in the preoperative assessment of prostate cancer. BJU Int. 2010 May; 105(9):1237-41. Eisenberg ML, Cowan JE, Carroll PR, Shinohara K. PMID: 19888980.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    435. UroVysion testing can lead to early identification of intravesical therapy failure in patients with high risk non-muscle invasive bladder cancer. Int Braz J Urol. 2009 Nov-Dec; 35(6):664-70; discussion 671-2. Whitson JM, Berry AB, Carroll PR, Konety BR. PMID: 20028572.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    436. Patient decision aids for prostate cancer treatment: a systematic review of the literature. CA Cancer J Clin. 2009 Nov-Dec; 59(6):379-90. Lin GA, Aaronson DS, Knight SJ, Carroll PR, Dudley RA. PMID: 19841280.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    437. Predictors of clinical metastasis in prostate cancer patients receiving androgen deprivation therapy: results from CaPSURE. Cancer. 2009 Oct 01; 115(19):4470-6. Abouassaly R, Paciorek A, Ryan CJ, Carroll PR, Klein EA. PMID: 19637339.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    438. Prostate specific antigen best practice statement: 2009 update. J Urol. 2009 Nov; 182(5):2232-41. Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P. PMID: 19781717.
      View in: PubMed   Mentions: 120     Fields:    Translation:Humans
    439. Measuring illness uncertainty in men undergoing active surveillance for prostate cancer. Appl Nurs Res. 2011 Nov; 24(4):193-9. Bailey DE, Wallace M, Latini DM, Hegarty J, Carroll PR, Klein EA, Albertsen PC. PMID: 20974073; PMCID: PMC3070758.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    440. Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository. Urology. 2010 Feb; 75(2):407-13. Newcomb LF, Brooks JD, Carroll PR, Feng Z, Gleave ME, Nelson PS, Thompson IM, Lin DW. PMID: 19758683; PMCID: PMC3827723.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansPHPublic Health
    441. Predictive value of serial measurements of quality of life on all-cause mortality in prostate cancer patients: data from CaPSURE (cancer of the prostate strategic urologic research endeavor) database. Qual Life Res. 2009 Oct; 18(8):1019-27. Sadetsky N, Hubbard A, Carroll PR, Satariano W. PMID: 19697155; PMCID: PMC2744792.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    442. The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized disease. BJU Int. 2010 Feb; 105(4):472-5. Porten SP, Cooperberg MR, Carroll PR. PMID: 19681901; PMCID: PMC2821458.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    443. Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy. J Clin Oncol. 2009 Sep 10; 27(26):4306-13. Cooperberg MR, Hinotsu S, Namiki M, Ito K, Broering J, Carroll PR, Akaza H. PMID: 19667269; PMCID: PMC2744272.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    444. Prostate-cancer screening. N Engl J Med. 2009 Jul 09; 361(2):203; author reply 204-5. Cooperberg MR, Carroll PR. PMID: 19593852.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    445. Adequacy of lymphadenectomy among men undergoing robot-assisted laparoscopic radical prostatectomy. BJU Int. 2010 Jan; 105(1):88-92. Cooperberg MR, Kane CJ, Cowan JE, Carroll PR. PMID: 19549119.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    446. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. J Natl Cancer Inst. 2009 Jun 16; 101(12):878-87. Cooperberg MR, Broering JM, Carroll PR. PMID: 19509351; PMCID: PMC2697208.
      View in: PubMed   Mentions: 128     Fields:    Translation:Humans
    447. The impact of obesity on overall and cancer specific survival in men with prostate cancer. J Urol. 2009 Jul; 182(1):112-7; discussion 117. Davies BJ, Smaldone MC, Sadetsky N, Dall'era M, Carroll PR. PMID: 19447437.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    448. Outcomes and follow-up strategies for patients on active surveillance. Curr Opin Urol. 2009 May; 19(3):258-62. Dall'Era MA, Carroll PR. PMID: 19295434.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    449. ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate. Int J Radiat Oncol Biol Phys. 2009 Jul 01; 74(3):667-72. Michalski JM, Roach M, Merrick G, Anscher MS, Beyer DC, Lawton CA, Lee WR, Pollack A, Rosenthal SA, Vijayakumar S, Carroll PR. PMID: 19386445.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    450. The importance of tumor palpability and transrectal ultrasonographic appearance in the contemporary clinical staging of prostate cancer. Urol Oncol. 2011 Mar-Apr; 29(2):171-6. Eisenberg ML, Cowan JE, Davies BJ, Carroll PR, Shinohara K. PMID: 19362864.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    451. Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy. Eur Urol. 2010 Apr; 57(4):622-9. Eisenberg ML, Davies BJ, Cooperberg MR, Cowan JE, Carroll PR. PMID: 19375843; PMCID: PMC2930030.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    452. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000. Cancer. 2009 Apr 01; 115(7):1435-47. David KA, Mallin K, Milowsky MI, Ritchey J, Carroll PR, Nanus DM. PMID: 19215030.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    453. Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer. BMC Cancer. 2009 Feb 26; 9:69. Ross PL, Cheng I, Liu X, Cicek MS, Carroll PR, Casey G, Witte JS. PMID: 19245716; PMCID: PMC2657151.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    454. Sociodemographic predictors of prostate cancer risk category at diagnosis: unique patterns of significant and insignificant disease. J Urol. 2009 Apr; 181(4):1622-7; discussion 1627. Dall'era MA, Hosang N, Konety B, Cowan JE, Carroll PR. PMID: 19230923.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    455. Pathological outcomes of candidates for active surveillance of prostate cancer. J Urol. 2009 Apr; 181(4):1628-33; discussion 1633-4. Conti SL, Dall'era M, Fradet V, Cowan JE, Simko J, Carroll PR. PMID: 19233388.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansPHPublic Health
    456. Maximum vs. mono androgen blockade and the risk of recurrence in men with localized prostate cancer undergoing brachytherapy. Int J Radiat Oncol Biol Phys. 2009 Sep 01; 75(1):36-9. Chen RC, Sadetsky N, Chen MH, Carroll PR, D'Amico AV. PMID: 19233568.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    457. A multicolour fluorescence in situ hybridization test predicts recurrence in patients with high-risk superficial bladder tumours undergoing intravesical therapy. BJU Int. 2009 Aug; 104(3):336-9. Whitson J, Berry A, Carroll P, Konety B. PMID: 19220253.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    458. Are age-based criteria the best way to determine eligibility for prostate cancer screening? Ann Intern Med. 2009 Feb 03; 150(3):220-1; author reply 221-2. Konety BR, Cooperberg MR, Carroll PR. PMID: 19189916.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    459. Sequential intravesical gemcitabine and mitomycin C chemotherapy regimen in patients with non-muscle invasive bladder cancer. Urol Oncol. 2010 Sep-Oct; 28(5):510-4. Breyer BN, Whitson JM, Carroll PR, Konety BR. PMID: 19171491; PMCID: PMC3565601.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    460. The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol. 2009 Apr; 55(4):826-35. Karl A, Carroll PR, Gschwend JE, Knüchel R, Montorsi F, Stief CG, Studer UE. PMID: 19150582.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    461. Geographic distribution of urologists throughout the United States using a county level approach. J Urol. 2009 Feb; 181(2):760-5; discussion 765-6. Odisho AY, Fradet V, Cooperberg MR, Ahmad AE, Carroll PR. PMID: 19091334.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    462. The clinical impact of an early decline in kidney function in patients following heart transplantation. Am J Transplant. 2009 Feb; 9(2):348-54. Cantarovich M, Hirsh A, Alam A, Giannetti N, Cecere R, Carroll P, Edwardes ME. PMID: 19120080.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    463. Evaluating localized prostate cancer and identifying candidates for focal therapy. Urology. 2008 Dec; 72(6 Suppl):S12-24. Sartor AO, Hricak H, Wheeler TM, Coleman J, Penson DF, Carroll PR, Rubin MA, Scardino PT. PMID: 19095124.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    464. Conventional treatments of localized prostate cancer. Urology. 2008 Dec; 72(6 Suppl):S25-35. Zerbib M, Zelefsky MJ, Higano CS, Carroll PR. PMID: 19095125.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    465. New treatments for localized prostate cancer. Urology. 2008 Dec; 72(6 Suppl):S36-43. Marberger M, Carroll PR, Zelefsky MJ, Coleman JA, Hricak H, Scardino PT, Abenhaim LL. PMID: 19095127.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    466. Pretreatment predictors of death from other causes in men with prostate cancer. J Urol. 2008 Dec; 180(6):2447-51; discussion 2451-2. Simone NL, Singh AK, Cowan JE, Soule BP, Carroll PR, Litwin MS. PMID: 18930498; PMCID: PMC3013289.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    467. Quality of life in men with locally advanced adenocarcinoma of the prostate: an exploratory analysis using data from the CaPSURE database. J Urol. 2008 Dec; 180(6):2409-13; discussion 2414. White WM, Sadetsky N, Waters WB, Carroll PR, Litwin MS. PMID: 18930270.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    468. Health related quality of life in patients treated with multimodal therapy for prostate cancer. J Urol. 2008 Dec; 180(6):2415-22; discussion 2422. Wu AK, Cooperberg MR, Sadetsky N, Carroll PR. PMID: 18930279.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    469. Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks. Eur Urol. 2009 Jan; 55(1):62-75. Isbarn H, Boccon-Gibod L, Carroll PR, Montorsi F, Schulman C, Smith MR, Sternberg CN, Studer UE. PMID: 18945543; PMCID: PMC3090670.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    470. Impact of radical prostatectomy positive surgical margins on fear of cancer recurrence: results from CaPSURE. Urol Oncol. 2010 May-Jun; 28(3):268-73. Hong YM, Hu JC, Paciorek AT, Knight SJ, Carroll PR. PMID: 18848785.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    471. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol. 2008 Nov; 9(11):1048-57. Ornish D, Lin J, Daubenmier J, Weidner G, Epel E, Kemp C, Magbanua MJ, Marlin R, Yglecias L, Carroll PR, Blackburn EH. PMID: 18799354.
      View in: PubMed   Mentions: 136     Fields:    Translation:HumansCellsCTClinical Trials
    472. An oncogenic role for the multiple endocrine neoplasia type 1 gene in prostate cancer. Prostate Cancer Prostatic Dis. 2009; 12(2):184-91. Paris PL, Sridharan S, Hittelman AB, Kobayashi Y, Perner S, Huang G, Simko J, Carroll P, Rubin MA, Collins C. PMID: 18779856; PMCID: PMC2844124.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    473. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database. J Urol. 2008 Oct; 180(4):1330-4; discussion 1334-5. Barocas DA, Cowan JE, Smith JA, Carroll PR, CaPSURE Investigators. PMID: 18707731.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    474. Clinical events in prostate cancer lifestyle trial: results from two years of follow-up. Urology. 2008 Dec; 72(6):1319-23. Frattaroli J, Weidner G, Dnistrian AM, Kemp C, Daubenmier JJ, Marlin RO, Crutchfield L, Yglecias L, Carroll PR, Ornish D. PMID: 18602144.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    475. Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy. Magn Reson Med. 2008 Jul; 60(1):33-40. Swanson MG, Keshari KR, Tabatabai ZL, Simko JP, Shinohara K, Carroll PR, Zektzer AS, Kurhanewicz J. PMID: 18581409; PMCID: PMC2643975.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    476. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer. 2008 Jul 01; 113(1):78-83. Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. PMID: 18491376.
      View in: PubMed   Mentions: 203     Fields:    Translation:Humans
    477. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci U S A. 2008 Jun 17; 105(24):8369-74. Ornish D, Magbanua MJ, Weidner G, Weinberg V, Kemp C, Green C, Mattie MD, Marlin R, Simko J, Shinohara K, Haqq CM, Carroll PR. PMID: 18559852; PMCID: PMC2430265.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansCells
    478. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer. 2008 Jun 15; 112(12):2664-70. Dall'Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, Meng MV, Kane CJ, Perez N, Master VA, Carroll PR. PMID: 18433013.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansCTClinical Trials
    479. Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004. J Urol. 2008 Jun; 179(6):2131-5. Cooperberg MR, Mallin K, Ritchey J, Villalta JD, Carroll PR, Kane CJ. PMID: 18423754.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    480. Prostate cancer: is inapparent tumor at endorectal MR and MR spectroscopic imaging a favorable prognostic finding in patients who select active surveillance? Radiology. 2008 May; 247(2):444-50. Cabrera AR, Coakley FV, Westphalen AC, Lu Y, Zhao S, Shinohara K, Carroll PR, Kurhanewicz J. PMID: 18430877; PMCID: PMC3705558.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    481. Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE. J Urol. 2008 May; 179(5 Suppl):S14-8. Arredondo SA, Downs TM, Lubeck DP, Pasta DJ, Silva SJ, Wallace KL, Carroll PR. PMID: 18405740.
      View in: PubMed   Mentions: 4     Fields:    
    482. Active surveillance for early-stage prostate cancer: review of the current literature. Cancer. 2008 Apr 15; 112(8):1650-9. Dall'Era MA, Cooperberg MR, Chan JM, Davies BJ, Albertsen PC, Klotz LH, Warlick CA, Holmberg L, Bailey DE, Wallace ME, Kantoff PW, Carroll PR. PMID: 18306379.
      View in: PubMed   Mentions: 103     Fields:    Translation:HumansPHPublic Health
    483. High-risk prostate cancer in the United States, 1990-2007. World J Urol. 2008 Jun; 26(3):211-8. Cooperberg MR, Cowan J, Broering JM, Carroll PR. PMID: 18369637; PMCID: PMC2948572.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    484. Racial differences among boys with testicular germ cell tumors in the United States. J Urol. 2008 May; 179(5):1961-5. Walsh TJ, Davies BJ, Croughan MS, Carroll PR, Turek PJ. PMID: 18355842.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    485. Fear of recurrence, symptom burden, and health-related quality of life in men with prostate cancer. Urology. 2008 Dec; 72(6):1269-73. Bellizzi KM, Latini DM, Cowan JE, DuChane J, Carroll PR. PMID: 18342930.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    486. Sex differences in renal cell cancer presentation and survival: an analysis of the National Cancer Database, 1993-2004. J Urol. 2008 May; 179(5):1709-13; discussion 1713. Woldrich JM, Mallin K, Ritchey J, Carroll PR, Kane CJ. PMID: 18343430.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    487. Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSURE. J Urol. 2008 May; 179(5):1797-803; discussion 1803. Konety BR, Cowan JE, Carroll PR, CaPSURE Investigators. PMID: 18343440.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    488. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor. BJU Int. 2008 Mar; 101(6):691-7. Sadetsky N, Lubeck DP, Pasta DJ, Latini DM, DuChane J, Carroll PR. PMID: 18291018.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    489. Effect of BMI on primary treatment of prostate cancer. Urology. 2008 Aug; 72(2):406-11. Davies BJ, Walsh TJ, Ross PL, Knight SJ, Sadetsky N, Carroll PR, Kane CJ. PMID: 18267336.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    490. A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy. J Urol. 2008 Mar; 179(3):906-10; discussion 910. Choueiri TK, Dreicer R, Paciorek A, Carroll PR, Konety B. PMID: 18207194.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    491. The impact of treatment choice for localized prostate cancer on response to phosphodiesterase inhibitors. J Urol. 2008 Mar; 179(3):1072-6; discussion 1076. Lee IH, Sadetsky N, Carroll PR, Sandler HM. PMID: 18206926.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    492. Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer. 2008 Jan 15; 112(2):307-14. Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR, Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE). PMID: 18050294.
      View in: PubMed   Mentions: 123     Fields:    Translation:Humans
    493. Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol. 2008 Jan; 18(1):71-7. Kurhanewicz J, Vigneron D, Carroll P, Coakley F. PMID: 18090494; PMCID: PMC2804482.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    494. Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortality. Urology. 2008 Jan; 71(1):136-40. Chung CS, Chen MH, Cullen J, McLeod D, Carroll P, D'Amico AV. PMID: 18242382.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    495. Predicting PSA failure following salvage radiotherapy for a rising PSA post-prostatectomy: from the CaPSURE database. Urol Oncol. 2008 May-Jun; 26(3):271-5. Macdonald OK, D'Amico AV, Sadetsky N, Shrieve DC, Carroll PR. PMID: 18452818.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    496. Prostate cancer in the Baby Boomer generation: results from CaPSURE. Urology. 2007 Dec; 70(6):1162-7. Scales CD, Moul JW, Curtis LH, Elkin EP, Hughes ME, Carroll PR, CaPSURE Investigators. PMID: 18158039.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    497. Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging. Radiology. 2008 Jan; 246(1):177-84. Westphalen AC, Coakley FV, Qayyum A, Swanson M, Simko JP, Lu Y, Zhao S, Carroll PR, Yeh BM, Kurhanewicz J. PMID: 18024434.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    498. Prostate biopsy patterns in the CaPSURE database: evolution with time and impact on outcome after prostatectomy. J Urol. 2008 Jan; 179(1):136-40. Shah JB, McKiernan JM, Elkin EP, Carroll PR, Meng MV, CaPSURE Investigators. PMID: 17997437.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    499. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol. 2007 Dec; 178(6):2260-7. Eggener SE, Scardino PT, Carroll PR, Zelefsky MJ, Sartor O, Hricak H, Wheeler TM, Fine SW, Trachtenberg J, Rubin MA, Ohori M, Kuroiwa K, Rossignol M, Abenhaim L, International Task Force on Prostate Cancer and the Focal Lesion Paradigm. PMID: 17936815.
      View in: PubMed   Mentions: 82     Fields:    Translation:Humans
    500. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. J Natl Cancer Inst. 2007 Oct 17; 99(20):1516-24. Tsai HK, D'Amico AV, Sadetsky N, Chen MH, Carroll PR. PMID: 17925537.
      View in: PubMed   Mentions: 165     Fields:    Translation:Humans
    501. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database. Prostate Cancer Prostatic Dis. 2008; 11(3):280-7. Sadetsky N, Elkin EP, Latini DM, DuChane J, Carroll PR, CaPSURE Investigators. PMID: 17893700.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    502. Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of testicular cancer. J Urol. 2007 Oct; 178(4 Pt 1):1440-6; discussion 1446. Walsh TJ, Dall'Era MA, Croughan MS, Carroll PR, Turek PJ. PMID: 17706709.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    503. Prostate-specific antigen level at initiation of hormonal therapy after prostate-specific antigen failure following prostatectomy or radiotherapy and therapeutic response. Urology. 2007 Aug; 70(2):320-3. Alexander BM, Chen MH, Carroll P, D'Amico AV. PMID: 17826497.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    504. Prostate cancer early detection. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2007 Aug; 5(7):714-36. Kawachi MH, Bahnson RR, Barry M, Carroll PR, Carter HB, Catalona WJ, Epstein JI, Etzioni RB, Hemstreet GP, Howe RJ, Kopin JD, Lange PH, Lilja H, Mohler J, Moul J, Nadler RB, Patterson S, Pollack A, Presti JC, Stroup AM, Urban DA, Wake R, Wei JT, National Comprehensive Cancer Network. PMID: 17692177.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    505. Innovations and challenges in prostate cancer: summary statement for the 6th Cambridge Conference. J Urol. 2007 Sep; 178(3 Pt 2):S5-8; quiz S4. Kantoff PW, Beer TM, D'Amico AV, Dipaola RS, Eisenberger MA, Hussain MH, Kelly WK, Mathew P, Morris MJ, Ryan CJ, Sandler HM, Thompson IM, Carroll PR. PMID: 17644118.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    506. Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol. 2007 Sep; 178(3 Pt 2):S14-9. Cooperberg MR, Broering JM, Kantoff PW, Carroll PR. PMID: 17644125; PMCID: PMC2987559.
      View in: PubMed   Mentions: 155     Fields:    Translation:Humans
    507. Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer. Support Care Cancer. 2008 Feb; 16(2):161-9. Hart SL, Latini DM, Cowan JE, Carroll PR, CaPSURE Investigators. PMID: 17638026.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    508. The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance. J Urol. 2007 Sep; 178(3 Pt 1):826-31; discussion 831-2. Latini DM, Hart SL, Knight SJ, Cowan JE, Ross PL, Duchane J, Carroll PR, CaPSURE Investigators. PMID: 17632144.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    509. Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen recurrence from the CaPSURE database. Urology. 2007 Jul; 70(1):106-10. Macdonald OK, D'Amico AV, Sadetsky N, Shrieve DC, Carroll PR. PMID: 17656218.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    510. Initial treatment patterns and outcome of contemporary prostate cancer patients with bone metastases at initial presentation: data from CaPSURE. Cancer. 2007 Jul 01; 110(1):81-6. Ryan CJ, Elkin EP, Cowan J, Carroll PR. PMID: 17516446.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    511. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE. J Urol. 2007 Aug; 178(2):529-34; discussion 534. Elliott SP, Meng MV, Elkin EP, McAninch JW, Duchane J, Carroll PR, CaPSURE Investigators. PMID: 17570425.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansPHPublic Health
    512. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. J Urol. 2007 Aug; 178(2):451-4. David KA, Milowsky MI, Ritchey J, Carroll PR, Nanus DM. PMID: 17561135.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    513. Quality of life in young men after radical prostatectomy. Prostate Cancer Prostatic Dis. 2008; 11(1):67-73. Wright JL, Lin DW, Cowan JE, Carroll PR, Litwin MS, CaPSURE Investigators. PMID: 17519925.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    514. Prostate cancer--more information and more questions. J Urol. 2007 May; 177(5):1607-8. Dall'Era M, Carroll PR. PMID: 17437768.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    515. Education predicts quality of life among men with prostate cancer cared for in the Department of Veterans Affairs: a longitudinal quality of life analysis from CaPSURE. Cancer. 2007 May 01; 109(9):1769-76. Knight SJ, Latini DM, Hart SL, Sadetsky N, Kane CJ, DuChane J, Carroll PR, CaPSURE Investigators. PMID: 17380491.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    516. Recovery of urinary continence following radical prostatectomy: the impact of prostate volume--analysis of data from the CaPSURE Database. J Urol. 2007 Apr; 177(4):1423-5; discussion 1425-6. Konety BR, Sadetsky N, Carroll PR, CaPSURE Investigators. PMID: 17382745.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    517. Prostate brachytherapy: a descriptive analysis from CaPSURE. Brachytherapy. 2007 Apr-Jun; 6(2):123-8. Lee WR, Sharkey J, Cowan JE, DuChane J, Carroll PR, CaPSURE Investigators. PMID: 17434105.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    518. Time to an undetectable prostate-specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer-specific mortality. Cancer. 2007 Apr 01; 109(7):1290-5. D'Amico AV, McLeod DG, Carroll PR, Cullen J, Chen MH. PMID: 17315162.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    519. Bladder cancer incidence and risk factors in men with prostate cancer: results from Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol. 2007 Mar; 177(3):883-7; discussion 887-8. Boorjian S, Cowan JE, Konety BR, DuChane J, Tewari A, Carroll PR, Kane CJ, Cancer of the Prostate Strategic Urologic Research Endeavor Investigators. PMID: 17296367.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    520. Factors affecting outcomes after radical cystectomy in African Americans. Cancer. 2007 Feb 01; 109(3):542-8. Konety BR, Allareddy V, Carroll PR. PMID: 17200961.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    521. Cumulative cost pattern comparison of prostate cancer treatments. Cancer. 2007 Feb 01; 109(3):518-27. Wilson LS, Tesoro R, Elkin EP, Sadetsky N, Broering JM, Latini DM, DuChane J, Mody RR, Carroll PR. PMID: 17186528.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    522. Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE. J Urol. 2007 Feb; 177(2):526-29; discussion 529-30. Berglund RK, Sadetsky N, DuChane J, Carroll PR, Klein EA. PMID: 17222625.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    523. Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging. BJU Int. 2007 Jan; 99(1):41-5. Coakley FV, Chen I, Qayyum A, Westphalen AC, Carroll PR, Hricak H, Chen MH, Kurhanewicz J. PMID: 17227490.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    524. Quality of life for men receiving a second treatment for prostate cancer. J Urol. 2007 Jan; 177(1):273-8; discussion 278-9. Arredondo SA, Latini DM, Sadetsky N, Kawakami J, Pasta DJ, DuChane J, Carroll PR, CaPSURE Investigators. PMID: 17162062.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    525. Relationship of dietary protein and soy isoflavones to serum IGF-1 and IGF binding proteins in the Prostate Cancer Lifestyle Trial. Nutr Cancer. 2007; 58(1):35-42. Dewell A, Weidner G, Sumner MD, Barnard RJ, Marlin RO, Daubenmier JJ, Chi C, Carroll PR, Ornish D. PMID: 17571965.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    526. High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features--initial experience. Radiology. 2007 Feb; 242(2):483-9. Hom JJ, Coakley FV, Simko JP, Lu Y, Qayyum A, Westphalen AC, Schmitt LD, Carroll PR, Kurhanewicz J. PMID: 17179396.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    527. Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE. Urology. 2006 Dec; 68(6):1242-7. Latini DM, Chan JM, Cowan JE, Arredondo SA, Kane CJ, Penson DF, DuChane J, Carroll PR, CaPSURE Investigators. PMID: 17141841.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    528. Recommendations for defining and treating high risk localized prostate cancer. J Urol. 2006 Dec; 176(6 Pt 2):S6-S10; quiz S3-5. Thompson IM, Carroll PR, Carducci MA. PMID: 17084170.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    529. Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer. Cancer. 2006 Dec 01; 107(11):2597-603. Tsai HK, Chen MH, McLeod DG, Carroll PR, Richie JP, D'Amico AV. PMID: 17039498.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    530. Genomic profiling of hormone-naïve lymph node metastases in patients with prostate cancer. Neoplasia. 2006 Dec; 8(12):1083-9. Paris PL, Hofer MD, Albo G, Kuefer R, Gschwend JE, Hautmann RE, Fridyland J, Simko J, Carroll PR, Rubin MA, Collins C. PMID: 17217626; PMCID: PMC1783716.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    531. Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy. Cancer. 2006 Nov 15; 107(10):2384-91. Cooperberg MR, Freedland SJ, Pasta DJ, Elkin EP, Presti JC, Amling CL, Terris MK, Aronson WJ, Kane CJ, Carroll PR. PMID: 17039503.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    532. Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE. J Urol. 2006 Oct; 176(4 Pt 1):1382-6. Kawakami J, Meng MV, Sadetsky N, Latini DM, Duchane J, Carroll PR, CaPSURE Investigators. PMID: 16952638.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    533. Reduced incidence of bony metastasis at initial prostate cancer diagnosis: data from CaPSURE. Urol Oncol. 2006 Sep-Oct; 24(5):396-402. Ryan CJ, Elkin EP, Small EJ, Duchane J, Carroll P. PMID: 16962488.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    534. Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality. Urology. 2006 Aug; 68(2):342-7. Efstathiou JA, Chen MH, Catalona WJ, McLeod DG, Carroll PR, Moul JW, Roehl KA, D'Amico AV. PMID: 16904449.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    535. Impact of increased number of biopsies on the nature of prostate cancer identified. J Urol. 2006 Jul; 176(1):63-8; discussion 69. Meng MV, Elkin EP, DuChane J, Carroll PR. PMID: 16753368.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    536. Laparoscopic versus open cytoreductive nephrectomy in advanced renal-cell carcinoma. J Endourol. 2006 Jul; 20(7):504-8. Eisenberg MS, Meng MV, Master VA, Stoller ML, Rini BI, Carroll PR, Kane CJ. PMID: 16859465.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    537. Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy. Magn Reson Med. 2006 Jun; 55(6):1257-64. Swanson MG, Zektzer AS, Tabatabai ZL, Simko J, Jarso S, Keshari KR, Schmitt L, Carroll PR, Shinohara K, Vigneron DB, Kurhanewicz J. PMID: 16685733.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansCells
    538. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). Cancer. 2006 Apr 15; 106(8):1708-14. Kawakami J, Cowan JE, Elkin EP, Latini DM, DuChane J, Carroll PR, CaPSURE Investigators. PMID: 16544313.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    539. Comorbidity and primary treatment for localized prostate cancer: data from CaPSURE. J Urol. 2006 Apr; 175(4):1326-31. Marr PL, Elkin EP, Arredondo SA, Broering JM, DuChane J, Carroll PR. PMID: 16515991.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    540. Modifying urology residency training: time to speed up or slow down? J Urol. 2006 Mar; 175(3 Pt 1):811-2. Carroll PR. PMID: 16469555.
      View in: PubMed   Mentions: 1     Fields:    
    541. Impact of comorbidity on health-related quality of life in men undergoing radical prostatectomy: data from CaPSURE. Urology. 2006 Mar; 67(3):559-65. Arredondo SA, Elkin EP, Marr PL, Latini DM, DuChane J, Litwin MS, Carroll PR, CaPSURE Investigators. PMID: 16527580.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    542. Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer: data from CaPSURE. Cancer. 2006 Feb 15; 106(4):789-95. Latini DM, Elkin EP, Cooperberg MR, Sadetsky N, Duchane J, Carroll PR. PMID: 16400651.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    543. Elongational flow induced ordering in surfactant micelles and mesophases. J Phys Chem B. 2006 Jan 19; 110(2):1073-82. Penfold J, Staples E, Tucker I, Carroll P, Clayton I, Cowan JS, Lawton G, Amin S, Ferrante A, Ruddock N. PMID: 16471644.
      View in: PubMed   Mentions: 5     Fields:    
    544. Prostate biopsy tumor extent but not location predicts recurrence after radical prostatectomy: results from CaPSURE. J Urol. 2006 Jan; 175(1):125-9; discussion 129. Greene KL, Elkin EP, Karapetian A, Duchane J, Carroll PR, Kane CJ, CaPSURE Investigators. PMID: 16406887.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    545. Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma. Cancer. 2006 Jan 01; 106(1):79-86. Enokida H, Shiina H, Urakami S, Terashima M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Igawa M, Dahiya R. PMID: 16323173.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    546. Prostate cancer: endorectal MR imaging and MR spectroscopic imaging--distinction of true-positive results from chance-detected lesions. Radiology. 2006 Jan; 238(1):192-9. Hom JJ, Coakley FV, Simko JP, Qayyum A, Lu Y, Schmitt L, Carroll PR, Kurhanewicz J. PMID: 16373767.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    547. Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance. Urology. 2006 Jan; 67(1):125-30. Daubenmier JJ, Weidner G, Marlin R, Crutchfield L, Dunn-Emke S, Chi C, Gao B, Carroll P, Ornish D. PMID: 16413347.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansPHPublic Health
    548. Magnetic resonance imaging and spectroscopy of prostate cancer. Rev Urol. 2006; 8 Suppl 1:S4-S10. Carroll PR, Coakley FV, Kurhanewicz J. PMID: 17021625; PMCID: PMC1578527.
      View in: PubMed   Mentions: 17  
    549. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer. Urology. 2005 Dec; 66(6):1223-8. Chan JM, Elkin EP, Silva SJ, Broering JM, Latini DM, Carroll PR. PMID: 16360447.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    550. The changing face of prostate cancer. J Clin Oncol. 2005 Nov 10; 23(32):8146-51. Cooperberg MR, Moul JW, Carroll PR. PMID: 16278465.
      View in: PubMed   Mentions: 99     Fields:    Translation:Humans
    551. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology. 2005 Nov; 66(5):1060-5. Bassett WW, Cooperberg MR, Sadetsky N, Silva S, DuChane J, Pasta DJ, Chan JM, Anast JW, Carroll PR, Kane CJ. PMID: 16286124.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    552. The independent impact of extended pattern biopsy on prostate cancer stage migration. J Urol. 2005 Nov; 174(5):1789-93; discussion 1793. Master VA, Chi T, Simko JP, Weinberg V, Carroll PR. PMID: 16217288.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    553. Androgen deprivation use with external beam radiation for prostate cancer: results from CaPSURE. J Urol. 2005 Nov; 174(5):1802-7. Park S, Meng MV, Elkin EP, Speight JL, DuChane J, Carroll PR. PMID: 16217291.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    554. Who is the average patient presenting with prostate cancer? Urology. 2005 Nov; 66(5 Suppl):76-82. Greene KL, Cowan JE, Cooperberg MR, Meng MV, DuChane J, Carroll PR, Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) Investigators. PMID: 16194711.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    555. Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer. Oncogene. 2005 Oct 13; 24(45):6765-72. Ogishima T, Shiina H, Breault JE, Terashima M, Honda S, Enokida H, Urakami S, Tokizane T, Kawakami T, Ribeiro-Filho LA, Fujime M, Kane CJ, Carroll PR, Igawa M, Dahiya R. PMID: 16007175.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    556. Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res. 2005 Oct 01; 11(19 Pt 1):7012-22. Blaveri E, Brewer JL, Roydasgupta R, Fridlyand J, DeVries S, Koppie T, Pejavar S, Mehta K, Carroll P, Simko JP, Waldman FM. PMID: 16203795.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    557. Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Clin Oncol. 2005 Oct 01; 23(28):6992-8. Zhou P, Chen MH, McLeod D, Carroll PR, Moul JW, D'Amico AV. PMID: 16192586.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    558. Ethnic and racial differences in prostate stromal estrogen receptor alpha. Prostate. 2005 Oct 01; 65(2):101-9. Haqq C, Li R, Khodabakhsh D, Frolov A, Ginzinger D, Thompson T, Wheeler T, Carroll P, Ayala G. PMID: 15880569.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    559. Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure. J Clin Oncol. 2005 Sep 20; 23(27):6556-60. Stewart AJ, Scher HI, Chen MH, McLeod DG, Carroll PR, Moul JW, D'Amico AV. PMID: 16170163.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    560. Multigene methylation analysis for detection and staging of prostate cancer. Clin Cancer Res. 2005 Sep 15; 11(18):6582-8. Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R. PMID: 16166436.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    561. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol. 2005 Sep; 174(3):1065-9; discussion 1069-70. Ornish D, Weidner G, Fair WR, Marlin R, Pettengill EB, Raisin CJ, Dunn-Emke S, Crutchfield L, Jacobs FN, Barnard RJ, Aronson WJ, McCormac P, McKnight DJ, Fein JD, Dnistrian AM, Weinstein J, Ngo TH, Mendell NR, Carroll PR. PMID: 16094059.
      View in: PubMed   Mentions: 132     Fields:    Translation:HumansCellsCTClinical Trials
    562. History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States). Cancer Causes Control. 2005 Sep; 16(7):789-97. Chan JM, Latini DM, Cowan J, Duchane J, Carroll PR. PMID: 16132789.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    563. Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer. Int J Cancer. 2005 Aug 20; 116(2):174-81. Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Pookot D, Li LC, Tabatabai ZL, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R. PMID: 15800905.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    564. Management of isolated renal fossa recurrence following radical nephrectomy. J Urol. 2005 Aug; 174(2):473-7; discussion 477. Master VA, Gottschalk AR, Kane C, Carroll PR. PMID: 16006867.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    565. CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer. Cancer. 2005 Jul 01; 104(1):44-52. Zhao H, Shiina H, Greene KL, Li LC, Tanaka Y, Kishi H, Igawa M, Kane CJ, Carroll P, Dahiya R. PMID: 15895377.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    566. Update on chemotherapy for advanced bladder cancer. J Urol. 2005 Jul; 174(1):14-20. Rosenberg JE, Carroll PR, Small EJ. PMID: 15947569.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    567. Clinical and pathological characteristics of unstageable prostate cancer: analysis of the CaPSURE database. J Urol. 2005 Jul; 174(1):118-20. Langenstroer P, Carroll P, Thrasher JB. PMID: 15947594.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    568. Preliminary evaluation of prostate cancer metastatic risk biomarkers. Int J Biol Markers. 2005 Jul-Sep; 20(3):141-5. Paris PL, Weinberg V, Simko J, Andaya A, Albo G, Rubin MA, Carroll PR, Collins C. PMID: 16247872.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    569. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol. 2005 Jun; 173(6):1938-42. Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Du Chane J, Carroll PR. PMID: 15879786; PMCID: PMC2948569.
      View in: PubMed   Mentions: 270     Fields:    Translation:Humans
    570. Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res. 2005 Jun 01; 11(11):4044-55. Blaveri E, Simko JP, Korkola JE, Brewer JL, Baehner F, Mehta K, Devries S, Koppie T, Pejavar S, Carroll P, Waldman FM. PMID: 15930339.
      View in: PubMed   Mentions: 148     Fields:    Translation:HumansCells
    571. Multidisciplinary management of advanced prostate cancer: changing perspectives on referring patients and enhancing collaboration between oncologists and urologists in clinical trials. Urology. 2005 May; 65(5 Suppl):18-22; discussion 22. Carducci MA, Carroll PR. PMID: 15885275.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    572. Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE). J Urol. 2005 May; 173(5):1557-61. Meng MV, Elkin EP, Latini DM, Duchane J, Carroll PR. PMID: 15821485.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    573. Surrogate end point for prostate cancer specific mortality in patients with nonmetastatic hormone refractory prostate cancer. J Urol. 2005 May; 173(5):1572-6. D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH. PMID: 15821488.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    574. Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE. J Urol. 2005 Apr; 173(4):1126-31. Mitchell JA, Cooperberg MR, Elkin EP, Lubeck DP, Mehta SS, Kane CJ, Carroll PR. PMID: 15758720.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    575. The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE). J Urol. 2005 Apr; 173(4):1132-8. Anast JW, Sadetsky N, Pasta DJ, Bassett WW, Latini D, DuChane J, Chan JM, Cooperberg MR, Carroll PR, Kane CJ. PMID: 15758721.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    576. Early stage prostate cancer--do we have a problem with over-detection, overtreatment or both? J Urol. 2005 Apr; 173(4):1061-2. Carroll PR. PMID: 15758699.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansPHPublic Health
    577. CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells. Int J Cancer. 2005 Mar 20; 114(2):182-9. Retz MM, Sidhu SS, Blaveri E, Kerr SC, Dolganov GM, Lehmann J, Carroll P, Simko J, Waldman FM, Basbaum C. PMID: 15540205.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    578. Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer. Cancer Res. 2005 Mar 15; 65(6):2130-8. Shiina H, Breault JE, Basset WW, Enokida H, Urakami S, Li LC, Okino ST, Deguchi M, Kaneuchi M, Terashima M, Yoneda T, Shigeno K, Carroll PR, Igawa M, Dahiya R. PMID: 15781623.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    579. Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE. J Urol. 2005 Mar; 173(3):732-6. Kane CJ, Bassett WW, Sadetsky N, Silva S, Wallace K, Pasta DJ, Cooperberg MR, Chan JM, Carroll PR. PMID: 15711258.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    580. Lifestyle correlates of health perception and treatment satisfaction in a clinical cohort of men with prostate cancer. Clin Prostate Cancer. 2005 Mar; 3(4):239-45. Sheriff SK, Shohara RA, Dumican SB, Small EJ, Carroll PR, Chan JM. PMID: 15882480.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    581. Demographics, insurance coverage, and utilization of medical services in newly diagnosed prostate cancer: data from caPSURE. Manag Care Interface. 2005 Feb; 18(2):25-30. Sadetsky N, Lubeck DP, Latini DM, Pasta DJ, Kawakami J, DuChane J, Carroll PR, Capsure Investigators. PMID: 15766061.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    582. Epigenetic changes in prostate cancer: implication for diagnosis and treatment. J Natl Cancer Inst. 2005 Jan 19; 97(2):103-15. Li LC, Carroll PR, Dahiya R. PMID: 15657340.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansCells
    583. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 1):557-64. Breault JE, Shiina H, Igawa M, Ribeiro-Filho LA, Deguchi M, Enokida H, Urakami S, Terashima M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R. PMID: 15701841.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    584. Inactivation of the hMSH3 mismatch repair gene in bladder cancer. Biochem Biophys Res Commun. 2004 Dec 17; 325(3):934-42. Kawakami T, Shiina H, Igawa M, Deguchi M, Nakajima K, Ogishima T, Tokizane T, Urakami S, Enokida H, Miura K, Ishii N, Kane CJ, Carroll PR, Dahiya R. PMID: 15541380.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    585. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology. 2004 Dec; 233(3):701-8. Jung JA, Coakley FV, Vigneron DB, Swanson MG, Qayyum A, Weinberg V, Jones KD, Carroll PR, Kurhanewicz J. PMID: 15564406.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    586. Ferromagnetic thermal ablation of locally recurrent prostate cancer: prostate specific antigen results and immediate/intermediate morbidities. J Urol. 2004 Dec; 172(6 Pt 1):2197-202. Master VA, Shinohara K, Carroll PR. PMID: 15538231.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    587. Kidney gene database: a curated and integrated database of genes involved in kidney disease. J Urol. 2004 Dec; 172(6 Pt 1):2344-6. Zhao H, Li LC, Okino ST, Kane CJ, Carroll PR, Dahiya R. PMID: 15538263.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    588. Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy or brachytherapy, with and without neoadjuvant androgen ablation: data from CaPSURE. Int J Radiat Oncol Biol Phys. 2004 Nov 15; 60(4):1066-75. Speight JL, Elkin EP, Pasta DJ, Silva S, Lubeck DP, Carroll PR, Litwin MS. PMID: 15519776.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    589. Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE. J Urol. 2004 Nov; 172(5 Pt 1):1830-4. Arredondo SA, Downs TM, Lubeck DP, Pasta DJ, Silva SJ, Wallace KL, Carroll PR. PMID: 15540732.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    590. The relative impact and future burden of prostate cancer in the United States. J Urol. 2004 Nov; 172(5 Pt 2):S13-6; discussion S17. Chan JM, Jou RM, Carroll PR. PMID: 15535436.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    591. Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment. J Urol. 2004 Nov; 172(5 Pt 2):S3-5. Carroll PR, Chan JM, D'Amico AV, Gelmann EP, Iversen P, Klotz L, Nelson JB, Nelson PS, Nelson WG, Oh WK, Rosen N, Rubin MA, Sandler H, Sellers WR, Smith MR, Xu J, McMann MC, Kantoff PW. PMID: 15535434.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    592. Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy. J Urol. 2004 Nov; 172(5 Pt 2):S42-6; discussion S46-7. D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH. PMID: 15535442.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    593. The impact of patient advocacy: the University of California-San Francisco experience. J Urol. 2004 Nov; 172(5 Pt 2):S58-61; discussion S61-2. Carroll PR, Prostate Cancer Advocates. PMID: 15535445.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    594. Molecular analysis of WFDC1/ps20 gene in prostate cancer. Prostate. 2004 Oct 01; 61(2):192-9. Watson JE, Kamkar S, James K, Kowbel D, Andaya A, Paris PL, Simko J, Carroll P, McAlhany S, Rowley D, Collins C. PMID: 15305342.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    595. Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol. 2004 Oct; 183(4):1079-83. Qayyum A, Coakley FV, Lu Y, Olpin JD, Wu L, Yeh BM, Carroll PR, Kurhanewicz J. PMID: 15385308.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    596. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer. Cancer Res. 2004 Sep 01; 64(17):5956-62. Enokida H, Shiina H, Igawa M, Ogishima T, Kawakami T, Bassett WW, Anast JW, Li LC, Urakami S, Terashima M, Verma M, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R. PMID: 15342374.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    597. Prostate cancer 2004: insights from national disease registries. Oncology (Williston Park). 2004 Sep; 18(10):1239-47; discussion 1248-50, 1256-8. Cooperberg MR, Park S, Carroll PR. PMID: 15526829.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    598. Age-dependent methylation of ESR1 gene in prostate cancer. Biochem Biophys Res Commun. 2004 Aug 20; 321(2):455-61. Li LC, Shiina H, Deguchi M, Zhao H, Okino ST, Kane CJ, Carroll PR, Igawa M, Dahiya R. PMID: 15358197.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    599. Distribution of a single nucleotide polymorphism on codon 211 of the androgen receptor gene and its correlation with human renal cell cancer in Japanese patients. Biochem Biophys Res Commun. 2004 Aug 20; 321(2):468-71. Sasaki M, Nomoto M, Yonezawa S, Nakagawa M, Sakuragi N, Fujimoto S, Carroll PR, Dahiya R. PMID: 15358199.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    600. Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure). J Urol. 2004 Jun; 171(6 Pt 1):2255-9. Greene KL, Meng MV, Elkin EP, Cooperberg MR, Pasta DJ, Kattan MW, Wallace K, Carroll PR. PMID: 15126797.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    601. Patterns of practice in the United States: insights from CaPSURE on prostate cancer management. Curr Urol Rep. 2004 Jun; 5(3):166-72. Cooperberg MR, Broering JM, Latini DM, Litwin MS, Wallace KL, Carroll PR. PMID: 15161564.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    602. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol. 2004 Jun 01; 22(11):2141-9. Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR. PMID: 15169800; PMCID: PMC2997214.
      View in: PubMed   Mentions: 172     Fields:    Translation:Humans
    603. Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum Mol Genet. 2004 Jul 01; 13(13):1303-13. Paris PL, Andaya A, Fridlyand J, Jain AN, Weinberg V, Kowbel D, Brebner JH, Simko J, Watson JE, Volik S, Albertson DG, Pinkel D, Alers JC, van der Kwast TH, Vissers KJ, Schroder FH, Wildhagen MF, Febbo PG, Chinnaiyan AM, Pienta KJ, Carroll PR, Rubin MA, Collins C, van Dekken H. PMID: 15138198.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    604. Mutation of the slow myosin heavy chain rod domain underlies hyaline body myopathy. Neurology. 2004 May 11; 62(9):1518-21. Bohlega S, Abu-Amero SN, Wakil SM, Carroll P, Al-Amr R, Lach B, Al-Sayed Y, Cupler EJ, Meyer BF. PMID: 15136674.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    605. Lifestyle recommendations to prevent prostate cancer, part I: time to redirect our attention? Urol Clin North Am. 2004 May; 31(2):289-300. Moyad MA, Carroll PR. PMID: 15123408.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    606. Lifestyle recommendations to prevent prostate cancer, part II: time to redirect our attention? Urol Clin North Am. 2004 May; 31(2):301-11. Moyad MA, Carroll PR. PMID: 15123409.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    607. Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failure. J Natl Cancer Inst. 2004 Apr 07; 96(7):509-15. D'Amico AV, Moul JW, Carroll PR, Cote K, Sun L, Lubeck D, Renshaw AA, Loffredo M, Chen MH. PMID: 15069112.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    608. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. J Urol. 2004 Apr; 171(4):1393-401. Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, Carroll PR, CaPSURE Investigators. PMID: 15017184.
      View in: PubMed   Mentions: 107     Fields:    Translation:Humans
    609. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis. Prostate. 2004 Apr 01; 59(1):43-58. Strohmeyer DM, Berger AP, Moore DH, Bartsch G, Klocker H, Carroll PR, Loening SA, Jensen RH. PMID: 14991865.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    610. Radical retropubic prostatectomy frustrated by prior laparoscopic mesh herniorrhaphy. Surgery. 2004 Apr; 135(4):452-3; discussion 454. Cooperberg MR, Downs TM, Carroll PR. PMID: 15041971.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    611. Evaluation of the patient with hematuria. Med Clin North Am. 2004 Mar; 88(2):329-43. Yun EJ, Meng MV, Carroll PR. PMID: 15049581.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    612. Treatment and outcome of invasive bladder cancer in patients after renal transplantation. J Urol. 2004 Mar; 171(3):1085-8. Master VA, Meng MV, Grossfeld GD, Koppie TM, Hirose R, Carroll PR. PMID: 14767276.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    613. Laparoscopic partial nephrectomy with temporary arterial occlusion: description of technique and renal functional outcomes. Urology. 2004 Feb; 63(2):241-6. Kane CJ, Mitchell JA, Meng MV, Anast J, Carroll PR, Stoller ML. PMID: 14972462.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    614. Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol. 2004 Feb; 171(2 Pt 1):703-7; discussion 707-8. Hu JC, Elkin EP, Pasta DJ, Lubeck DP, Kattan MW, Carroll PR, Litwin MS. PMID: 14713791.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    615. Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy. Radiology. 2004 Jan; 230(1):215-20. Dhingsa R, Qayyum A, Coakley FV, Lu Y, Jones KD, Swanson MG, Carroll PR, Hricak H, Kurhanewicz J. PMID: 14695396.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    616. Patterns of secondary cancer treatment for biochemical failure following radical prostatectomy: data from CaPSURE. J Urol. 2004 Jan; 171(1):215-9. Mehta SS, Lubeck DP, Sadetsky N, Pasta DJ, Carroll PR. PMID: 14665879.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    617. The polyglycine and polyglutamine repeats in the androgen receptor gene in Japanese and Caucasian populations. Biochem Biophys Res Commun. 2003 Dec 26; 312(4):1244-7. Sasaki M, Kaneuchi M, Sakuragi N, Fujimoto S, Carroll PR, Dahiya R. PMID: 14652007.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    618. Predictors of treatment after initial surveillance in men with prostate cancer: results from CaPSURE. J Urol. 2003 Dec; 170(6 Pt 1):2279-83. Meng MV, Elkin EP, Harlan SR, Mehta SS, Lubeck DP, Carroll PR. PMID: 14634396.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    619. Third international conference on innovations and challenges in prostate cancer: prevention, detection and treatment. J Urol. 2003 Dec; 170(6 Pt 2):S3-5. Carroll PR, Benaron DA, Blackledge G, Coakley FV, D'Amico AV, Higano CS, Iversen P, Kattan M, Nanus DM, Nelson JB, Oh WK, Roach M, Sellers WR, Smith MR, McMann MC, Kantoff PW. PMID: 14610403.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    620. Impact of patient educational level on treatment for patients with prostate cancer: data from CaPSURE. Urology. 2003 Dec; 62(6):1035-9. Kane CJ, Lubeck DP, Knight SJ, Spitalny M, Downs TM, Grossfeld GD, Pasta DJ, Mehta SS, Carroll PR. PMID: 14665350.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    621. The evolving role of androgen deprivation therapy in the management of prostate cancer. Minerva Urol Nefrol. 2003 Dec; 55(4):219-38. Cooperberg MR, Small EJ, D'Amico A, Carroll PR. PMID: 14765015.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    622. Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE). J Urol. 2003 Dec; 170(6 Pt 2):S21-5; discussion S26-7. Cooperberg MR, Lubeck DP, Mehta SS, Carroll PR, CaPSURE. PMID: 14610406.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansPHPublic Health
    623. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE. J Urol. 2003 Nov; 170(5):1822-7. Downs TM, Sadetsky N, Pasta DJ, Grossfeld GD, Kane CJ, Mehta SS, Carroll PR, Lubeck DP. PMID: 14532784.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    624. Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues. Magn Reson Med. 2003 Nov; 50(5):944-54. Swanson MG, Vigneron DB, Tabatabai ZL, Males RG, Schmitt L, Carroll PR, James JK, Hurd RE, Kurhanewicz J. PMID: 14587005.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    625. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE. J Urol. 2003 Nov; 170(5):1804-7. Harlan SR, Cooperberg MR, Elkin E, Lubeck DP, Meng M, Mehta SS, Carroll PR. PMID: 14532780.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    626. Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Natl Cancer Inst. 2003 Sep 17; 95(18):1376-83. D'Amico AV, Moul JW, Carroll PR, Sun L, Lubeck D, Chen MH. PMID: 13130113.
      View in: PubMed   Mentions: 120     Fields:    Translation:Humans
    627. Mouse urogenital development: a practical approach. Differentiation. 2003 Sep; 71(7):402-13. Staack A, Donjacour AA, Brody J, Cunha GR, Carroll P. PMID: 12969333.
      View in: PubMed   Mentions: 62     Fields:    Translation:Animals
    628. Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE. J Urol. 2003 Sep; 170(3):905-8. Cooperberg M, Lubeck DP, Penson D, Mehta SS, Carroll PR, Kane CJ. PMID: 12913727.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    629. Health related quality of life significance of single pad urinary incontinence following radical prostatectomy. J Urol. 2003 Aug; 170(2 Pt 1):512-5. Cooperberg MR, Master VA, Carroll PR. PMID: 12853811.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    630. National practice patterns and time trends in androgen ablation for localized prostate cancer. J Natl Cancer Inst. 2003 Jul 02; 95(13):981-9. Cooperberg MR, Grossfeld GD, Lubeck DP, Carroll PR. PMID: 12837834; PMCID: PMC2994265.
      View in: PubMed   Mentions: 107     Fields:    Translation:Humans
    631. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res. 2003 Jun 01; 63(11):2872-80. Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, DeVries S, Carroll P, Kuo WL, Pinkel D, Albertson D, Cordon-Cardo C, Jain AN, Waldman FM. PMID: 12782593.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    632. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol. 2003 Jun 01; 21(11):2163-72. D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH. PMID: 12775742.
      View in: PubMed   Mentions: 124     Fields:    Translation:Humans
    633. Imaging clinically localized prostate cancer. Urol Clin North Am. 2003 May; 30(2):279-93. Purohit RS, Shinohara K, Meng MV, Carroll PR. PMID: 12735504.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    634. Methyl-CpG-DNA binding proteins in human prostate cancer: expression of CXXC sequence containing MBD1 and repression of MBD2 and MeCP2. Biochem Biophys Res Commun. 2003 Mar 21; 302(4):759-66. Patra SK, Patra A, Zhao H, Carroll P, Dahiya R. PMID: 12646234.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    635. High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays. Am J Pathol. 2003 Mar; 162(3):763-70. Paris PL, Albertson DG, Alers JC, Andaya A, Carroll P, Fridlyand J, Jain AN, Kamkar S, Kowbel D, Krijtenburg PJ, Pinkel D, Schröder FH, Vissers KJ, Watson VJ, Wildhagen MF, Collins C, Van Dekken H. PMID: 12598311; PMCID: PMC1868117.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    636. Quantitation of apoptotic activity following castration in human prostatic tissue in vivo. Prostate. 2003 Feb 15; 54(3):212-9. Staack A, Kassis AP, Olshen A, Wang Y, Wu D, Carroll PR, Grossfeld GD, Cunha GR, Hayward SW. PMID: 12518326.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    637. Fourier transform infrared imaging spectroscopy (FT-IRIS) of mineralization in bisphosphonate-treated oim/oim mice. Calcif Tissue Int. 2003 May; 72(5):604-9. Camacho NP, Carroll P, Raggio CL. PMID: 12574874.
      View in: PubMed   Mentions: 16     Fields:    Translation:Animals
    638. How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE. Urology. 2003 Jan; 61(1):190-6. Cooperberg MR, Koppie TM, Lubeck DP, Ye J, Grossfeld GD, Mehta SS, Carroll PR, CaPSURE. PMID: 12559294.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    639. Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer. J Urol. 2003 Jan; 169(1):157-63. Grossfeld GD, Latini DM, Lubeck DP, Mehta SS, Carroll PR. PMID: 12478126.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    640. Health-related quality of life in men with metastatic prostate cancer: the misleading effect of lead-time bias. BJU Int. 2003 Jan; 91(1):9-13. Litwin MS, Saigal CS, Lubeck DP, Li YP, Henning JM, Carroll PR. PMID: 12614241.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    641. Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy? J Urol. 2002 Dec; 168(6):2510-5. Grossfeld GD, Latini DM, Downs T, Lubeck DP, Mehta SS, Carroll PR. PMID: 12441951.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    642. Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109. J Urol. 2002 Nov; 168(5):2016-9. Powell IJ, Tangen CM, Miller GJ, Lowe BA, Haas G, Carroll PR, Osswald MB, DeVERE WHITE R, Thompson IM, Crawford ED. PMID: 12394698.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    643. Sociodemographic characteristics and health related quality of life in men attending prostate cancer support groups. J Urol. 2002 Nov; 168(5):2092-6. Katz D, Koppie TM, Wu D, Meng MV, Grossfeld GD, Sadesky N, Lubeck DP, Carroll PR. PMID: 12394716.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    644. Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer. Urology. 2002 Sep; 60(3 Suppl 1):1-6. Carroll PR, Kantoff PW, Balk SP, Brown MA, D'amico AV, George DJ, Grossfeld GD, Johnson CS, Kelly WK, Klotz L, Lee WR, Lubeck DP, Mcleod DG, Oh WK, Pollack A, Sartor O, Smith MR, Hart C, Second International Conference on Newer Approaches to Androgen Deprivation Therapy (ADT) in Prostat. PMID: 12231036.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    645. Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer. Urology. 2002 Sep; 60(3 Suppl 1):7-11; discussion 11-2. Meng MV, Grossfeld GD, Sadetsky N, Mehta SS, Lubeck DP, Carroll PR. PMID: 12231037.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    646. Patterns of failure after primary local therapy for prostate cancer and rationale for secondary therapy. Urology. 2002 Sep; 60(3 Suppl 1):57-62; discussion 62-3. Grossfeld GD, Li YP, P Lubeck DP, Carroll PR. PMID: 12231051.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    647. A review of measurement of patient preferences for treatment outcomes after prostate cancer. Urology. 2002 Sep; 60(3 Suppl 1):72-7; discussion 77-8. Lubeck DP, Grossfeld GD, Carroll PR. PMID: 12231054.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    648. Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor. J Urol. 2002 Aug; 168(2):491-5. Cooperberg MR, Lubeck DP, Grossfeld GD, Mehta SS, Carroll PR. PMID: 12131295.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    649. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor. J Urol. 2002 Aug; 168(2):530-5. Grossfeld GD, Li YP, Lubeck DP, Broering JM, Mehta SS, Carroll PR. PMID: 12131303.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    650. Mental health in men treated for early stage prostate carcinoma: a posttreatment, longitudinal quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor. Cancer. 2002 Jul 01; 95(1):54-60. Litwin MS, Lubeck DP, Spitalny GM, Henning JM, Carroll PR. PMID: 12115317.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    651. Origin of urothelial carcinoma after renal transplant determined by fluorescence in situ hybridization. J Urol. 2002 Jun; 167(6):2521-2. Master VA, Meng MV, Koppie TM, Carroll PR, Grossfeld GD. PMID: 11992074.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    652. Utility of intraoperative frozen section analysis of surgical margins in region of neurovascular bundles at radical prostatectomy. Urology. 2002 May; 59(5):709-14. Goharderakhshan RZ, Sudilovsky D, Carroll LA, Grossfeld GD, Marn R, Carroll PR. PMID: 11992845.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    653. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology. 2002 Apr; 223(1):91-7. Coakley FV, Kurhanewicz J, Lu Y, Jones KD, Swanson MG, Chang SD, Carroll PR, Hricak H. PMID: 11930052.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    654. Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE. Urology. 2002 Apr; 59(4):560-5. Grossfeld GD, Latini DM, Lubeck DP, Broering JM, Li YP, Mehta SS, Carroll PR. PMID: 11927314.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    655. How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavor. J Urol. 2002 Apr; 167(4):1653-7; discussion 1657-8. Penson DF, Grossfeld GD, Li YP, Henning JM, Lubeck DP, Carroll PR. PMID: 11912382.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    656. Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression. Urology. 2002 Jan; 59(1):97-102. Grossfeld GD, Carroll PR, Lindeman N, Meng M, Groshen S, Feng AC, Hawes D, Cote RJ. PMID: 11796289.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    657. Health related quality of life differences between black and white men with prostate cancer: data from the cancer of the prostate strategic urologic research endeavor. J Urol. 2001 Dec; 166(6):2281-5. Lubeck DP, Kim H, Grossfeld G, Ray P, Penson DF, Flanders SC, Carroll PR. PMID: 11696752.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    658. Expression of Deltex1 during mouse embryogenesis: comparison with Notch1, 2 and 3 expression. Mech Dev. 2001 Dec; 109(2):399-403. Mitsiadis TA, Gayet O, Zhang N, Carroll P. PMID: 11731257.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    659. Spectroscopy in prostate cancer: hope or hype? Oncology (Williston Park). 2001 Nov; 15(11):1399-410; discussion 1415-6, 1418. Roach M, Kurhanewicz J, Carroll P. PMID: 11758871.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    660. Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases. J Urol. 2001 Oct; 166(4):1322-7. Moul JW, Connelly RR, Lubeck DP, Bauer JJ, Sun L, Flanders SC, Grossfeld GD, Carroll PR. PMID: 11547066.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    661. Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer. Clin Cancer Res. 2001 Sep; 7(9):2712-8. Meng MV, Grossfeld GD, Williams GH, Dilworth S, Stoeber K, Mulley TW, Weinberg V, Carroll PR, Tlsty TD. PMID: 11555583.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    662. Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer. J Urol. 2001 Aug; 166(2):705-9. Li LC, Zhao H, Nakajima K, Oh BR, Ribeiro Filho LA, Carroll P, Dahiya R. PMID: 11458121.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    663. Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy. Urology. 2001 Aug; 58(2 Suppl 1):56-64. Grossfeld GD, Small EJ, Lubeck DP, Latini D, Broering JM, Carroll PR. PMID: 11502450.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    664. Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging. Magn Reson Med. 2001 Jul; 46(1):49-57. Mueller-Lisse UG, Swanson MG, Vigneron DB, Hricak H, Bessette A, Males RG, Wood PJ, Noworolski S, Nelson SJ, Barken I, Carroll PR, Kurhanewicz J. PMID: 11443710.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    665. Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy? J Urol. 2001 Jul; 166(1):111-5. Koppie TM, Grossfeld GD, Nudell DM, Weinberg VK, Carroll PR. PMID: 11435834.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    666. Is it necessary to do staging pelvic lymph node dissection for T1c prostate cancer? Curr Urol Rep. 2001 Jun; 2(3):237-41. Meng MV, Carroll PR. PMID: 12084271.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    667. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. J Urol. 2001 May; 165(5):1409-14. Park S, Shinohara K, Grossfeld GD, Carroll PR. PMID: 11342887.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    668. Serum prostate-specific antigen for prostate cancer early detection: total, free, age- stratified, or complexed? Urology. 2001 Apr; 57(4):591-3. Carroll PR. PMID: 11306354.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    669. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part I: definition, detection, prevalence, and etiology. Urology. 2001 Apr; 57(4):599-603. Grossfeld GD, Litwin MS, Wolf JS, Hricak H, Shuler CL, Agerter DC, Carroll PR. PMID: 11306356.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansPHPublic Health
    670. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology. 2001 Apr; 57(4):604-10. Grossfeld GD, Litwin MS, Wolf JS, Hricak H, Shuler CL, Agerter DC, Carroll PR. PMID: 11306357.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    671. Dietary trial in prostate cancer: Early experience and implications for clinical trial design. Urology. 2001 Apr; 57(4 Suppl 1):200-1. Ornish DM, Lee KL, Fair WR, Pettengill EB, Carroll PR. PMID: 11295627.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    672. Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations. Am Fam Physician. 2001 Mar 15; 63(6):1145-54. Grossfeld GD, Wolf JS, Litwan MS, Hricak H, Shuler CL, Agerter DC, Carroll PR. PMID: 11277551.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    673. Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE database. Urology. 2001 Mar; 57(3):499-503. Penson DF, Schonfeld WH, Flanders SC, Henke CJ, Warolin KL, Carroll PR, Litwin MS. PMID: 11248628.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    674. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database. J Urol. 2001 Mar; 165(3):851-6. Grossfeld GD, Chang JJ, Broering JM, Li YP, Lubeck DP, Flanders SC, Carroll PR. PMID: 11176485.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    675. Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up. Urology. 2001 Feb; 57(2):225-9. Carroll P, Coley C, McLeod D, Schellhammer P, Sweat G, Wasson J, Zietman A, Thompson I. PMID: 11182325.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    676. Prostate-specific antigen best practice policy--part I: early detection and diagnosis of prostate cancer. Urology. 2001 Feb; 57(2):217-24. Carroll P, Coley C, McLeod D, Schellhammer P, Sweat G, Wasson J, Zietman A, Thompson I. PMID: 11182324.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    677. Local therapy for prostate-specific antigen recurrence after definitive treatment. Prostate Cancer Prostatic Dis. 2001; 4(1):20-27. Meng MV, Carroll PR. PMID: 12497059.
      View in: PubMed   Mentions:    Fields:    
    678. When is pelvic lymph node dissection necessary before radical prostatectomy? A decision analysis. J Urol. 2000 Oct; 164(4):1235-40. Meng MV, Carroll PR. PMID: 10992372.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    679. Additional treatments and reimbursement rates associated with prostate cancer treatment for patients undergoing radical prostatectomy, interstitial brachytherapy, and external beam radiotherapy. Urology. 2000 Oct 01; 56(4):622-6. Goharderakhshan RZ, Grossfeld GD, Kassis A, Shinohara K, Roach M, Carroll PR. PMID: 11018618.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    680. Does the completeness of prostate sampling predict outcome for patients undergoing radical prostatectomy?: data from the CAPSURE database. Urology. 2000 Sep 01; 56(3):430-5. Grossfeld GD, Chang JJ, Broering JM, Miller DP, Yu J, Flanders SC, Carroll PR. PMID: 10962308.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    681. Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization. Carcinogenesis. 2000 Sep; 21(9):1721-6. Muscheck M, Abol-Enein H, Chew K, Moore D, Bhargava V, Ghoneim MA, Carroll PR, Waldman FM. PMID: 10964104.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    682. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol. 2000 Aug; 164(2):400-4. Wefer AE, Hricak H, Vigneron DB, Coakley FV, Lu Y, Wefer J, Mueller-Lisse U, Carroll PR, Kurhanewicz J. PMID: 10893595.
      View in: PubMed   Mentions: 89     Fields:    Translation:Humans
    683. Management of a positive surgical margin after radical prostatectomy: decision analysis. J Urol. 2000 Jul; 164(1):93-9; discussion 100. Grossfeld GD, Tigrani VS, Nudell D, Roach M, Weinberg VK, Presti JC, Small EJ, Carroll PR. PMID: 10840431.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    684. Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from The CaPSURE database. Cancer of the Prostate Strategic Urological Research Endeavor. J Urol. 2000 Jul; 164(1):81-8. Koppie TM, Grossfeld GD, Miller D, Yu J, Stier D, Broering JM, Lubeck D, Henning JM, Flanders SC, Carroll PR. PMID: 10840429.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    685. Pretreatment prostate-specific antigen and Gleason score predict the risk of extracapsular extension and the risk of failure following radiotherapy in patients with clinically localized prostate cancer. Semin Urol Oncol. 2000 May; 18(2):108-14. Roach M, Chen A, Song J, Diaz A, Presti J, Carroll P. PMID: 10875450.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    686. Frequent genotype changes at -308, and 488 regions of the tumor necrosis factor-alpha (TNF-alpha) gene in patients with prostate cancer. J Urol. 2000 May; 163(5):1584-7. Oh BR, Sasaki M, Perinchery G, Ryu SB, Park YI, Carroll P, Dahiya R. PMID: 10751892.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    687. Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database. J Urol. 2000 Apr; 163(4):1171-7; quiz 1295. Grossfeld GD, Chang JJ, Broering JM, Miller DP, Yu J, Flanders SC, Henning JM, Stier DM, Carroll PR. PMID: 10737489.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    688. Deletion of Y-chromosome specific genes in human prostate cancer. J Urol. 2000 Apr; 163(4):1339-42. Perinchery G, Sasaki M, Angan A, Kumar V, Carroll P, Dahiya R. PMID: 10737540.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    689. Prostate biopsy: a wealth of information when done and interpreted correctly. J Clin Oncol. 2000 Mar; 18(6):1161-3. Carroll PR. PMID: 10715283.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    690. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res. 2000 Feb 15; 60(4):873-6. Li LC, Chui RM, Sasaki M, Nakajima K, Perinchery G, Au HC, Nojima D, Carroll P, Dahiya R. PMID: 10706097.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCells
    691. Potential role of nephrectomy in the treatment of metastatic renal cell carcinoma: a retrospective analysis. Urology. 2000 Jan; 55(1):36-40. Tigrani VS, Reese DM, Small EJ, Presti JC, Carroll PR. PMID: 10654891.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    692. Imaging for recurrent prostate cancer. Radiol Clin North Am. 2000 Jan; 38(1):213-29. Nudell DM, Wefer AE, Hricak H, Carroll PR. PMID: 10664674.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    693. Is the use of anti-androgen monotherapy appropriate in patients with advanced prostate cancer? J Clin Oncol. 2000 Jan; 18(2):448-50. Roach M, Reese D, Weinberg V, Small EJ, Carroll PR. PMID: 10637263.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    694. An instrument to measure patient satisfaction with healthcare in an observational database: results of a validation study using data from CaPSURE. Am J Manag Care. 2000 Jan; 6(1):70-6. Lubeck DP, Litwin MS, Henning JM, Mathias SD, Bloor L, Carroll PR. PMID: 11009748.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    695. Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns. Urology. 1999 Dec; 54(6):1049-57. Nudell DM, Grossfeld GD, Weinberg VK, Roach M, Carroll PR. PMID: 10604707.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    696. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology. 1999 Nov; 213(2):481-8. Yu KK, Scheidler J, Hricak H, Vigneron DB, Zaloudek CJ, Males RG, Nelson SJ, Carroll PR, Kurhanewicz J. PMID: 10551230.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    697. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. Radiology. 1999 Nov; 213(2):473-80. Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang LR, Zaloudek CJ, Nelson SJ, Carroll PR, Kurhanewicz J. PMID: 10551229.
      View in: PubMed   Mentions: 125     Fields:    Translation:Humans
    698. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 1999 Oct 01; 59(19):5002-11. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR. PMID: 10519415; PMCID: PMC3300837.
      View in: PubMed   Mentions: 636     Fields:    Translation:HumansAnimalsCells
    699. Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol. 1999 Oct; 162(4):1295-300. Overstreet JW, Fuh VL, Gould J, Howards SS, Lieber MM, Hellstrom W, Shapiro S, Carroll P, Corfman RS, Petrou S, Lewis R, Toth P, Shown T, Roy J, Jarow JP, Bonilla J, Jacobsen CA, Wang DZ, Kaufman KD. PMID: 10492183.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    700. The efficacy of cryosurgical ablation of prostate cancer: the University of California, San Francisco experience. J Urol. 1999 Aug; 162(2):427-32. Koppie TM, Shinohara K, Grossfeld GD, Presti JC, Carroll PR. PMID: 10411051.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    701. Single shot intraoperative excretory urography for the immediate evaluation of renal trauma. J Urol. 1999 Apr; 161(4):1088-92. Morey AF, McAninch JW, Tiller BK, Duckett CP, Carroll PR. PMID: 10081844.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    702. Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE. Urology. 1999 Jan; 53(1):180-6. Lubeck DP, Litwin MS, Henning JM, Stoddard ML, Flanders SC, Carroll PR. PMID: 9886609.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    703. Cellular proliferation and cell-cell cycle regulatory proteins as prognostic markers for transitional cell carcinoma of the bladder. Adv Exp Med Biol. 1999; 462:425-35. Grossfeld GD, Muscheck M, Stein JP, Chew K, Cote RJ, Ginsberg DA, Waldman FM, Carroll PR. PMID: 10599445.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    704. Use of imaging tests for staging newly diagnosed prostate cancer: trends from the CaPSURE database. J Urol. 1998 Dec; 160(6 Pt 1):2102-6. Kindrick AV, Grossfeld GD, Stier DM, Flanders SC, Henning JM, Carroll PR. PMID: 9817332.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    705. Evaluation of asymptomatic microscopic hematuria. Urol Clin North Am. 1998 Nov; 25(4):661-76. Grossfeld GD, Carroll PR. PMID: 10026773.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    706. Radiation therapy for the management of biopsy proved local recurrence after radical prostatectomy. J Urol. 1998 Nov; 160(5):1748-53. Rogers R, Grossfeld GD, Roach M, Shinohara K, Presti JC, Carroll PR. PMID: 9783945.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    707. Use of second treatment following definitive local therapy for prostate cancer: data from the caPSURE database. J Urol. 1998 Oct; 160(4):1398-404. Grossfeld GD, Stier DM, Flanders SC, Henning JM, Schonfeld W, Warolin K, Carroll PR. PMID: 9751363.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    708. Prediction of patient outcome after radical prostatectomy by imaging: choice of outcome measure. Acad Radiol. 1998 Sep; 5 Suppl 2:S347-8. Yu KK, Hricak H, Grossfeld GD, Carroll PR. PMID: 9750850.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    709. Genetic alterations in primary bladder cancers and their metastases. Cancer Res. 1998 Aug 15; 58(16):3555-60. Hovey RM, Chu L, Balazs M, DeVries S, Moore D, Sauter G, Carroll PR, Waldman FM. PMID: 9721860.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    710. Epidemiological trends and financial outcomes in radical prostatectomy among Medicare beneficiaries, 1991 to 1993. J Urol. 1998 Aug; 160(2):445-8. Litwin MS, Pasta DJ, Stoddard ML, Henning JM, Carroll PR. PMID: 9679895.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    711. Low frequency epithelial cells in bone marrow aspirates from prostate carcinoma patients are cytogenetically aberrant. Cancer. 1998 Aug 01; 83(3):538-46. Mueller P, Carroll P, Bowers E, Moore D, Cher M, Presti J, Wessman M, Pallavicini MG. PMID: 9690547.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    712. Fertility issues and their management in men with testis cancer. Urol Clin North Am. 1998 Aug; 25(3):517-31. Turek PJ, Lowther DN, Carroll PR. PMID: 9728221.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    713. Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: results of the CaPSURE database. J Urol. 1998 Jun; 159(6):1988-92. Litwin MS, Lubeck DP, Henning JM, Carroll PR. PMID: 9598504.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    714. High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest. 1998 Jun 01; 101(11):2301-8. McCune JM, Loftus R, Schmidt DK, Carroll P, Webster D, Swor-Yim LB, Francis IR, Gross BH, Grant RM. PMID: 9616201; PMCID: PMC508819.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    715. Inconclusive clinical and ultrasound evaluation of the scrotum: impact of magnetic resonance imaging on patient management and cost. Urology. 1998 Jun; 51(6):1018-21. Serra AD, Hricak H, Coakley FV, Kim B, Dudley A, Morey A, Tschumper B, Carroll PR. PMID: 9609643.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    716. Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity. J Urol. 1998 May; 159(5):1437-43. Grossfeld GD, Olumi AF, Connolly JA, Chew K, Gibney J, Bhargava V, Waldman FM, Carroll PR. PMID: 9554329.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    717. Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancer. Prostate Cancer Prostatic Dis. 1998 Mar; 1(3):134-143. Penson DF, Litwin MS, Lubeck DP, Flanders S, Pasta DJ, Carroll PR. PMID: 12496906.
      View in: PubMed   Mentions: 4     Fields:    
    718. Oral bropirimine immunotherapy of bladder carcinoma in situ after prior intravesical bacille Calmette-Guérin. Urology. 1998 Feb; 51(2):226-31. Sarosdy MF, Manyak MJ, Sagalowsky AI, Belldegrun A, Benson MC, Bihrle W, Carroll PR, Ellis WJ, Hudson MA, Sharkey FE. PMID: 9495702.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    719. A novel p53 mutation hotspot at codon 132 (AAG-->AGG) in human renal cancer. Biochem Mol Biol Int. 1998 Feb; 44(2):407-15. Dahiya R, Deng G, Selph C, Carroll P, Presti J. PMID: 9530523.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    720. Continence mechanism of the ileal neobladder in women: a urodynamics study. World J Urol. 1998; 16(6):400-4. Aboseif SR, Borirakchanyavat S, Lue TF, Carroll PR. PMID: 9870288.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    721. Intermittent androgen deprivation for clinically localized prostate cancer: initial experience. Urology. 1998 Jan; 51(1):137-44. Grossfeld GD, Small EJ, Carroll PR. PMID: 9457309.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    722. Cryosurgical ablation of prostate cancer: patterns of cancer recurrence. J Urol. 1997 Dec; 158(6):2206-9; discussion 2209-10. Shinohara K, Rhee B, Presti JC, Carroll PR. PMID: 9366345.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    723. The effect of cryosurgical ablation of the prostate on erectile function. Br J Urol. 1997 Dec; 80(6):918-22. Aboseif S, Shinohara K, Borirakchanyavat S, Deirmenjian J, Carroll PR. PMID: 9439410.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    724. Cryosurgery for locally advanced (T3) prostate cancer. Semin Urol Oncol. 1997 Nov; 15(4):244-9. Connolly JA, Shinohara K, Carroll PR. PMID: 9421452.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    725. Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy. Urology. 1997 Sep; 50(3):373-8. Borirakchanyavat S, Bhargava V, Shinohara K, Toke A, Carroll PR, Presti JC. PMID: 9301700.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    726. Continence mechanism of the isolated female urethra: an anatomical study of the intrapelvic somatic nerves. J Urol. 1997 Sep; 158(3 Pt 1):822-6. Borirakchanyavat S, Aboseif SR, Carroll PR, Tanagho EA, Lue TF. PMID: 9258091.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    727. Accelerated tumor proliferation rates in locally recurrent prostate cancer after radical prostatectomy. J Urol. 1997 Aug; 158(2):515-8. Connolly JA, Presti JC, Cher ML, Chew K, Shinohara K, Carroll PR. PMID: 9224336.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    728. Deletion of chromosome 11p15, p12, q22, q23-24 loci in human prostate cancer. Int J Cancer. 1997 Jul 17; 72(2):283-8. Dahiya R, McCarville J, Lee C, Hu W, Kaur G, Carroll P, Deng G. PMID: 9219834.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    729. Measurement of health-related quality of life in men with prostate cancer: the CaPSURE database. Qual Life Res. 1997 Jul; 6(5):385-92. Lubeck DP, Litwin MS, Henning JM, Carroll PR. PMID: 9290305.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    730. Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization. Genes Chromosomes Cancer. 1997 Jun; 19(2):84-9. Balázs M, Carroll P, Kerschmann R, Sauter G, Waldman FM. PMID: 9171998.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    731. Summary of immunohistologic dissection of the human kidney using monoclonal antibodies (by Neil H. Bander, MD, Carlos Cordon-Cardo, MD, PhD, Connie L. Finstad, PhD, Willet F. Whitmore, Jr, MD, E. Darracott Vaughan, Jr, MD, Herbert F. Oettgen, MD, Myron Melamed, MD, and Lloyd J. Old, MD). 1985. Semin Urol Oncol. 1997 May; 15(2):123-9. Bander NH, Carroll PR, Russo P. PMID: 9134607.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    732. Prostate-specific antigen after cryosurgical ablation of the prostate. Defining the appropriate response. Urol Clin North Am. 1997 May; 24(2):415-20. Connolly JA, Shinohara K, Presti JC, Carroll PR. PMID: 9126239.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    733. A study of reproductive function in patients with seminoma treated with radiotherapy and orchidectomy: (SWOG-8711). Southwest Oncology Group. Int J Radiat Oncol Biol Phys. 1997 Apr 01; 38(1):83-94. Gordon W, Siegmund K, Stanisic TH, McKnight B, Harris IT, Carroll PR, Paradelo JC, Meyers FJ, Chapman RA, Meyskens FL. PMID: 9212008.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    734. Focal therapy for prostate cancer 1996: maximizing outcome. Urology. 1997 Mar; 49(3A Suppl):84-94. Carroll PR, Presti JC, Small E, Roach M. PMID: 9123742.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    735. MR imaging evaluation of renal cell carcinoma. Abdom Imaging. 1997 Mar-Apr; 22(2):216-25. Narumi Y, Hricak H, Presti JC, Forstner R, Sica GT, Kuroda C, Sawai Y, Kotake T, Kinouchi T, Carroll PR. PMID: 9013538.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    736. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of carcinoma of the prostate: ethnic variations. J Urol. 1997 Mar; 157(3):907-11; discussion 911-2. Presti JC, Hovey R, Bhargava V, Carroll PR, Shinohara K. PMID: 9072597.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    737. Endoscopic management of upper tract urothelial tumors. Tech Urol. 1997; 3(3):152-7. Stoller ML, Gentle DL, McDonald MW, Reese JH, Tacker JR, Carroll PR, Best C. PMID: 9422447.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    738. Can hematuria be a predictor as well as a symptom or sign of bladder cancer? Cancer Epidemiol Biomarkers Prev. 1996 Dec; 5(12):993-6. Friedman GD, Carroll PR, Cattolica EV, Hiatt RA. PMID: 8959322.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    739. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology. 1996 Nov; 48(5):773-7. Lubeck DP, Litwin MS, Henning JM, Stier DM, Mazonson P, Fisk R, Carroll PR. PMID: 8911524.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    740. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate. J Urol. 1996 Nov; 156(5):1685-90. Presti JC, Hovey R, Carroll PR, Shinohara K. PMID: 8863571.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    741. Should cryosurgery be considered a therapeutic option in localized prostate cancer? Urol Clin North Am. 1996 Nov; 23(4):623-31. Connolly JA, Shinohara K, Presti JC, Carroll PR. PMID: 8948416.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    742. Prediction of focal extracapsular extension at radical prostatectomy: Relative merit of transrectal ultrasound, endorectal magnetic resonance imaging, prostate specific antigen, prostate specific antigen density, and systematic biopsy. Urol Oncol. 1996 Nov-Dec; 2(6):177-83. Presti JC, Hricak H, Shinohara K, Carroll PR. PMID: 21224166.
      View in: PubMed   Mentions: 1     Fields:    
    743. A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium. Cancer. 1996 Oct 15; 78(8):1775-80. Small EJ, Fippin LJ, Ernest ML, Carroll PR. PMID: 8859191.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    744. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. Urology. 1996 Oct; 48(4):594-9. Parivar F, Hricak H, Shinohara K, Kurhanewicz J, Vigneron DB, Nelson SJ, Carroll PR. PMID: 8886066.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    745. Comparison of systematic sextant and lesion directed biopsies in prostate cancer detection. Urol Oncol. 1996 Sep-Oct; 2(5):136-8. Seltzer MA, Shinohara K, Bhargava V, Carroll PR, Presti JC. PMID: 21224157.
      View in: PubMed   Mentions: 1     Fields:    
    746. Use of prostate-specific antigen (PSA) and PSA density in the detection of stage T1 carcinoma of the prostate. Semin Urol Oncol. 1996 Aug; 14(3):134-8. Presti JC, Carroll PR. PMID: 8865474.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    747. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Radiology. 1996 Aug; 200(2):489-96. Kurhanewicz J, Vigneron DB, Hricak H, Parivar F, Nelson SJ, Shinohara K, Carroll PR. PMID: 8685346.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    748. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res. 1996 Jul 01; 56(13):3091-102. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH. PMID: 8674067.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCells
    749. Bropirimine immunotherapy of upper urinary tract carcinoma in situ. Urology. 1996 Jul; 48(1):28-32. Sarosdy MF, Pisters LL, Carroll PR, Benson MC, Moon TD, Lamm DL, Hudson MA, Lerner SP, Koch MO, Schellhammer PF. PMID: 8693647.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    750. Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results. J Urol. 1996 Jul; 156(1):115-20; discussion 120-1. Shinohara K, Connolly JA, Presti JC, Carroll PR. PMID: 8648771.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    751. Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging. AJR Am J Roentgenol. 1996 May; 166(5):1157-63. Chen M, Hricak H, Kalbhen CL, Kurhanewicz J, Vigneron DB, Weiss JM, Carroll PR. PMID: 8615261.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    752. Cellular proliferative fraction of metastatic lymph nodes predicts survival in stage D1 (TxN+M0) prostate cancer. J Urol. 1996 May; 155(5):1674-7. Cher ML, Stephenson RA, James BC, Carroll PR. PMID: 8627851.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    753. Prostate carcinoma: MR imaging findings after cryosurgery. Radiology. 1996 Mar; 198(3):807-11. Kalbhen CL, Hricak H, Shinohara K, Chen M, Parivar F, Kurhanewicz J, Vigneron DB, Carroll PR. PMID: 8628875.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    754. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Radiology. 1996 Mar; 198(3):795-805. Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll P, Nelson SJ. PMID: 8628874.
      View in: PubMed   Mentions: 131     Fields:    Translation:Humans
    755. Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. Urology. 1996 Feb; 47(2):225-31. Connolly JA, Shinohara K, Presti JC, Carroll PR. PMID: 8607239.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    756. Local staging of prostatic carcinoma: comparison of transrectal sonography and endorectal MR imaging. AJR Am J Roentgenol. 1996 Jan; 166(1):103-8. Presti JC, Hricak H, Narayan PA, Shinohara K, White S, Carroll PR. PMID: 8571856.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    757. Intraoperative electrostimulation of the cavernous nerve: technique, results and limitations. J Urol. 1995 Oct; 154(4):1426-8. Lue TF, Gleason CA, Brock GB, Carroll PR, Tanagho EA. PMID: 7658549.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    758. The significance of prostatic intra-epithelial neoplasia. Br J Urol. 1995 Sep; 76(3):355-9. Aboseif S, Shinohara K, Weidner N, Narayan P, Carroll PR. PMID: 7551846.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    759. Prostate cancer--many treatments but not enough answers. J Urol. 1995 Aug; 154(2 Pt 1):454-5. Carroll PR. PMID: 7609107.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    760. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol. 1995 Jul; 154(1):69-71. Jaeger TM, Weidner N, Chew K, Moore DH, Kerschmann RL, Waldman FM, Carroll PR. PMID: 7539869.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    761. Cost-effectiveness v patient preference in the choice of treatment for distal ureteral calculi: a literature-based decision analysis. J Endourol. 1995 Jun; 9(3):243-8. Wolf JS, Carroll PR, Stoller ML. PMID: 7550267.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    762. High failure rate associated with long-term follow-up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancer. Br J Urol. 1995 Jun; 75(6):771-7. Cher ML, Shinohara K, Breslin S, Vapnek J, Carroll PR. PMID: 7542137.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    763. Anterior bladder neck tube reconstruction at radical prostatectomy preserves functional urethral length--a comparative urodynamic study. Br J Urol. 1995 Jun; 75(6):766-70. Connolly JA, Presti JC, Carroll PR. PMID: 7613835.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    764. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology. 1995 May; 195(2):385-90. White S, Hricak H, Forstner R, Kurhanewicz J, Vigneron DB, Zaloudek CJ, Weiss JM, Narayan P, Carroll PR. PMID: 7724756.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    765. c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization. Am J Pathol. 1995 May; 146(5):1131-9. Sauter G, Carroll P, Moch H, Kallioniemi A, Kerschmann R, Narayan P, Mihatsch MJ, Waldman FM. PMID: 7747807; PMCID: PMC1869279.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    766. Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer. Int J Cancer. 1995 Apr 21; 64(2):99-103. Sauter G, Moch H, Carroll P, Kerschmann R, Mihatsch MJ, Waldman FM. PMID: 7615360.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    767. Cytogenetic findings in a metastatic renal cell carcinoma. Cancer Genet Cytogenet. 1995 Apr; 80(2):168-9. Peier AM, Meloni AM, Sandberg AA, Leong SP, Carroll PR. PMID: 7736440.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    768. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys. 1995 Mar 30; 31(5):1257-80. Marks LB, Carroll PR, Dugan TC, Anscher MS. PMID: 7713787.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansAnimalsPHPublic Health
    769. The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J Urol. 1995 Mar; 153(3 Pt 2):993-9. Wolf JS, Cher M, Dall'era M, Presti JC, Hricak H, Carroll PR. PMID: 7853590.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    770. Screening for prostate cancer. West J Med. 1995 Mar; 162(3):235-42. Cher ML, Carroll PR. PMID: 7536993; PMCID: PMC1022708.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    771. Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression. Prostate. 1995 Feb; 26(2):87-93. Cher ML, Chew K, Rosenau W, Carroll PR. PMID: 7855002.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    772. Blunt renal trauma: renal preservation through careful staging and selective surgery. Semin Urol. 1995 Feb; 13(1):83-9. Nguyen HT, Carroll PR. PMID: 7597358.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    773. Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH). J Urol. 1995 Jan; 153(1):249-54. Cher ML, Ito T, Weidner N, Carroll PR, Jensen RH. PMID: 7966782.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    774. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils. Radiology. 1994 Dec; 193(3):703-9. Hricak H, White S, Vigneron D, Kurhanewicz J, Kosco A, Levin D, Weiss J, Narayan P, Carroll PR. PMID: 7972810.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCTClinical Trials
    775. Primary osteogenic sarcoma of the urinary bladder successfully treated with combination therapy. Urology. 1994 Nov; 44(5):771-4. Phan CN, Wilkinson M, Cohen MB, Dunn S, Carroll P. PMID: 7974956.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    776. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. Radiology. 1994 Oct; 193(1):239-45. Kim B, Semelka RC, Ascher SM, Chalpin DB, Carroll PR, Hricak H. PMID: 8090898.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    777. Laparoscopically implantable nerve-stimulating electrode (LINSE): application to the cavernous nerve in acute and chronic canine models. J Endourol. 1994 Oct; 8(5):375-8. Wolf JS, Brock GB, Gleason CA, Zvara P, Lue TF, Carroll PR. PMID: 7858627.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    778. The Escherichia coli AlkB protein protects human cells against alkylation-induced toxicity. J Bacteriol. 1994 Oct; 176(20):6255-61. Chen BJ, Carroll P, Samson L. PMID: 7928996; PMCID: PMC196966.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    779. Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 1994 Sep 30; 30(2):323-9. Diaz A, Roach M, Marquez C, Coleman L, Pickett B, Wolfe JS, Carroll P, Narayan P. PMID: 7523343.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    780. Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications. J Urol. 1994 Jul; 152(1):120-3. Shinohara K, Wolf JS, Narayan P, Carroll PR. PMID: 7515447.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    781. Laparoscopic urological surgery: differentiating what should be done from what can be done. J Urol. 1994 Jun; 151(6):1603-4. Carroll PR. PMID: 8189573.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    782. A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinoma. Cancer. 1994 Jun 01; 73(11):2803-7. Small EJ, Frye JW, Wilkinson MJ, Carroll PR, Ernest ML, Stagg RJ. PMID: 8194022.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    783. Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer. Int J Cancer. 1994 May 15; 57(4):508-14. Sauter G, Haley J, Chew K, Kerschmann R, Moore D, Carroll P, Moch H, Gudat F, Mihatsch MJ, Waldman F. PMID: 8181854.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    784. Outcome after temporary vascular occlusion for the management of renal trauma. J Urol. 1994 May; 151(5):1171-3. Carroll PR, McAninch JW, Wong A, Wolf JS, Newton C. PMID: 8158752.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    785. Neoadjuvant hormonal therapy and radical prostatectomy for clinical stage C carcinoma of the prostate. Br J Urol. 1994 May; 73(5):544-8. Narayan P, Lowe BA, Carroll PR, Thompson IM. PMID: 8012777.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    786. Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization. Am J Pathol. 1994 Apr; 144(4):756-66. Sauter G, Deng G, Moch H, Kerschmann R, Matsumura K, De Vries S, George T, Fuentes J, Carroll P, Mihatsch MJ, et al. PMID: 8160775; PMCID: PMC1887234.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    787. Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome. Urology. 1994 Mar; 43(3):408-10. Small EJ, Carroll PR. PMID: 7510915.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    788. Screening for prostate cancer. West J Med. 1994 Mar; 160(3):250. Cher ML, Carroll PR. PMID: 7514824; PMCID: PMC1022392.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    789. Watchful waiting for localized prostate cancer. West J Med. 1994 Mar; 160(3):249. Carroll PR. PMID: 8191759; PMCID: PMC1022391.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    790. Nephrectomy for metastatic renal cell carcinoma: a component of systemic treatment regimens. J Surg Oncol. 1994 Jan; 55(1):7-13. Wolf JS, Aronson FR, Small EJ, Carroll PR. PMID: 8289458.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    791. Staging accuracy of magnetic resonance imaging versus transrectal ultrasound in stages A and B prostatic cancer. Urol Int. 1994; 53(4):191-5. Vapnek JM, Hricak H, Shinohara K, Popovich M, Carroll P. PMID: 7855937.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    792. Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1994 Jan 01; 28(1):33-7. Roach M, Marquez C, Yuo HS, Narayan P, Coleman L, Nseyo UO, Navvab Z, Carroll PR. PMID: 7505775.
      View in: PubMed   Mentions: 100     Fields:    Translation:HumansCTClinical Trials
    793. Selection of patients for laparoscopic pelvic lymphadenectomy prior to radical prostatectomy: a decision analysis. Urology. 1993 Dec; 42(6):680-8. Wolf JS, Shinohara K, Kerlikowske KM, Narayan P, Stoller ML, Carroll PR. PMID: 8256401.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    794. Adrenal gland trauma: diagnosis and management. J Trauma. 1993 Dec; 35(6):870-4. Gómez RG, McAninch JW, Carroll PR. PMID: 8263985.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    795. Negative repeat transurethral resection of prostate fails to identify patients with stage A1 prostatic carcinoma at lower risk of progression: a long-term study. Urology. 1993 Nov; 42(5):528-32. Ingerman A, Broderick G, Williams RD, Carroll PR. PMID: 8236594.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    796. Laparoscopic marsupialization of a simple renal cyst. J Urol. 1993 Nov; 150(5 Pt 1):1486-8. Stoller ML, Irby PB, Osman M, Carroll PR. PMID: 8411433.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    797. Rat ciliary neurotrophic factor (CNTF): gene structure and regulation of mRNA levels in glial cell cultures. Glia. 1993 Nov; 9(3):176-87. Carroll P, Sendtner M, Meyer M, Thoenen H. PMID: 8294148.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    798. Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506). Ann Intern Med. 1993 Oct 01; 119(7 Pt 1):595-8. Abu-Elmagd K, Van Thiel DH, Jegasothy BV, Jacobs JC, Carroll P, Rodriquez-Rilo H, Ackerman CD, Fung JJ, Starzl TE. PMID: 7689802; PMCID: PMC3091479.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    799. Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression. Transplant Proc. 1993 Aug; 25(4):2435. Odocha O, McCauley J, Scantlebury V, Shapiro R, Carroll P, Jordan M, Vivas C, Fung JJ, Starzl TE. PMID: 7689269; PMCID: PMC2978522.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    800. Renal gunshot wounds: methods of salvage and reconstruction. J Trauma. 1993 Aug; 35(2):279-83; discussion 283-4. McAninch JW, Carroll PR, Armenakas NA, Lee P. PMID: 8355309.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    801. Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression. Transplant Proc. 1993 Aug; 25(4):2433-4. Odocha O, McCauley J, Scantlebury V, Shapiro R, Carroll P, Jordan M, Vivas C, Fung JJ, Starzl TE. PMID: 7689268; PMCID: PMC2981169.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    802. Combined role of transrectal ultrasonography, Gleason score, and prostate-specific antigen in predicting organ-confined prostate cancer. Urology. 1993 Aug; 42(2):131-7. Wolf JS, Shinohara K, Carroll PR, Narayan P. PMID: 7690168.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    803. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 1993 Aug; 143(2):401-9. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. PMID: 7688183; PMCID: PMC1887042.
      View in: PubMed   Mentions: 372     Fields:    Translation:Humans
    804. Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder. Hum Pathol. 1993 Jul; 24(7):772-8. Cohen MB, Waldman FM, Carroll PR, Kerschmann R, Chew K, Mayall BH. PMID: 8100555.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    805. A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma. Cancer. 1993 Jun 01; 71(11):3601-4. Wilkinson MJ, Frye JW, Small EJ, Venook AP, Carroll PR, Ernest ML, Stagg RJ. PMID: 8490909.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    806. Heterogeneity of erbB-2 gene amplification in bladder cancer. Cancer Res. 1993 May 15; 53(10 Suppl):2199-203. Sauter G, Moch H, Moore D, Carroll P, Kerschmann R, Chew K, Mihatsch MJ, Gudat F, Waldman F. PMID: 8097962.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    807. The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy. J Urol. 1993 May; 149(5):1024-8. Foster LS, Jajodia P, Fournier G, Shinohara K, Carroll P, Narayan P. PMID: 7683341.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    808. Cell proliferation in prostatic adenocarcinoma: in vitro measurement by 5-bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression. J Urol. 1993 Feb; 149(2):403-7. Carroll PR, Waldman FM, Rosenau W, Cohen MB, Vapnek JM, Fong P, Narayan P, Mayall BH. PMID: 8093910.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    809. Fertility and testis cancer. Urol Clin North Am. 1993 Feb; 20(1):173-9. Presti JC, Herr HW, Carroll PR. PMID: 8434435.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    810. 5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder. Mod Pathol. 1993 Jan; 6(1):20-4. Waldman FM, Carroll PR, Cohen MB, Kerschmann R, Chew K, Mayall BH. PMID: 8093979.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    811. Continence after radical cystoprostatectomy and total bladder replacement: a urodynamic analysis. J Urol. 1992 Dec; 148(6):1861-4. Gasparini ME, Hinman F, Presti JC, Schmidt RA, Carroll PR. PMID: 1433621.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    812. Determination of prostate volume with transrectal ultrasound for cancer screening. Part I. Comparison with prostate specific antigen assays. Invest Radiol. 1992 Sep; 27(9):751-3. Hricak H, Carroll P. PMID: 1383174.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    813. Comparison of plicated and stapled continent ileocecal stoma. Urology. 1992 Aug; 40(2):107-9. Carroll PR, Presti JC. PMID: 1502742.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    814. Surgical anatomy of the male and female urethra. Urol Clin North Am. 1992 May; 19(2):339-46. Carroll PR, Dixon CM. PMID: 1574824.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    815. Recent advances in imaging studies for staging of penile and urethral carcinoma. Urol Clin North Am. 1992 May; 19(2):257-66. Vapnek JM, Hricak H, Carroll PR. PMID: 1574816.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    816. Detection and staging of prostatic carcinoma after transurethral resection or open enucleation of the prostate: accuracy of magnetic resonance imaging. J Urol. 1992 Feb; 147(2):402-6. Carroll PR, Sugimura K, Cohen MB, Hricak H. PMID: 1370698.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    817. Magnetic resonance imaging of renal carcinoma with extension into the vena cava: staging accuracy and recent advances. Br J Urol. 1991 Dec; 68(6):571-8. Myneni L, Hricak H, Carroll PR. PMID: 1773285.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    818. Bilateral renal oncocytomas: management and nuclear analysis. J Surg Oncol. 1991 Dec; 48(4):272-6. Wolf JS, Carroll PR. PMID: 1745053.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    819. Bilateral spontaneous renal hemorrhage due to polyarteritis nodosa. West J Med. 1991 Nov; 155(5):527-8. Presti JC, Carroll PR. PMID: 1687716; PMCID: PMC1003079.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    820. Palliative percutaneous and endoscopic urinary diversion for malignant ureteral obstruction. Urology. 1991 Nov; 38(5):408-12. Gasparini M, Carroll P, Stoller M. PMID: 1719688.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    821. Acquired immunodeficiency syndrome-related Kaposi's sarcoma of the male genitalia: management with radiation therapy. J Urol. 1991 Aug; 146(2):333-6. Vapnek JM, Quivey JM, Carroll PR. PMID: 1856928.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    822. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res. 1991 Jul 15; 51(14):3807-13. Waldman FM, Carroll PR, Kerschmann R, Cohen MB, Field FG, Mayall BH. PMID: 1676611.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    823. Renal reconstruction after injury. J Urol. 1991 May; 145(5):932-7. McAninch JW, Carroll PR, Klosterman PW, Dixon CM, Greenblatt MN. PMID: 2016804.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    824. Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses. Radiology. 1991 Mar; 178(3):803-9. Semelka RC, Hricak H, Stevens SK, Finegold R, Tomei E, Carroll PR. PMID: 1994422.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    825. Use of the ileocecal segment for bladder substitution or continent urinary diversion. Urol Int. 1991; 46(3):283-9. Carroll PR, McAninch JW. PMID: 1926643.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    826. Testicular carcinoma in patients positive and at risk for human immunodeficiency virus. J Urol. 1990 Nov; 144(5):1157-9. Wilkinson M, Carroll PR. PMID: 2231890.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    827. [The surgical treatment of renal trauma]. Vestn Khir Im I I Grek. 1990 Nov; 145(11):64-72. McAninch JW, Dixon CM, Carroll PR. PMID: 1966179.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    828. Pyoderma gangrenosum presenting as Fournier's gangrene. J Urol. 1990 Oct; 144(4):984-6. Baskin LS, Dixon C, Stoller ML, Carroll PR. PMID: 2398576.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    829. Necrotising soft tissue infections of the perineum and genitalia. Bacteriology, treatment and risk assessment. Br J Urol. 1990 May; 65(5):524-9. Baskin LS, Carroll PR, Cattolica EV, McAninch JW. PMID: 2354320.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    830. Renovascular trauma: risk assessment, surgical management, and outcome. J Trauma. 1990 May; 30(5):547-52; discussion 553-4. Carroll PR, McAninch JW, Klosterman P, Greenblatt M. PMID: 2342137.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    831. Pathophysiology of urinary incontinence after radical prostatectomy. J Urol. 1990 May; 143(5):975-8. Presti JC, Schmidt RA, Narayan PA, Carroll PR, Tanagho EA. PMID: 2329614.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    832. Functional characteristics of the continent ileocecal urinary reservoir: mechanisms of urinary continence. J Urol. 1989 Oct; 142(4):1032-6. Carroll PR, Presti JC, McAninch JW, Tanagho EA. PMID: 2795726.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    833. Staging of renal trauma. Urol Clin North Am. 1989 May; 16(2):193-201. Carroll PR, McAninch JW. PMID: 2652849.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    834. Renal exploration after trauma. Indications and reconstructive techniques. Urol Clin North Am. 1989 May; 16(2):203-12. McAninch JW, Carroll PR. PMID: 2652850.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    835. Radiographic assessment of renal trauma: a 10-year prospective study of patient selection. J Urol. 1989 May; 141(5):1095-8. Mee SL, McAninch JW, Robinson AL, Auerbach PS, Carroll PR. PMID: 2709493.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    836. Ureteral obstruction caused by vasculitis. J Urol. 1989 Apr; 141(4):933-5. Baskin L, Mee S, Matthay M, Carroll PR. PMID: 2564444.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    837. Early vascular control for renal trauma: a critical review. J Urol. 1989 Apr; 141(4):826-9. Carroll PR, Klosterman P, McAninch JW. PMID: 2926873.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    838. Ureteral and renal pelvic injuries from external trauma: diagnosis and management. J Trauma. 1989 Mar; 29(3):370-4. Presti JC, Carroll PR, McAninch JW. PMID: 2926851.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    839. Treatment of impotence in cancer patients. Important Adv Oncol. 1989; 193-203. Lue TF, Carroll PR, Moore C. PMID: 2651288.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    840. Treatment options for hormone-insensitive or independent prostatic carcinoma. Semin Urol. 1988 Nov; 6(4):322-35. Carroll PR, Narayan P. PMID: 3068770.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    841. Surgical management of renal trauma: analysis of risk factors, technique, and outcome. J Trauma. 1988 Jul; 28(7):1071-7. Carroll PR, Klosterman PW, McAninch JW. PMID: 3398086.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    842. Imaging the testis: comparison between MR imaging and US. Radiology. 1988 Jun; 167(3):631-6. Thurnher S, Hricak H, Carroll PR, Pobiel RS, Filly RA. PMID: 3283834.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    843. Primary signet-ring cell carcinoma of urinary bladder. Urology. 1988 May; 31(5):432-6. Bernstein SA, Reuter VE, Carroll PR, Whitmore WF. PMID: 2834858.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    844. A second DNA methyltransferase repair enzyme in Escherichia coli. Proc Natl Acad Sci U S A. 1988 May; 85(9):3039-43. Rebeck GW, Coons S, Carroll P, Samson L. PMID: 3283737; PMCID: PMC280138.
      View in: PubMed   Mentions: 26     Fields:    Translation:Cells
    845. Detection and staging of renal neoplasms: a reassessment of MR imaging. Radiology. 1988 Mar; 166(3):643-9. Hricak H, Thoeni RF, Carroll PR, Demas BE, Marotti M, Tanagho EA. PMID: 3340757.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    846. Testicular germ cell tumor in patient with Klinefelter syndrome. Urology. 1988 Jan; 31(1):72-4. Carroll PR, Morse MJ, Koduru PP, Chaganti RS. PMID: 3336933.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    847. Fertility status of patients with clinical stage I testis tumors on a surveillance protocol. J Urol. 1987 Jul; 138(1):70-2. Carroll PR, Morse MJ, Whitmore WF, Sogani PC, Klotz L, Herr HW, Fair WR, Feldshuh R, Chaganti RS. PMID: 3599224.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    848. Testicular failure in patients with extragonadal germ cell tumors. Cancer. 1987 Jul 01; 60(1):108-13. Carroll PR, Whitmore WF, Richardson M, Bajorunas D, Herr HW, Williams RD, Fair WR, Chaganti RS. PMID: 3034394.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    849. Abnormalities at chromosome region 3p12-14 characterize clear cell renal carcinoma. Cancer Genet Cytogenet. 1987 Jun; 26(2):253-9. Carroll PR, Murty VV, Reuter V, Jhanwar S, Fair WR, Whitmore WF, Chaganti RS. PMID: 3471307.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    850. Endocrine and exocrine profiles of men with testicular tumors before orchiectomy. J Urol. 1987 Mar; 137(3):420-3. Carroll PR, Whitmore WF, Herr HW, Morse MJ, Sogani PC, Bajorunas D, Fair WR, Chaganti RS. PMID: 3029434.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    851. Necrotizing soft-tissue infections of the perineum and genitalia. Etiology and early reconstruction. West J Med. 1986 Feb; 144(2):174-8. Carroll PR, Cattolica EV, Turzan CW, McAninch JW. PMID: 3953086; PMCID: PMC1306554.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    852. Improved continuous flow transurethral prostatectomy. J Urol. 1985 Jul; 134(1):77-80. Bretan PN, Carroll PR, McClure RD, Williams RD. PMID: 4009829.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    853. Operative indications in penetrating renal trauma. J Trauma. 1985 Jul; 25(7):587-93. Carroll PR, McAninch JW. PMID: 4009764.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    854. Incidental carcinoma of the prostate: significance of staging transurethral resection. J Urol. 1985 May; 133(5):811-4. Carroll PR, Leitner TC, Yen TS, Watson RA, Williams RD. PMID: 3989921.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    855. Penile replantation: current concepts. J Urol. 1985 Feb; 133(2):281-5. Carroll PR, Lue TF, Schmidt RA, Trengrove-Jones G, McAninch JW. PMID: 3968751.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    856. Renal trauma: re-evaluation of the indications for radiographic assessment. J Urol. 1985 Feb; 133(2):183-7. Nicolaisen GS, McAninch JW, Marshall GA, Bluth RF, Carroll PR. PMID: 3968728.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    857. Mitomycin C reused: an in vitro cost-effectiveness study. J Urol. 1984 Sep; 132(3):583-6. Carroll PR, Williams RD, Kim MJ, Dombrovskis S. PMID: 6433045.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    858. Major bladder trauma: mechanisms of injury and a unified method of diagnosis and repair. J Urol. 1984 Aug; 132(2):254-7. Carroll PR, McAninch JW. PMID: 6737572.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    859. Major bladder trauma: the accuracy of cystography. J Urol. 1983 Nov; 130(5):887-8. Carroll PR, McAninch JW. PMID: 6632094.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    860. Microscopic hematuria, left renal mass with renal vein obstruction and elevated serum level of carcinoembryonic antigen in a 56-year-old man. J Urol. 1983 Mar; 129(3):568-73. Carroll PR, Pellegrini C, Hedgcock MW, Stein R, Williams RD. PMID: 6300473.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    861. Renal trauma: kidney preservation through improved vascular control-a refined approach. J Trauma. 1982 Apr; 22(4):285-90. McAninch JW, Carroll PR. PMID: 7077686.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    862. Primary melanoma of the bladder: a case report and review. J Urol. 1980 Feb; 123(2):278-81. Willis AJ, Huang AH, Carroll P. PMID: 7354540.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    863. Primary penile reanastomosis. Urology. 1978 May; 11(5):500-3. Bux R, Carroll P, Berger M, Yarbrough W. PMID: 675907.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    864. SIGMOID SEGMENT FOR BLADDER SUBSTITUTE AFTER TOTAL OR SUBTOTAL CYSTECTOMY. J Urol. 1963 Sep; 90:289-95. BAKER R, CARROLL P, HAYES D. PMID: 14055990.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Peter's Networks
    Concepts (1280)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (184)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.